<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS202387</article-id><article-id pub-id-type="doi">10.1101/2024.12.13.628384</article-id><article-id pub-id-type="archive">PPR959388</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Synchronous 3D patterning of diverse CNS progenitors generates motor neurons of broad axial identity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Buchner</surname><given-names>Felix</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Dokuzluoglu</surname><given-names>Zeynep</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Thomas</surname><given-names>Joshua</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Caldarelli</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kavali</surname><given-names>Shrutika</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rost</surname><given-names>Fabian</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Grass</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodríguez-Muela</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043j0f473</institution-id><institution>German Center for Neurodegenerative Diseases e.V. (DZNE)</institution></institution-wrap>, <city>Dresden</city>, <country country="DE">Germany</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Technische Universität Dresden (TUD)</institution></institution-wrap>, Center for Regenerative Therapies Dresden, <city>Dresden</city>, <country country="DE">Germany</country></aff><aff id="A3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05b8d3w18</institution-id><institution>Max Planck Institute for Molecular Cell Biology and Genetics</institution></institution-wrap>, <city>Dresden</city>, <country country="DE">Germany</country></aff><author-notes><corresp id="CR1">
<label>*</label>Corresponding author: <email>natalia.rodriguez-muela@dzne.de</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>17</day><month>01</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>17</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">In vitro human organoid models have become transformative tools for studying organogenesis, enabling the generation of spinal cord organoids (SCOs) that mimic aspects of spinal cord biology. However, current models do not produce spinal motor neurons (spMNs) with a wide range of axial identities along spinal cord segments within a single structure, limiting their utility in understanding human neural axial specification and the selective vulnerability of spMN subpopulations in motor neuron diseases. Here, we present a novel approach to enhance spMN axial heterogeneity in an advanced SCO model derived from neural stem cells (NSCs) and retinoic acid (RA)-primed neuromesodermal progenitors (NMPs). RA priming guided NMP differentiation into caudal neural progenitors, generating SCOs enriched in spMNs with posterior axial identities. To further diversify spMN populations, we optimized differentiation by synchronously patterning NSCs with RA-primed NMPs. Incorporating an endothelial-like network and skeletal muscle cells enhanced the organoids’ physiological complexity and neural maturation and organoid cell viability. This comprehensive approach, termed CASCO, provides a robust platform to study human spMN specification and model neurodegenerative diseases.</p></abstract><kwd-group><kwd>Axial Heterogeneity</kwd><kwd>Neuromesodermal Progenitors</kwd><kwd>Homeobox Genes</kwd><kwd>Spinal Cord Organoids</kwd><kwd>In vitro Models</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Advancements in 3D in vitro modelling of the human central nervous system hold great promise to help understand human physiology and pathology of the brain and the spinal cord. Following established protocols on human induced pluripotent stem cells (hiPSCs), researchers have successfully constructed region-specific organoids, including those of the retina, hippocampus, thalamus, midbrain, and cerebellum (reviewed in <xref ref-type="bibr" rid="R58">Guy et al. 2021</xref>, <xref ref-type="bibr" rid="R105">Mulder et al. 2023</xref>). Recent progress has also enabled the directed differentiation of stem cells into spinal cord-like organoids (SCOs). However, replicating the molecular diversity of spinal motor neurons (spMNs) found in vivo in a single organoid has not been achieved. spMNs are cholinergic neurons located in the ventral horn of the spinal cord and are responsible for muscle contraction and motor function. Developing such an organoid would be instrumental to dissect the plethora of events orchestrating axial spMN specification during human spinal cord development and the underlying mechanisms of the selective degeneration of specific spMN subpopulations occurring in motor neuron diseases. Several approaches have successfully patterned pluripotent stem cells (PSCs) into 2D neural spinal progenitors and spinal spheroids using chemically defined media containing specific patterning molecules that mimic key spinal cord developmental steps. The first studies used dual SMAD inhibition to block Activin/nodal and BMP signalling pathways of the TGFß superfamily, which generated a high percentage of PAX6<sup>+</sup> NSCs (<xref ref-type="bibr" rid="R24">Chambers et al. 2009</xref>, <xref ref-type="bibr" rid="R148">Surmacz et al. 2012</xref>). These cells were then exposed to retinoic acid (RA) – which induces rostral Homeobox (HOX) gene expression (<xref ref-type="bibr" rid="R74">Kawanishi et al. 2003</xref>, <xref ref-type="bibr" rid="R71">Joksimovic et al. 2005</xref>, <xref ref-type="bibr" rid="R99">Mazzoni et al. 2013</xref>) – and Sonic hedgehog agonists – which direct neural progenitors toward a ventral spinal cord fate (<xref ref-type="bibr" rid="R163">Wicherle et al. 2002</xref>, <xref ref-type="bibr" rid="R144">Stanton et Peng 2010</xref>, <xref ref-type="bibr" rid="R36">Dessaud et al. 2010</xref>, <xref ref-type="bibr" rid="R116">Ogura et al. 2018</xref>) – to imitate developmental signals released from somites (RA) and Floor Plate/notochord (SHH) during neural tube development in vivo (<xref ref-type="bibr" rid="R163">Wichterle et al. 2002</xref>, <xref ref-type="bibr" rid="R101">Meinhardt et al. 2014</xref>, <xref ref-type="bibr" rid="R32">Davis-Dusenbery 2014</xref>). While we and others have applied similar guided differentiation approaches to in vitro modelling of diseases affecting spMNs (<xref ref-type="bibr" rid="R125">Rodriguez Muela et al. 2017</xref>, <xref ref-type="bibr" rid="R126">Rodriguez Muela et al. 2018</xref>, <xref ref-type="bibr" rid="R64">Hor et al 2018</xref>, <xref ref-type="bibr" rid="R13">Baxi et al. 2022</xref>), the existing protocols are limited at generating a wide heterogeneity of spMNs along the rostro-caudal (RC) axis (<xref ref-type="bibr" rid="R18">Buchner et al. 2023</xref>).</p><p id="P3">Neuromesodermal progenitors (NMPs) are a bipotent cell population located in the caudal lateral epiblast zone of the developing embryo. They are crucial for the axial extension of the embryo and secondary neurulation, as they contribute to both neuroectoderm and mesoderm lineages (<xref ref-type="bibr" rid="R136">Shaker et al. 2021</xref>). NMPs are developmentally primed to generate CNS caudal structures, which include the spinal cord and musculoskeletal system (<xref ref-type="bibr" rid="R55">Gouti et al. 2014</xref>; <xref ref-type="bibr" rid="R153">Tsakiridis et al. 2014</xref>, <xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>). It has been recently demonstrated that the establishment of an axial identity occurs before further lineage allocation during spinal cord development (<xref ref-type="bibr" rid="R102">Metzis et al. 2018</xref>) and that key signaling pathways regulate the molecular identity, emergence and function of NMPs, balancing their self-renewal and differentiation capacity (<xref ref-type="bibr" rid="R55">Gouti et al. 2014</xref>). Gradients of WNT, FGFs and GDF11 regulate <italic>HOX</italic> gene expression during body axis elongation during early embryo development (<xref ref-type="bibr" rid="R26">Ciruna et Rossant 2001</xref>; <xref ref-type="bibr" rid="R45">Forlani et al. 2003</xref>, <xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>). Most importantly, these pathways induce the expression of the transcription factor <italic>CDX2</italic> (<xref ref-type="bibr" rid="R114">Nordström et al. 2006</xref>), an upstream regulator of central and posterior <italic>HOX</italic> genes (<xref ref-type="bibr" rid="R75">Keenan et al. 2006</xref>; <xref ref-type="bibr" rid="R52">Gaunt et al. 2004</xref>; <xref ref-type="bibr" rid="R51">Gaunt et al. 2017</xref>; <xref ref-type="bibr" rid="R108">Neijts et al. 2017</xref>) key for axial elongation (<xref ref-type="bibr" rid="R2">Amin et al. 2016</xref>) that is suppressed when stem cells have committed to an anterior neural fate (<xref ref-type="bibr" rid="R114">Nordström et al. 2006</xref>, <xref ref-type="bibr" rid="R102">Metzis et al. 2018</xref>). Similarly, in vivo experiments have demonstrated that GDF11, accumulating in the tailbud region, is indispensable for the correct anatomical formation of the different axial segments of the spinal cord and skeleton (Jurberg et al. 2014), and specifically instructs <italic>HOX8-HOX10</italic> gene expression in the thoracic and lumbar spinal cord, as well as <italic>HOX13</italic> expression in the most caudal region of the tailbud (<xref ref-type="bibr" rid="R88">Liu et al. 2001</xref>; <xref ref-type="bibr" rid="R89">Liu 2006</xref>; <xref ref-type="bibr" rid="R7">Andersson et al. 2006</xref>, <xref ref-type="bibr" rid="R10">Aires et al. 2019</xref>). Furthermore, in vivo, RA has been shown to guide NMPs toward an NSC fate (<xref ref-type="bibr" rid="R55">Gouti et al. 2014</xref>; <xref ref-type="bibr" rid="R136">Shaker et al. 2021</xref>). By modulating the concentration and timing of RA exposure to NMPs in vitro, researchers can guide the regional identity of the developing neurons toward caudal fates, which is crucial for modeling lower spinal cord regions, corresponding to the vertebral levels L1 to S5 (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>; <xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>). The RC axial identity of spMNs is determined by the <italic>HOX</italic> gene expression code (<xref ref-type="bibr" rid="R141">Soshnikova et al. 2013</xref>). <italic>HOX</italic> genes are expressed in a collinear fashion along the RC axis, with their genomic order corresponding to their spatial expression in the developing embryo. This arrangement is critical for establishing the positional identity of spMNs, ensuring that they acquire characteristics appropriate to their location along the spine (<xref ref-type="bibr" rid="R35">Deschamps et al. 2017</xref>). On a molecular level, RA also plays a key role in this process by firstly promoting primary neurogenesis through inducing the expression of proneural genes such as <italic>NEUROD1</italic> (<xref ref-type="bibr" rid="R91">Maden et al. 1996</xref>, <xref ref-type="bibr" rid="R37">Diez del Corral 2003</xref>, <xref ref-type="bibr" rid="R69">Janesick et al. 2015</xref>, <xref ref-type="bibr" rid="R59">Haushalter et al. 2017</xref>) and, secondly, by activating anterior <italic>HOX</italic> genes in the cervical region of the neural tube, targeting specific genomic sites within the <italic>HOX4-5</italic> gene cluster (<xref ref-type="bibr" rid="R92">Mahony et al. 2011</xref>).</p><p id="P4">Several SCO models have used NMPs to produce a variety of cell types that mimic the early stages of spinal cord development, serving as a foundational component to replicate the complex architecture of the human spinal cord (reviewed in <xref ref-type="bibr" rid="R18">Buchner et al. 2023</xref>, Zhou et al. 2024). However, recent in vitro patterning protocols aimed at generating SCOs starting from NMPs often encounter significant challenges. Due to the low amount of RA used in these protocols, these approaches frequently result in a limited number of spMNs, while retaining a high proportion of progenitor cells. Additionally, the use of NMPs as a starting cell population frequently leads to the production of non-neuronal lineages, such as muscle cells, due to the bipotent nature of these cells. According to the knowledge gained through developmental neurobiology studies on model organisms, controlling axial allocation fates should be possible by adjusting the culture time of NMPs in media containing WNT agonist, FGF2/8b and GDF11 before RA stimulation (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>). Early exposure of NPCs or NMPs to this growth factor cocktail advances HOX clock progression towards caudal spMN fate allowing the cells to maintain their established axial identity even after neural differentiation (<xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>; <xref ref-type="bibr" rid="R102">Metzis et al. 2018</xref>, <xref ref-type="bibr" rid="R56">Grass et al. 2024</xref>). A recent study reported the in vitro generation of spMNs across the entire RC axis within embryo-like structures using FISH against <italic>HOX</italic> transcripts as readout; however, this work primarily focused on the morphogenetic processes during the elongation of the model, and the specific anatomical identity of the generated spMNs was not characterized (<xref ref-type="bibr" rid="R57">Gribaudo et al. 2023</xref>).</p><p id="P5">Most organoid platforms to model neuromuscular diseases have a neuroscentric focus and lack the cell lineage diversity found in vivo, such as skeletal muscle cells and a functional vasculature. Without vasculature, organoids struggle with inefficient nutrient delivery and waste removal, leading to necrotic cores and limited size expansion (<xref ref-type="bibr" rid="R21">Cakir et al. 2019</xref>, <xref ref-type="bibr" rid="R18">Buchner et al. 2023</xref>). The contribution of vasculature-derived signalling molecules to developmental neurogenesis, as well as to neuronal maturation and the establishment of functional neural networks is also proven (<xref ref-type="bibr" rid="R158">Vogenstahl et al. 2022</xref>, <xref ref-type="bibr" rid="R166">Wimmer et al. 2019</xref>, <xref ref-type="bibr" rid="R112">Ng et al. 2021</xref>, <xref ref-type="bibr" rid="R21">Cakir et al. 2019</xref>). Similarly, without skeletal muscle cells, spMNs in the organoids lack their physiological target, as well as the mechanical forces and signalling cues provided by the muscle, which are essential for proper tissue function (Faustino-Martins et al. 2021). Incorporating a functional endothelial network and skeletal muscle elements should thus enhance nutrient exchange, support sustained growth and provide the necessary biomechanical environment, thus ultimately improving the physiological relevance of the model for studying human physiology and disease (<xref ref-type="bibr" rid="R96">Matthews et al. 2009</xref>, <xref ref-type="bibr" rid="R67">Iyer et al. 2022</xref>, <xref ref-type="bibr" rid="R147">Sun et al. 2022</xref>).</p><p id="P6">Building on the existing literature on mouse and human spinal cord development, as well as on studies on in vitro spMN differentiation from PSCs, we developed an advanced protocol to generate SCOs composed by spMNs with a balanced RC diversity embedded in a physiologically relevant environment. This new method starts by shortly exposing hiPSC-induced NMPs to RA to prime them to efficiently commit towards the neural lineage. These primed NMPs exhibited a strong bias for neuroectoderm over mesodermal lineage formation and showed high efficiency in differentiating into caudal neural progenitors. Using these neuroectoderm-poised NMPs as starting stem cell source, we designed and screened 12 differentiation protocols to identify the most effective method at generating a diverse array of RC spMN subpopulations. We further optimized this method by subjecting an even mix of NSCs - which, under our culture conditions, commit to anterior regions of the spinal cord- and caudally-primed NMPs as starting stem cell pool to the selected differentiation protocol. To the best of our knowledge, this approach produces SCOs composed of a high abundance of spMNs with the widest axial heterogeneity reported to date. The controlled and synchronous development of functional vasculature-like structures and skeletal muscle cells intertwined with the neural tissue added physiological relevance of this model. Our novel comprehensive axial spinal cord organoid (CASCO) approach for SCO formation sets the stage for more accurate human in vitro modelling of spinal cord development and provides a platform to investigate the selective degeneration of specific spMN subtypes in neuromuscular diseases.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Commonly applied paradigms for hiPSC-derived spMN formation mostly produce neurons with rostral identity</title><p id="P7">Most existing protocols for generating spMNs from hiPSCs are adaptations of the original method established by <xref ref-type="bibr" rid="R163">Wichterle et al. (Cell, 2002)</xref> using mouse embryonic stem cells. This field-standard protocol, which induces the formation of NSCs through dual SMAD inhibition via SB431542 (SB) and LDN193189 (LDN), and relies on an early and extended exposure of high RA concentration to promote ventralization, results predominantly in the formation of rostral spMNs (<xref ref-type="bibr" rid="R163">Wichterle et al. 2002</xref>; <xref ref-type="bibr" rid="R148">Surmacz et al. 2012</xref>; <xref ref-type="bibr" rid="R3">Amoroso et al. 2013</xref>) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Given our objective to develop a procedure capable of specifying spMNs across the entire RC axis, we used this method as a "rostral" benchmark for comparison against our new protocols. Following this protocol, we patterned a healthy hiPSC line (BJ-siPS) into spinal spheroids, which abundantly expressed the spMN progenitor marker OLIG2 and the spMN marker ISL1/2 by day 20 of differentiation (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). As expected, single-cell RNA sequencing showed that these spheres are predominantly composed of rostral spMNs. Six main cell clusters were identified (<xref ref-type="fig" rid="F1">Fig. 1C-D</xref>). The majority of cells expressed pan neuronal markers such as <italic>MAP2, STMN1/2</italic> and <italic>ELAV4</italic> and early spMN development markers, such as <italic>ONECUT2</italic>; only ~5% remained progenitors in a proliferative state, expressing the cell cycle markers <italic>TOP2A</italic>, <italic>MKI67</italic> or <italic>CDK1</italic> (<xref ref-type="fig" rid="F1">Fig. 1C-F</xref>). A subset of cells (10-20%) expressed canonical spMN identity markers, <italic>MNX1(HB9), ISL1</italic> or <italic>CHAT</italic>. 25% of all cells showed a transcriptomic profile compatible with cervical/cranial spMN identity, expressing <italic>MEIS1, ALCAM</italic> and <italic>PHOX2A/B</italic> (<xref ref-type="bibr" rid="R130">Sagner et al 2018</xref>, <xref ref-type="bibr" rid="R131">Sagner et al. 2021</xref>) (<xref ref-type="fig" rid="F1">Fig. 1D-F</xref>), and more than 90% of cells expressed rostral <italic>HOX</italic> genes like <italic>HOXB4</italic> or <italic>HOXA5</italic> (<xref ref-type="fig" rid="F1">Fig. 1D-E, G</xref>). Only 10% of cells adopted a more caudal, brachial-thoracic identity, expressing <italic>HOXC6</italic>, <italic>HOXC8</italic> or <italic>HOXC9</italic>. No cells expressed lumbar <italic>HOXA10</italic> or <italic>HOXC10</italic> genes (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). In summary, this NSC-based protocol is efficient at generating rostral spMNs, but does not enable the formation of spMNs corresponding to lumbar spinal cord segments, which originate from NMPs. Therefore, for our advanced protocol we decided to optimize the initial steps of stem cell patterning and used NMPs as a starting stem cell pool, with the goal of producing a more varied axial spMN diversity.</p></sec><sec id="S4"><title>hiPSC-derived NMPs primed by retinoic acid efficiently generate caudal neuroectoderm</title><p id="P8">We and others have shown that hiPSC-derived NMPs constitute a powerful source to generate neuromuscular organoids (<xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>, <xref ref-type="bibr" rid="R118">Pereira et al. 2021</xref>, <xref ref-type="bibr" rid="R56">Grass et al. 2024</xref>, <xref ref-type="bibr" rid="R50">Gao et al. 2024</xref>). As previously introduced, the molecular identity of NMPs is safeguarded by overlapping morphogen activity, including WNT, FGF and RA signalling. Importantly, loss of RA activity disrupts the cell fate balance in the NMP niche, leading to increased <italic>TBX6</italic><sup>+</sup> mesoderm near the primitive streak, reduced <italic>SOX2</italic> expression in the caudal epiblast and overall impaired neural differentiation (<xref ref-type="bibr" rid="R29">Cunningham et al. 2011</xref>, <xref ref-type="bibr" rid="R28">Cunningham et al. 2015</xref>, <xref ref-type="bibr" rid="R70">Javali et al. 2017</xref>). To generate NMPs poised to commit to a neural lineage, we exposed hiPSCs to WNT agonist CHIRON99021 (CHIR) and FGF2 for 3 days according to previous studies (<xref ref-type="bibr" rid="R55">Gouti et al. 2014</xref>, <xref ref-type="bibr" rid="R28">Cunningham et al. 2015</xref>), then exposed them for 2 hours to RA (<xref ref-type="bibr" rid="R65">Horton et Maden 1995</xref>) and analyzed the samples the next day. We compared these spheres with a separate group generated following the standard NSC-based protocol described above (SB+LDN) (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). This new approach resulted in the efficient generation of spheres composed of SOX2<sup>Low+</sup>:CDX2<sup>+</sup> and PAX6<sup>Low+</sup>:TBXT<sup>+</sup> NMPs, while the spheres generated from the NSC-based protocol were mostly comprised of SOX2<sup>+</sup> and PAX6<sup>+</sup> cells (<xref ref-type="fig" rid="F2">Fig. 2B-C</xref>). Although SOX2 transcript levels were only slightly decreased in the NMP condition relative to SB+LDN cultures, we observed a clear decrease in the number of SOX2<sup>+</sup> cells. NMP-condition cultures also exhibited an increase in the levels of NMP-specific transcripts TBXT, GBX2, NT5E and WNT3A (<xref ref-type="fig" rid="F2">Fig. 2D</xref>), and acquired a different cell morphology (<xref ref-type="fig" rid="F2">Fig. 2E</xref>).</p><p id="P9">The primary challenge when generating SCOs from NMPs as a starting population is to refine the differentiation protocols to effectively steer these progenitor cells toward neural lineage commitment by improving neural progenitor expansion, while minimizing their tendency to differentiate into mesodermal lineages (<xref ref-type="fig" rid="F2">Fig. 2F</xref>). This can be achieved by tuning their exposure to WNT signalling and RA (<xref ref-type="bibr" rid="R28">Cunningham et al. 2015</xref>, <xref ref-type="bibr" rid="R117">Patani et al. 2011</xref>). To evaluate the efficacy of RA in guiding the differentiation trajectory of NMPs towards ventral spinal cord neural lineage, we cultured the spheres for 6 additional days and exposed them to different paradigms: NSC induction (SB+LDN), NMP induction (CHIR+FGF2), NMP induction with RA exposure (CHIR+FGF2+RA) and as a treatment control, NMP induction with RA and RA inhibitor treatment (UVI/AGN) (<xref ref-type="fig" rid="F2">Fig. 2G</xref>). qPCR analysis from the differently cultured spheres revealed a reduced expression of neural progenitor markers (<italic>SOX2</italic>, <italic>PAX6</italic>, <italic>NES</italic>, <italic>NKX6.1</italic>) in the NMP condition (CHIR+FGF2) compared to the NSC spheres (SB+LDN), and highest expression levels in the RA-primed NMPs (CHIR+FGF2+RA) (<xref ref-type="fig" rid="F2">Fig. 2H</xref>). This effect was specific to RA pulse, as evidenced by its reversal with RA inhibitors (CHIR+FGF2+RA+RAi). The NMP condition still showed an increase, yet non-significant, in mesodermal transcripts (<italic>CXCR4</italic>, <italic>TBX6</italic>) that was abolished in the RA primed-NMP condition (<xref ref-type="fig" rid="F2">Fig. 2I</xref>). As expected, the NMP spheres and RA-primed NMP spheres expressed more caudal transcripts (<italic>FGF8</italic>, <italic>HOXC9</italic>, <italic>GDF11</italic>, <italic>CDX2</italic>) than the NSC spheres (<xref ref-type="fig" rid="F2">Fig. 2J</xref>) and, importantly, exposure to RA or RA+RAi did not significantly alter their caudal identity. Moreover, interestingly, <italic>FGF8</italic> levels appeared higher in the CHIR+FGF2+RA+RAi condition compared to RA alone, matching in vivo studies which showed that RA counteracts <italic>FGF8</italic> expression (<xref ref-type="bibr" rid="R81">Kumar et Duester 2014</xref>). Next, we examined the different spheres at day 21 to explore whether the initial neural-bias introduced by the RA pulse on the NMPs was maintained as the progenitors developed and whether this was sufficient to generate caudal neurons. qPCR analysis of <italic>HOX</italic> genes on day 21 spheres revealed a shift from rostral (<italic>HOXA5, HOXA7, HOXC4, HOXC6</italic>) to caudal transcripts (<italic>HOXC9</italic>) in the RA-primed NMP condition compared to the NSC condition (<xref ref-type="fig" rid="F2">Fig. 2K</xref>). No significant difference was observed in any of the neural genes measured (<italic>DCX</italic>, <italic>MAP2</italic>, <italic>TUBB3</italic>, <italic>OLIG2</italic>, <italic>NKX6.1</italic>) (<xref ref-type="fig" rid="F2">Fig. 2K</xref>). Together, these results indicate that priming NMPs with a brief RA pulse to direct their neural lineage commitment is sufficient to generate neurons at levels comparable to NSCs, without interfering with the caudal features of NMPs, and significantly enhances caudal HOX gene expression.</p></sec><sec id="S5"><title>Neuro-committed RA-primed NMPs generate thoracic and lumbar spMNs independently of the patterning approach followed</title><p id="P10">During early development, the mammalian embryo undergoes axial extension, with axial progenitors continuously proliferating and undergoing neural induction due to RA diffusing from the somites (<xref ref-type="bibr" rid="R35">Deschamps et al. 2017</xref>, <xref ref-type="bibr" rid="R136">Shaker et al. 2021</xref>). The timing of neural induction and caudalization of the tail bud region is closely interconnected, as the extension of the body axis through NMP proliferation during embryogenesis coincides with the secretion of neuronal fate-inducing molecules from the surrounding tissues, such as the notochord and presomitic mesoderm (<xref ref-type="bibr" rid="R2">Amin et al. 2016</xref>). However, it is unclear when NMPs need to be exposed to proliferative, neural inductive and caudalizing signals in vitro to expand their potential to efficiently generate caudal spMNs. To shed light on this problem, we designed an approach to systematically test 11 different differentiation protocols, divided into three modules (<xref ref-type="fig" rid="F3">Fig. 3A</xref>, <xref ref-type="supplementary-material" rid="SD1">S1A and Supplemental table 1</xref>): Module 1, simultaneous neuroprogenitor expansion/caudalization and neuroectoderm induction; Module 2, neuroectoderm induction followed by neuroprogenitor expansion/caudalization and Module 3, neuroprogenitor expansion/caudalization prior to neuroectoderm induction. A key difference between these protocols is when the neuroectoderm induction phase using SB+LDN (<xref ref-type="bibr" rid="R24">Chambers et al. 2009</xref>) is applied, either during, before or after caudalization signals, respectively. Patterning protocol #1 was used as control in which RA-primed NMPs were subjected to the field-standard spMN differentiation protocol (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), while patterning protocols #2 to #12 were tested to develop an improved method to effectively generate spMNs with a more diverse RC identity (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). For this purpose, we conducted a comparative assessment of neural, spMN and <italic>HOX</italic> expression levels at multiple time points corresponding to different stages of SCO development (<xref ref-type="fig" rid="F3">Fig. 3B</xref>).</p><p id="P11">Gene expression analysis from day 9 spheres showed that exposing the hiPSC-induced NMPs to CHIR+FGF2 for longer than the commonly applied 72h (<xref ref-type="bibr" rid="R55">Gouti et al. 2014</xref>, <xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>, <xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>, <xref ref-type="bibr" rid="R56">Grass et al. 2024</xref>), resulted in higher levels of the caudal gene <italic>FGF8</italic> than when the NMPs were switched to neural induction signals earlier (protocols #2-12 vs protocol #1) (<xref ref-type="supplementary-material" rid="SD1">Fig. S1B</xref>). This increase in caudal specification did not compromise their neural differentiation potential, as <italic>SOX2</italic> and <italic>NES</italic> levels did not significantly change when compared to the standard protocol (#1), except for condition #5 (<xref ref-type="supplementary-material" rid="SD1">Fig. S1 C-D</xref>). The rostro-to-caudal shift observed in the new protocols was further validated in day 21 SCOs, where the expression of the rostral <italic>HOX5</italic> was markedly decreased compared to protocol #1, and the expression of more caudal <italic>HOXs</italic> (<italic>HOXA10</italic>, <italic>HOXC10</italic>) was significantly increased (<xref ref-type="supplementary-material" rid="SD1">Fig. S1E</xref>). In addition, SCOs generated through the new protocols showed an enhanced maturation profile, as 3 fold higher levels of <italic>ISL1</italic> (mature spMN marker) and up to 4 fold lower levels of <italic>MNX1</italic> (immature spMNs), 2-3 fold reduction of <italic>OLIG2</italic> expression (pMNs), <italic>NKX6.1</italic> (ventral spinal cord domain progenitors) or <italic>DCX</italic> (newly differentiated neurons) indicated (<xref ref-type="supplementary-material" rid="SD1">Fig. S1 F</xref>). Immunostaining analysis validated the increased presence of caudal HOX<sup>+</sup> cells in detriment of rostral ones (<xref ref-type="supplementary-material" rid="SD1">Fig. S1</xref> GI) in the new protocols compared to the standard #1. No clear difference in the number of OLIG2<sup>+</sup> progenitors or NeuN<sup>+</sup> neurons was detected across the protocols (<xref ref-type="supplementary-material" rid="SD1">Fig. S1 J-L</xref>), and interestingly, protocol #3 showed a 50% increase in the number of ISL1<sup>+</sup> spMN (<xref ref-type="supplementary-material" rid="SD1">Fig. S1 M</xref>).</p><p id="P12">While all the new patterning protocols showed a higher caudalization potential than the standard one, no other major differences among them were detected. Thus, we selected one paradigm from each of the modules (#3, #7, and #10) to perform a longitudinal transcriptomic analysis along the SCO development in comparison to the standard protocol (#1) and test whether the new methods accurately recapitulated the temporal sequence of in vivo developmental processes (<xref ref-type="bibr" rid="R131">Sagner et al 2021</xref>). In all conditions, transcript levels of early neural development (<italic>SOX2</italic>, <italic>PAX6</italic>) appropriately decreased as development progressed (<xref ref-type="supplementary-material" rid="SD1">Fig. S2 A-B</xref>), while markers of more advanced stages during spinal cord development (<italic>NKX6.1</italic> and <italic>SYN1</italic>) showed an expected simultaneous increase (<xref ref-type="supplementary-material" rid="SD1">Fig. S2 C-D</xref>). Interestingly, SCOs generated from the novel protocols showed a more rapid decline in <italic>OLIG2</italic> levels from day 9 to day 21, suggesting a faster progression away from progenitor states and towards more differentiated neural fates (<xref ref-type="supplementary-material" rid="SD1">Fig. S2E</xref>). Furthermore, while analogous levels of the mature spMN marker <italic>CHAT</italic> were detected throughout SCO development across the three selected protocols, and similar to the standard protocol #1, spMN <italic>ISL1</italic> transcript levels at day 21 were significantly elevated in protocols #3 and #7 (<xref ref-type="fig" rid="F3">Fig. 3C-D</xref>). This increase in <italic>ISL1</italic> expression points again to enhanced spMN formation under these conditions, in alignment with our qPCR and immunostaining results from the 12 protocol screen study (<xref ref-type="supplementary-material" rid="SD1">Fig. S2F-G</xref>). qPCR-analysis of RC <italic>HOX</italic> expression showed a marked decrease of rostral <italic>HOXA5</italic> transcript for the three new protocols compared to standard #1, no significant changes for the thoracic <italic>HOXA7</italic>, <italic>HOXC8</italic> or <italic>HOXC9</italic> and a marked increase in lumbar <italic>HOXA10</italic> and <italic>HOXC10</italic> transcripts, especially for protocols #3 and 7 (<xref ref-type="fig" rid="F3">Fig. 3E</xref>). To validate our gene expression data, we next carried out extensive immunostaining analysis of day 21 SCOs generated through the three selected protocols. As expected with the addition of extended NMP maintenance state, the novel protocol paradigms induced an axial identity shift in the SCOs. Compared to the SCOs generated following protocol #1, the new SCOs showed 10-15% less HOXA5<sup>+</sup> cervical cells (<xref ref-type="fig" rid="F3">Fig. 3F, H</xref>) and a 20% less thoracic HOXC9<sup>+</sup> cells (<xref ref-type="fig" rid="F3">Fig. 3F, G</xref>). Conversely, ~30% increase of lumbar cells with nuclear HOXC10<sup>+</sup> was found for the selected new protocols, and significantly for protocol #3 (<xref ref-type="fig" rid="F3">Fig. 3G, J</xref>). No differences in the number of cells positive for the ventral domain marker NKX6.1 were detected in immunostaining (<xref ref-type="fig" rid="F3">Fig. 3G, K</xref>), albeit we noticed significant differences in <italic>NKX6.1</italic> gene expression (<xref ref-type="supplementary-material" rid="SD1">Fig. S2C</xref>). In addition, protocol #3 again showed a significant increase in the percentage of ISL1<sup>+</sup> spMNs compared to other protocols (<xref ref-type="fig" rid="F3">Fig. 3F, G, L, P, Q</xref>). To deepen our analysis of spMN axial identity in the SCOs generated by the selected new protocols, we quantified the percentage of ISL1<sup>+</sup> spMNs with rostral, thoracic or lumbar HOX identity. The new protocols resulted in a drastic decrease in ISL1<sup>+</sup>;HOXA5<sup>+</sup>;HOXC9<sup>-</sup> cervical spMNs (<xref ref-type="fig" rid="F3">Fig. 3M</xref>), and a mild decrease in ISL1<sup>+</sup>;HOXA5<sup>+</sup>;HOXC9<sup>+</sup> thoracic spMNs (<xref ref-type="fig" rid="F3">Fig. 3N</xref>), accompanied by a moderate increase in ISL1<sup>+</sup>;HOXC10<sup>+</sup> lumbar spMNs (<xref ref-type="fig" rid="F3">Fig. 3O</xref>).</p><p id="P13">Lastly, to further validate the efficiency of our new protocols at producing spMNs, we generated a reporter hiPSC line where the green fluorescent protein mNeonGreen (mNG) was knocked-in downstream of the endogenous <italic>ISL1</italic> locus (<xref ref-type="supplementary-material" rid="SD1">Fig. S2H-I</xref>). Using this reporter line, we live-tracked spMN differentiation during the maturation of SCOs generated according to the 12 protocols. Using this approach, the enhanced generation of spMNs by the new protocols compared to the standard protocol #1 was particularly evident for protocol #3 (<xref ref-type="fig" rid="F3">Fig. 3P-Q</xref> and <xref ref-type="supplementary-material" rid="SD1">S2J</xref>). In summary, SCOs generated using our new experimental differentiation modules exhibited greater spMN RC diversity without reducing overall spMN specification, compared to the commonly used NSC-based differentiation condition #1 that primarily yields spMNs with a rostral identity. Overall, protocol #3 consistently produced the highest quantity of ISL1<sup>+</sup> spMNs, as confirmed by qRT-PCR, immunostaining and live imaging. This protocol also showed a shift from cervical to lumbar <italic>HOX</italic> gene expression compared to the standard protocol. Together, we conclude that RA-primed NMPs, when subjected to differentiation protocol #3, efficiently generate spMNs with a broader RC molecular identity than the standard method. However, this protocol generated only ~2.5% of rostral spMNs (HOXA5+:HOXC9-:ISL1+). This highlights the need to achieve a balanced axial heterogeneity of spMNs within the same organoid by means other than modifying the patterning protocol.</p></sec><sec id="S6"><title>Pre-mixed NSCs/RA-primed NMPs generate SCOs comprised of progenitors with rostral and caudal neural identities</title><p id="P14">While the commonly used NSC-based SCO protocols primarily produce hindbrain and cervical spMNs (&gt;80%), our selected protocol paradigm #3, starting from RA-primed NMPs yielded an overall increased spMN population with predominantly thoracic and lumbar identities. Although this new protocol does not completely halt the specification of rostral spMNs, our aim was to develop an improved approach able to generate a balanced RC spMN diversity for a more physiologically relevant in vitro model to study spinal cord development and disease conditions. To achieve a greater axial heterogeneity within a single organoid, we therefore explored whether using a premix pool of RA-primed NMPs and NSCs as a starting stem cell population, rather than only RA-primed NMPs, would achieve that goal (<xref ref-type="fig" rid="F4">Fig. 4A</xref>). As different predisposition to differentiate into rostral or caudal fates between different hiPSC lines has been reported (<xref ref-type="bibr" rid="R78">Kim et al. 2024</xref>), we generated NSCs and RA-primed NMPs under adherent conditions from multiple healthy lines (BJ-siPS, 1016A, KOLFC1, 18A, CRTD1) and then used them in an even mixture to generate stem cell aggregates. Our adherently generated NSCs were clearly immunoreactive for panneuronal SOX1 and the stem cell marker REST (<xref ref-type="bibr" rid="R79">Kojima et al. 2001</xref>, <xref ref-type="bibr" rid="R66">Hwang et Zukin 2018</xref>), whereas NMPs were positive for caudal CDX2 and REST (<xref ref-type="supplementary-material" rid="SD1">Fig. S3A</xref>). As control conditions for our SCO patterning, either only RA-primed NMPs or only NSCs were used as starting stem cell populations. We characterized the resulting SCOs by longitudinally evaluating the expression of key genes governing spinal cord development and spMN specification during the SCO development by immunostaining and qRT-PCR. Notably, "NSC-NMP Mix" aggregates assembled robustly and uniformly (<xref ref-type="fig" rid="F4">Fig. 4B</xref>) and, at day 0, showed immunoreactivity for approximately equal levels of the mesodermalal lineage marker TBXT and the neural lineage marker PAX6, with a slightly lower amount of SOX2<sup>+</sup> NSCs (<xref ref-type="supplementary-material" rid="SD1">Fig. S3B-C</xref>). In contrast, NMP spheres showed TBXT, SOX2 and CDX2 expression without PAX6, while NSC spheres showed SOX2, PAX6 and neural NEUROD1 expression without TBXT or CDX2 (<xref ref-type="supplementary-material" rid="SD1">Fig. S3B-C</xref>). The NMP spheres also showed highest expression of other caudal progenitor and NMP marker genes, such as <italic>NT5E</italic> and <italic>HOXC9</italic> (<xref ref-type="supplementary-material" rid="SD1">Fig. S3D</xref>). We observed that in the mixed SCOs, both progenitor cell populations segregated into SOX2<sup>+</sup>:CDX2<sup>-</sup> and SOX2<sup>-</sup>:CDX2<sup>+</sup> areas (<xref ref-type="fig" rid="F4">Fig. 4C</xref>).</p><p id="P15">Next, we investigated whether the SCOs generated from a NSC:RA-primed NMP mixture and subjected to our new differentiation protocol #3 matured normally according to the embryonic development of the spinal cord (<xref ref-type="bibr" rid="R129">Sagner et al 2019</xref>). As expected, the number of NSCs (SOX2<sup>+</sup>, PAX6<sup>+</sup>) and NPCs (NGN2<sup>+</sup>, NKX2.2<sup>+</sup>) decreased from 70% to 30% from day 3 to day 15 (<xref ref-type="fig" rid="F4">Fig. 4D-J</xref>), similarly to the number of spMN progenitors (OLIG2<sup>+</sup>) (<xref ref-type="fig" rid="F4">Fig. 4F, K</xref>). We also observed that the number of PAX6<sup>+</sup>;HOXA10<sup>+</sup> caudal progenitors and the total number of HOXA10+ cells decreased as the SCOs developed (<xref ref-type="fig" rid="F4">Fig. 4E, L and 4E, M</xref>, respectively).</p><p id="P16">We next examined the emergence of spMN specific markers. Consistent with the literature, as the ventral progenitors in the SCOs acquired a spMN identity, the number of cells showing a nuclear HB9 staining, indicative of early-born spMNs (<xref ref-type="bibr" rid="R86">Letchuman et al. 2022</xref>), increased from day 3 to day 9-15 (<xref ref-type="fig" rid="F4">Fig. 4N-O</xref>). The quantification of the number of LHX3<sup>+</sup> cells, a transcription factor that together with ISL1 mediates the expression of genes critical for medial motor column spMN specification and maturation (<xref ref-type="bibr" rid="R43">Erb et al. 2017</xref>; <xref ref-type="bibr" rid="R139">Smith et al. 2020</xref>) increased from day 3 to day 9 (<xref ref-type="fig" rid="F4">Fig. 4N, P</xref>), as well as the number of ISL1/2<sup>+</sup> spMNs (<xref ref-type="fig" rid="F4">Fig. 4N, Q</xref>), indicating the differentiation of ventral progenitors into specific spMN subtypes. We validated our immunostaining-based results via longitudinal expression analysis. As expected, the developmental gene expression patterns from day 0 to day 42 SCOs generally matched our cell counts. <italic>SOX2</italic> peaked at day 3 and sharply declined thereafter (<xref ref-type="fig" rid="F4">Fig. 4R</xref>) and the early spMN marker HB9 was highest at day 3 (<xref ref-type="fig" rid="F4">Fig. 4S</xref>). It is important to note that HB9 is expressed in late, differentiating NMPs, as well as in immature spMNs, which could explain the 30 fold increase in expression from day 0 to day 3 (<xref ref-type="bibr" rid="R156">Verrier et al. 2018</xref>). Moreover, the expression of more mature neuronal markers <italic>MAP2</italic>, <italic>ISL1</italic> and <italic>CHAT</italic> gradually increased, reaching a plateau past day 21 (<xref ref-type="fig" rid="F4">Fig. 4T-V</xref>). All these results were recapitulated using two additional healthy hiPSC lines (<xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>). Overall, these results demonstrate that SCOs generated using an even mix of NSCs/RA-primed NMPs and subjected to the protocol #3 fairly recapitulate in vivo spinal cord developmental differentiation processes (<xref ref-type="bibr" rid="R130">Sagner et al. 2018</xref>, <xref ref-type="bibr" rid="R129">Sagner et al. 2019</xref>).</p></sec><sec id="S7"><title>Mature SCOs derived from the mixed stem cell pool are composed by a balanced axial spMNs diversity</title><p id="P17">Once we validated that the SCOs produced from the pre-mixed pool of adherently-generated NSCs and RA-primed NMPs and patterned according to protocol #3 contained neural progenitors with rostral and caudal differentiation potentials, we next decided to systematically quantify the number of hindbrain, cervical, thoracic and lumbar cells and spMNs derived from those progenitors in day 21 SCOs. We analysed SCOs generated from several healthy lines using the three different stem cell aggregate compositions (100% NSCs, 100% RA-primed NMPs and 50%:50%) to determine whether the even mixture of two different stem cell populations resulted in a larger axial heterogeneity and higher abundance of spMN compared to the other two approaches. First, we observed that the relative proportion of ISL1<sup>+</sup> (or ISL1<sup>+</sup>/2<sup>+</sup>) spMNs remained consistent (~40%) across conditions and lines (<xref ref-type="fig" rid="F5">Fig. 5A-C</xref> and <xref ref-type="supplementary-material" rid="SD1">S5A-K</xref>). Next, SCOs derived from the "50:50 mix" condition yielded 24% cervical-brachial (HOXB4<sup>+</sup>;HOXC10<sup>-</sup>, HOXA5<sup>+</sup>;HOXC9<sup>-</sup> or HOXC6<sup>+</sup>;HOXA10<sup>-</sup>) (<xref ref-type="fig" rid="F5">Fig. 5A-F, K</xref> and <xref ref-type="supplementary-material" rid="SD1">S3E-J</xref>), 48% thoracic (HOXA5<sup>-</sup>;HOXC9<sup>+</sup>) (<xref ref-type="fig" rid="F5">Fig. 5B, G, K</xref> and <xref ref-type="supplementary-material" rid="SD1">S3K-L</xref>), and 28% lumbar (HOXC6<sup>+</sup>;HOXA10<sup>+</sup> or HOXB4<sup>+</sup>;HOXC10<sup>+</sup>) (<xref ref-type="fig" rid="F5">Fig. 5A, C, H-I, K</xref> and <xref ref-type="supplementary-material" rid="SD1">S3M-P</xref>) spMNs.</p><p id="P18">These data fit with qRT-PCR analysis to assess the relative abundance of RC <italic>HOX</italic> mRNA transcripts across the three organoid conditions. NMP-derived SCOs showed a marked decrease in rostral <italic>HOX</italic> gene expression relative to the NSC and the mix SCOs. Conversely, NSC-derived SCOs displayed significantly lower caudal <italic>HOX</italic> gene expression levels than the NMP and the mix SCOs (<xref ref-type="fig" rid="F5">Fig. 5J</xref> and <xref ref-type="supplementary-material" rid="SD1">S3Q</xref>). Additionally, we observed that spMN subpopulations with different axial identities self-arranged in a regionalized manner within the SCOs segregating from each other (<xref ref-type="fig" rid="F5">Fig. 5 A-C</xref> and <xref ref-type="supplementary-material" rid="SD1">S5L-N</xref>). Overall, we observed a more balanced proportion of RC spMN identities in NSC:NMP SCOs (25:47:27) than in the ones generated solely from NSCs or NMPs (30:51:19 and 15:47:38, respectively (<xref ref-type="fig" rid="F5">Fig. 5K</xref>). This suggests that the relative proportion of RC spMN subtypes generated seemed to depend on the starting population of stem cells used for SCO formation. Importantly, statistical analysis based on 1015 imaged SCO cryosections from a total of 182 processed SCOs for ISL1/2 and HOX immunostaining (<xref ref-type="fig" rid="F5">Fig. 5L</xref>) showed statistical dependence of the “spMN Axial Subtype” factor on the “Starting Cell Population (NSC, NMP, MIX)” factor (<xref ref-type="fig" rid="F5">Fig. 5M</xref>).</p><p id="P19">In summary, while the specification of ISL1/2<sup>+</sup> spMNs did not differ across the three conditions and is therefore not dependent on the starting stem cell population, at least when subjected to our protocol condition #3, using an even mix of NSCs and RA-primed NMPs as the starting stem cell pool consistently enhanced the axial heterogeneity of the resulting spMNs. Together, this new organoid patterning protocol, that we name comprehensive axial spinal cord organoid (CASCO), constitutes a highly robust and efficient method for directional differentiation of neural progenitor cells into a wide variety of axial spMN identities.</p></sec><sec id="S8"><title>Inducible vasculature and skeletal muscle are beneficial for neural maturation in CASCOs</title><p id="P20">Most organoid models, particularly SCOs, suffer from the absence of vascular networks, which restricts oxygen and nutrient delivery to the innermost regions of the organoid. In addition, a crosstalk between spMNs and endothelial cells has been reported necessary for a correct spMN development (<xref ref-type="bibr" rid="R157">Vieira et al. 2022</xref>). Similarly, when modelling neuromuscular development and disease, integrating the spMN cell targets, muscle cells, into the organoids is critical to recapitulate the motor unit. As for endothelial cells, muscle fibers release growth factors that contribute to spMN development and maturation (<xref ref-type="bibr" rid="R132">Saini et al. 2021</xref>). To increase the resemblance of our new CASCO protocol to the in vivo environment, we generated CASCOs comprising a functional endothelial cell network and skeletal muscle cells intertwined with the neural tissue (<xref ref-type="fig" rid="F6">Fig. 6A</xref>). For this, we used a transposase-based approach to engineer hiPSCs carrying an inducible <italic>ETV2</italic> overexpressing construct that, upon doxycycline treatment, induces hiPSCs differentiation to endothelial cell lineage (<xref ref-type="bibr" rid="R21">Cakir et al. 2019</xref>, <xref ref-type="bibr" rid="R112">Ng et al. 2021</xref>). SCOs generated from this edited line, after being exposed to dox during the entire duration of the differentiation protocol and immunostained against the mature vascular marker CD31, showed tubular-like structures resembling endothelial micro-vessels that were integrated within the organoid tissue (<xref ref-type="fig" rid="F6">Fig. 6B</xref>). Once we validated the efficiency of this line to differentiate into endothelial CD31<sup>+</sup> cells and their self-organization in the organoids, we generated CASCOs from unedited and iETV2 hiPSC lines in an 80:20 cell ratio and studied several indicators of neural maturation commonly used in the organoid field (<xref ref-type="bibr" rid="R61">Hergenreder et al. 2024</xref>). High-resolution imaging of lineage-mixed CASCO cryosections on day 42 showed a significant increase in the number of Synaptophysin<sup>+</sup> (presynaptic marker) and PSD95<sup>+</sup> (post-synaptic) puncta compared to CASCOs only comprised of neural tissue (<xref ref-type="fig" rid="F6">Fig. 6C-F, G-H</xref>).The levels of the trophic factor BDNF, associated with synaptic plasticity and activity-dependent neuronal differentiation and maturation, were also significantly increased in the CASCOs+iETV2 condition (<xref ref-type="fig" rid="F6">Fig. 6E, I</xref>). Importantly, the number of mature spMNs stained with CHAT antibody was not reduced in the CASCOs+iETV2 organoids, despite these contained 20% fewer cells permissive to become spMNs due to the presence of dox-inducible endothelial cells (<xref ref-type="fig" rid="F6">Fig. 6E-F, J</xref>). These results indicate that introducing endothelial cells in our CASCOs, capable of self-assembling into vasculature-like structures, enhances the maturation of the neurons present in the mixed-lineage SCO.</p><p id="P21">Several studies have developed 2D co-cultures of hiPSC-derived spMNs and skeletal muscle cells or 3D neuromuscular organoids using various techniques to model and study neuromuscular junction formation in healthy and disease conditions (<xref ref-type="bibr" rid="R34">Demestre et al. 2015</xref>, <xref ref-type="bibr" rid="R85">Lenzi et al. 2016</xref>, <xref ref-type="bibr" rid="R151">Tiago et al. 2021</xref>, Urzi et al. 2024). Often these approaches include the addition of lineage-dependent cues and/or the supplementation of small molecule cocktails to induce the specification of the desired cell type and enhance organoid maturation (<xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>, <xref ref-type="bibr" rid="R61">Hergenreder et al. 2024</xref>). Using an analogous approach to the one undertaken for our CASCO+iETV2 system, we edited the same hiPSC line to introduce dox-inducible MYOD1 and BAF60C2 transcription factors, known to regulate muscle differentiation (<xref ref-type="bibr" rid="R161">Weintraub et al. 1991</xref>, Meng et al. 2018, <xref ref-type="bibr" rid="R151">Tiago et al. 2021</xref>). Myospheres generated using this edited hiPSC line and cultured under dox treatment broadly contained DESMIN<sup>+</sup> and MyoD<sup>+</sup> skeletal muscle cells (<xref ref-type="fig" rid="F6">Fig. 6K</xref>). Next, we generated CASCOs containing both inducible lineage-specific hiPSC lines in a 60:20:20 ratio (WT:iETV2:iMYOD+BAF60C) and compared the expression levels of endothelial, skeletal muscle, spMN/neuron and synaptic/activity markers across the three types of complex CASCOs (CASCO+iETV2, CASCO+iMYOD+BAF60C and CASCO+iETV2:iMYOD+BAF60C) relative to the control CASCOs only comprised of neural tissue at a mature developmental stage (day 42). We first quantified the mRNA levels of lineage-confirming genes in the organoids. As expected, the expression levels of the endothelial marker <italic>FLK1</italic> were highest in the CASCO+iETV2 condition (<xref ref-type="fig" rid="F6">Fig. 6L</xref>) and the skeletal muscle marker <italic>DESMIN</italic> expression was highest in the CASCO+iMYOD+BAF60C organoids (<xref ref-type="fig" rid="F6">Fig. 6M</xref>). Interestingly, despite being comprised by a lower percentage of cells committing to neural lineage (20% and 40% less in the bi- and tri-lineage organoids, respectively), the complex CASCOs containing either endothelial, muscle cells or both, showed increased <italic>ISL1</italic> and <italic>MAP2</italic> levels compared to the control CASCOs (<xref ref-type="fig" rid="F6">Fig. 6N, P</xref>). Moreover, we observed an increase in the expression of <italic>BDNF</italic> (<xref ref-type="fig" rid="F6">Fig. 6O</xref>) and the synaptic <italic>DLG4</italic> (<italic>PSD95</italic>), <italic>SYN1</italic> and <italic>HOMER1</italic> in the complex organoids (<xref ref-type="fig" rid="F6">Fig. 6 Q-S</xref>), and enhanced expression of the immediate early gene <italic>EGR1</italic> (<xref ref-type="bibr" rid="R39">Duclot et Kabbaj 2017</xref>) compared to control CASCOs (<xref ref-type="fig" rid="F6">Fig. 6T</xref>). These results suggest that the presence of endothelial and skeletal muscle cells in the organoids boosts the maturation of the existing neurons. Lastly, we detected that the presence of these non-neural cell lineages was beneficial for the overall organoid health, as measurement of ATP levels, a proxy for cell viability and metabolic activity, showed higher values in the multi-lineage CASCOs than in the control ones (<xref ref-type="fig" rid="F6">Fig. 6U</xref>). In conclusion, adding both a vasculature-like network and skeletal muscle cells developmentally intertwined with the neural tissue considerably improved the maturation and overall health state of the CASCOs.</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P22">In recent years, several studies using NGS approaches have described the cellular composition of the developing and adult human spinal cord, providing an invaluable tool to identify specific spMN subtypes based on precise transcriptomic signatures (<xref ref-type="bibr" rid="R123">Rayon et al. 2021</xref>; <xref ref-type="bibr" rid="R168">Yadav et al. 2023</xref>). Numerous protocols for generating SCOs from hiPSCs are also now available (<xref ref-type="bibr" rid="R167">Xu et al. 2023</xref>; Whye et al. 2023; <xref ref-type="bibr" rid="R57">Gribaudo et al. 2023</xref>; <xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>; <xref ref-type="bibr" rid="R116">Ogura et al. 2018</xref>; <xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>; <xref ref-type="bibr" rid="R56">Grass et al. 2024</xref>). However, currently, no methodology enables the production of a high amount and diversity of rostrocaudal spMNs within the same organoid. Such an approach would be instrumental for exploring the developmental cues governing human axial spMN specification, like gene regulatory networks (Dasen et al. 2005, <xref ref-type="bibr" rid="R82">Lacombe et al. 2013</xref>), the sequence of key transcription factor activation during spMN development (<xref ref-type="bibr" rid="R115">Novitch et al. 2001</xref>, <xref ref-type="bibr" rid="R129">Sagner et al. 2019</xref>) or the acquisition of columnar identiy (<xref ref-type="bibr" rid="R140">Sockanathan et Jessell 1998</xref>, <xref ref-type="bibr" rid="R11">Baek et al. 2017</xref>). Furthermore, in motor neuron diseases like ALS or SMA, spMNs corresponding to specific spinal segments show distintct vulnerabilities to the disease (<xref ref-type="bibr" rid="R138">Simon et al. 2017</xref>; <xref ref-type="bibr" rid="R110">Nizzardo et al. 2020</xref>), however the underlying mechanisms remain obscure (<xref ref-type="bibr" rid="R73">Kampmann 2024</xref>). An organoid model containing both resistant and vulnerable axial spMN populations would facilitate examining how specific stressors impact both subtypes, whether they cope differently with an external insult or when they acquire their divergent vulnerability nature. While recent studies using direct programming of PSCs into different MN types have started to elucidate distinct neuronal sensitivities to disease (<xref ref-type="bibr" rid="R4">An et al. 2019</xref>), this approach drives differentiation in an extremely fast manner that skips neurodevelopmental intermediates, which could hamper the discovery of mechanisms triggering the pathology. Additionally, this approach results in homogenous populations of cells, which lacks the rich heterogeneity of the nervous system. Historically, the protocols used to produce spMNs from PSCs gave rise primarily to neurons with rostral identity. While in recent years other protocols for patterning SCOs toward more lumbar fates have been developed, these approaches face limitations, including a reduced number of mature spMNs, limited spMN heterogeneity or a complete loss of spMN subpopulations (<xref ref-type="bibr" rid="R5">Andersen et al. 2020</xref>; <xref ref-type="bibr" rid="R116">Ogura et al. 2018</xref>; <xref ref-type="bibr" rid="R64">Hor et al. 2018</xref>; <xref ref-type="bibr" rid="R57">Gribaudo et al. 2023</xref>). In this study, we aimed to generate a human SCO model comprising spMNs with molecular diversity across the entire anatomical axis of the spinal cord. By refining the induction of more caudal fates from RA-primed NMPs simultaneously patterned with rostral NSCs, we achieved a near-physiological anatomical specification of spMNs in our CASCO model (<xref ref-type="fig" rid="F5">Fig. 5K</xref>), which are equivalent to the spMN profiles measured via scRNAseq along the spinal segments in the developing human spinal cord (Zhang et al. 2021). Furthermore, the inclusion of endothelial-like cells and skeletal muscle enhanced the physiological relevance and neural maturation of the model.</p><p id="P23">As the embryo undergoes axial extension, neural tube development occurs in two phases of neurulation that rely on two distinct progenitor populations, NSCs and NMPs, which contribute to the development of the CNS (<xref ref-type="bibr" rid="R135">Schoenwolf et Smith 1990</xref>, <xref ref-type="bibr" rid="R136">Shaker et al. 2021</xref>). Historically, most SCO protocols aimed at mimicking the formation of the rostral neuraxis. These protocols rely on the immediate induction of PSCs into NSCs, the first stem cell population contributing to the formation of the mammalian spinal cord. This induction is typically achieved through BMP pathway inhibition (<xref ref-type="bibr" rid="R24">Chambers et al. 2009</xref>). NSCs patterned in this way are fixed in their axial identity and therefore unable to generate more caudal neural structures (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>). While these protocols generate a high percentage of spMNs, these have mainly a rostral identity (<xref ref-type="bibr" rid="R64">Hor et al. 2018</xref>), and thus these organoids have severely limited axial heterogeneity, which we corroborated via scRNAseq analysis. The second stem cell source and the one most recently used to generate SCOs, NMPs, is a bipotent cell population responsible for forming the spinal cord and paraxial mesoderm. Unlike NSC-based approaches, NMP-based protocols may increase the axial heterogeneity of in vitro models. This is due to one key intrinsic property of NMPs: their <italic>HOX</italic> gene expression code and progressive axial identity shift with extended culture time (<xref ref-type="bibr" rid="R54">Gouti et al. 2017</xref>). It has been shown that PSC-derived NMPs maintained in vitro for short periods of time (resembling early stages of development) primarily express anterior <italic>HOX</italic> genes, while NMPs kept in culture for longer, which resemble the transcriptomic profile of E9.5 mouse embryos, predominantly express posterior HOX genes (<xref ref-type="bibr" rid="R54">Gouti et al. 2017</xref>; <xref ref-type="bibr" rid="R35">Deschamps et al. 2017</xref>). It is thus likely that axial progenitor identity is acquired before neurogenesis begins and retained until the later stages of development, as reported in vivo (<xref ref-type="bibr" rid="R102">Metzis et al. 2018</xref>). In our study, we aimed to prime NMPs towards a neural lineage commitment, which is necessary for generating SCOs with high neural content. Recent NMP-based SCO protocols utilized for disease modelling result in a high percentage of mesodermal derivatives, as only a small subset of caudal progenitors develops into spMNs in these organoids (<xref ref-type="bibr" rid="R44">Faustino-Martins et al. 2020</xref>; <xref ref-type="bibr" rid="R118">Pereira et al. 2021</xref>). We successfully generated NMPs expressing <italic>SOX2</italic>, <italic>TBXT</italic> and <italic>GBX2</italic>, and demonstrated that a short and early RA pulse promotes their neural priming while maintaining their intrinsic caudal fate. Interestingly, we observed a reduction of SOX2 immunoreactivity in hiPSC-derived NMPs compared to NSCs, which fits previous data by Kelle and colleagues on the in vitro development of human axial stem cells (<xref ref-type="bibr" rid="R76">Kelle et al. 2024</xref>). Our findings are supported by in vitro differentiation of RA-primed mouse NMPs (Cunningham et al 2016), RA-primed human gastruloids (<xref ref-type="bibr" rid="R63">Hamazaki et al 2024</xref>) and by in vivo neurodevelopmental studies that showed that early exposure to RA during neural progenitor development controls NMP identity and maintenance (<xref ref-type="bibr" rid="R81">Kumar et Duester 2014</xref>, <xref ref-type="bibr" rid="R28">Cunningham et al. 2015</xref>, <xref ref-type="bibr" rid="R41">Durston et al. 1989</xref>, <xref ref-type="bibr" rid="R17">Blumberg et al. 1997</xref>). In summary, the effects observed in our study are likely due to RA acting as the signal that initiates the shift of NMPs into a "posterior" developmental mode, by activating the expression of 3’ <italic>HOX</italic> genes that govern posterior identity (<xref ref-type="bibr" rid="R92">Mahony et al. 2011</xref>, <xref ref-type="bibr" rid="R113">Nolte et al. 2019</xref>).Since the field standard protocol to differentiate mouse PSCs into spMNs was described two decades ago (<xref ref-type="bibr" rid="R163">Witcherle et al. 2002</xref>), numerous modifications of such model have been published and there is no consensus on how to best recapitulate spMN development in vitro. Some studies have compared the effect of different concentrations of key morphogens for spinal cord development on spMN patterning outcomes, such as WNT agonists, FGF2, RA and Smoothened agonists, (<xref ref-type="bibr" rid="R5">Andersen et al. 2020</xref>). Other reports have examined how the duration of caudalizing signals in vitro determines spMN axial identity (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>; <xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>). Additional approaches focused on modulating the activity of the NOTCH signalling pathway in spMN progenitor maturation (<xref ref-type="bibr" rid="R98">Maury et al. 2015</xref>; Ben-Shushan et al. 2014; <xref ref-type="bibr" rid="R150">Tan et al. 2016</xref>). It is critical to consider which patterning molecules to use, at which concentration, timing and combination, as their corresponding signalling pathways directly influence the modulation of collinear <italic>HOX</italic> gene expression. Taking into account all the above evidence, we designed a protocol screen to systematically assess how patterning molecules commonly used in the field govern the generation of spMNs and the establishment of their specific axial identities. We began by comparing the original NSC-based approach with multiple variations of RA-primed NMP-based protocols. Importantly, to induce neuroectoderm fate on our hiPSC-derived RA-primed NMPs, we used only LDN during the majority of the GDF11 exposure phase to avoid blocking GDF11’s caudalizing effect with SB (<xref ref-type="bibr" rid="R90">Luo et al. 2019</xref>; <xref ref-type="bibr" rid="R48">Frohlich et al. 2022</xref>). In addition, and as developmental axial fate of CNS progenitors becomes relatively fixed after exposure to RA, we limited RA treatment window to 5-8 days and used it at a lower concentration than what is commonly used (50nM instead of 1 μM) to avoid stopping the HOX clock in the NPCs at anterior positions. Additionally, RA treatment of vertebrate embryos during gastrulation, when HOX gene expression is initiated, results in the rostralization of the CNS, skull defects and truncation of the axial skeleton (<xref ref-type="bibr" rid="R27">Conlon et Rossant 1992</xref>; <xref ref-type="bibr" rid="R77">Kessel et Gruss 1991</xref>; <xref ref-type="bibr" rid="R95">Marshall et al. 1992</xref>). We also tested including RA inhibitors intercalated with RA stimulation, as the specification of caudal HB9<sup>+</sup> spMNs has been reported independent of RA exposure (<xref ref-type="bibr" rid="R117">Patani et al. 2011</xref>). Overall, while all novel protocol conditions generally resulted in increased caudal spMN fates compared to the field standard protocol, we did not observe major differences in spMN axial identity across them, particularly in terms of the order of delivery of neural induction, caudalization and progenitor expansion signals. This again highlights the intrinsic caudal bias of NMPs that does not seem to be heavily impacted by further exposure to morphogens. However, protocol condition #3 yielded a significant increase in the number of spMNs compared to the other paradigms. The early and prolonged exposure of neural progenitors to RA inhibitors characteristic of protocol #3 could explain this result, in agreement with a study reporting increased formation of OLIG2+ spMN progenitors and spMNs under similar conditions (<xref ref-type="bibr" rid="R117">Patani et al. 2011</xref>). Interestingly, in the mature SCOs, we observed a degree of regionalization within the axial spMN pools, with rostral and caudal spMNs spatially segregating in a self-organizing manner. This may be due to differential expression of surface proteins that provide migratory guidance to developing ventral spMN progenitors (<xref ref-type="bibr" rid="R84">Laussu et al. 2017</xref>).</p><p id="P24">Regardless of the patterning design, in our study, RA-primed NMP-derived SCOs generated only low numbers of rostral spMNs, which contrasts early reports on NMPs contributing to the formation of both paraxial mesoderm and the neural tube of all post-cranial axial levels in mice (<xref ref-type="bibr" rid="R154">Tzouanacou et al. 2009</xref>). Nevertheless, our results agree with more recent evidence supporting that after a certain time in culture, NMPs are unable to generate rostral neuroectoderm progenitors, even when treated with high concentrations of RA (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>). Our data also agrees with studies showing that cervical neural tissues likely cannot be generated from neural-specific progenitors that originate from the axially-biased NMPs (<xref ref-type="bibr" rid="R102">Metzis et al. 2018</xref>, <xref ref-type="bibr" rid="R107">Nakamura et al. 2024</xref>, <xref ref-type="bibr" rid="R19">Bolondi et al. 2024</xref>). In addition, our NSC-derived SCOs, exposed to growth factors like GDF11 and FGF2 during their early development, contained few lumbar spMNs. According to literature, NSC exposure to RA at an early stage should completely halt the progression of the HOX clock towards caudal lineages and negate the effects of extrinsic caudalizing signals due to chromatin modifications (<xref ref-type="bibr" rid="R87">Lippmann et al. 2015</xref>; <xref ref-type="bibr" rid="R104">Mouilleau et al. 2021</xref>; <xref ref-type="bibr" rid="R57">Gribaudo et al. 2023</xref>). In differentiating mouse neural progenitors, RA activates RA receptors, which bind to rostral <italic>HOX</italic> chromatin domains, prompting a rapid removal of H3K27me3 and resulting in an irreversible cervical spinal identity (<xref ref-type="bibr" rid="R99">Mazzoni et al. 2013</xref>; <xref ref-type="bibr" rid="R1">Ahn et al. 2014</xref>). Based on our systematic analysis of numerous patterning paradigms showing that NSC-based SCOs still generate some caudal spMNs and NMP-based SCOs yet contain some rostral ones, we suggest that there may be some understudied overlap and plasticity between the processes of neurulation and axial identity acquisition, at least in vitro. We would like to emphasize, though, the importance of distinguishing between the intricate complexity of embryonic development and the inherent simplifications of cell culture models, which are designed to recapitulate specific developmental aspects. Discrepancies between in vitro and in vivo development -particularly when novel cell culture findings conflict with well-established developmental observations -are likely indicative of the need for further refinement of culture conditions rather than a misinterpretation of developmental processes.Once the generation of spMNs with a balanced RC identity was achieved, we aimed to enhance the physiological relevance of our CASCOs by incorporating endothelial-like cells and skeletal muscle. Our results showed that the presence of additional cell lineages seemed to provide crucial signals for promoting systemic neural maturation and the overall organoid health. Similar observations have been also reported by others, who demonstrated greater neural network activity and maturation in cerebral organoids transplanted in mouse cortex, likely through host-driven and engrafted endothelial vasculature (<xref ref-type="bibr" rid="R94">Mansour et al. 2018</xref>, <xref ref-type="bibr" rid="R120">Pham et al. 2018</xref>, <xref ref-type="bibr" rid="R124">Revah et al. 2022</xref>). No synergistic effect on the maturation parameters studied was detected when both cell types were added to the CASCOs versus only one of them. Worth noting, though, CASCOs containing both additional inducible cell lineages have ~20% fewer cells available for neuronal commitment than the “CASCO+iETV2” or “CASCO+iMYOD” conditions. Similarly, the lack of synergistic effect on the overall organoid heath (ATP levels) may be also attributed to the significantly higher demands for ATP production of neuronal cells compared to other cell types (Leary et al. 1998, Du et al. 2008, Vinokurov et al. 2024).</p><p id="P25">Altogether, with this study, which leverages developmental cues that guide neural tube formation in vivo and compiles knowledge from the plethora of available protocols, we developed an advanced method for differentiating hiPSCs into physiologically relevant SCOs containing a wide axial variety of spMNs. We believe that this experimental model will be instrumental in studying the emergence and consolidation of human spMN diversity during spinal cord development, as well as whether and how certain motor neuron diseases might alter these processes.</p></sec><sec id="S10" sec-type="methods | materials" specific-use="web-only"><title>Methods and Materials</title><sec id="S11"><title>Study approval and ethics</title><p id="P26">All experiments involving hiPSCs were performed in accordance with the ethical standards of the institutional and national research committees, as well as the 1964 Helsinki Declaration and its later amendments (<xref ref-type="bibr" rid="R53">General Assembly of the World Medical Association 2014</xref>). A positive evaluation by local ethics commission (Institutional Review Board) at the Technische Universität Dresden (Germany) was granted on 28th of Januaryy 2020 to use all the human iPSC lines (Reference Number: SR-EK 80022020).</p></sec><sec id="S12"><title>hiPSC culture</title><p id="P27">All hiPSCs lines (BJ-siPS, 1016A, KOLFC1, CRTD1, 18A) were thawed in presence of 10μM ROCKi, grown on P6 dishes (Corning), which were coated 40 min at RT with Matrigel-DMEM (Corning, Gibco). Cells were cultured in mTeSR plus (STEMCELL Technologies), which was refreshed every 2-3 days. Splitting of the hiPSCs was performed with 1 min incubation in 0.5M EDTA, once 60-80% confluency or terminal size of the colonies was achieved, then cells were washed with 1xDPBS, scraped off the plates and passaged in clumps. Cell lines were used for differentiation into spMNs, karyotyped and sequenced before (<xref ref-type="bibr" rid="R20">Boulting et al. 2011</xref>, <xref ref-type="bibr" rid="R111">Ng et al. 2015</xref>, <xref ref-type="bibr" rid="R125">Rodriguez-Muela et al. 2017</xref>, <xref ref-type="bibr" rid="R126">Rodriguez-Muela et al. 2018</xref>, <xref ref-type="bibr" rid="R62">Hildebrandt et al. 2019</xref>, <xref ref-type="bibr" rid="R159">Voelkner et al. 2022</xref>). Healthy hiPSCs were processed in clump-based dissociation, centrifuged for 5min at 1,000rpm and then transferred to CryoStor® CS10 (Stemcell), in Cryovials (Sigma Aldrich), and to a Mr. Frosty™ Freezing Container (Nalgene) and ultimately stored at -80°C for 1-2 days. Afterwards, Cryovials containing iPSCs were stored in liquid N2 tanks long term.</p></sec><sec id="S13"><title>CRISPR-Cas9 mediated tagging of the endogenous ISL1 locus</title><p id="P28">To generate Islet1 reporter line we followed a two-vector based knock-in approach. Briefly, one plasmid (px458, Addgene Plasmid #48138) expressing sgRNA as well as Cas9 was used to generate pTG-Cr- ISL1 and to introduce double-strand breaks near the stop codon of Exon 6 of Islet1 locus. To do so, a CRISPR guide (gRNA) with an estimated cleavage site right next to the stop codon of exon 6 of the <italic>ISL1</italic> locus were designed and single-stranded (ss) oligos (IDTDna) (listed in the <xref ref-type="table" rid="T1">Materials and Methods Table</xref>) were annealed and cloned into the px458 plasmid (Addgene # 48138) using BbsI and T7 DNA ligase in a one-step digestion-ligation reaction. Correct insertion of the ssOligos into px458 plasmid was confirmed via Sanger Sequencing (Microsynths). ssOligo Info see extended methods table and gBlock sequence available upon request. The second vector pTG-HR-ISL1-P2A-mNeonGreen was derived through modifications of the standard HR120-PA-1 vector (Systembio). To create a new multicistronic vector the copGFP-polyA cassette was removed via digest using EcoRI and NruI and the vector sequence was restored via gBlock cloning which introduced a P2A cassette. In subsequent steps the XhoI site and Gibson assembly was used to introduce a gBlock consisting of mNeonGreen CDS followed by a WPRE element. For introduction of the 5-prime homology arm the plasmid was digested with NHEI and a gBlock (IDT) consisting of a 429-bp sequence, encoding part of intron 5 as well as the last exon of the <italic>ISL1</italic> gene excluding the stop codon was cloned into the vector via Gibson assembly (NEB) (and in frame with p2A-mNeonGreen sequence followed by the WPRE site, loxP-flanked drug-resistance cassette and fluorescent marker mRuby). Next, the vector was digested with BamHI and the 3-prime homology arm containing of 421-bp homologous to intron 6 of the <italic>ISL1</italic> locus was cloned into the vector via Gibson assembly, resulting in pTG-HR-ISL1-p2A-mNeonGreen. For the generation the ISL1 reporter line cells were nucleofected with pTG-Cr-ISL1 and pTG-HR-ISL1-p2A-mNeonGreen plasmids using a 4-D nucleofector system (AMAXA) and the P3 Primary Cell 4D-Nucleofector Kit (Lonza) following manufacturer’s instructions. 2 days later succesful targeted cells were selected with puromycin for a total of 7 days, followed by nucleofection with pCAG-Cre:GFP plasmid (<xref ref-type="bibr" rid="R97">Matsuda and Cepko, 2007</xref>) to remove the loxP-flanked drug-resistance cassette and flurescent marker mRuby. 4 days later cells were FAC-sorted and mNeonGreen<sup>+</sup>/mRuby- cell population was enriched and plated at clonal densities on freshly Matrigel-coated cell culture dishes. 24 individual colonies were picked, expanded, gDNA was extracted using DirectPCR lysis reagent (CELL, Viagen) and Proteinase K (Viagen) and succesful targeting was confirmed via PCR strategy using primer strategy recently described by us (<xref ref-type="bibr" rid="R56">Grass et al, 2024</xref>). Out of the succesful targeted clones (data not shown), 2 were expanded and used for experiments. Validation of ISL1-p2A-mNeonGreen reporter was proven via co-immunstaining with commercially available antibody (Abcam), resulting in more than 90% overlap.</p></sec><sec id="S14"><title>Transposon-mediated gene editing of WT BJ-sIPS hiPSCs</title><p id="P29">Plasmids were propagated using One-Shot TOP10 Bacteria (E.coli) or VB Ultra Stable Bacteria (E.coli) with LB medium. Firstly, the BJ:ETV2ihiPSC line was generated by co-transfecting WT BJ siPS with 4 μg of pBAN-Puro-TT-hETV2-isoform2 (ENST00000402764.6) and 1 μg of pRP[Exp]-mCherry-CAG&gt;hyPBase vectors, similarly as described elsewhere (<xref ref-type="bibr" rid="R112">Ng et al. 2021</xref>). Selection was performed using 1 μg/ml puromycin for two weeks prior to clonal selection. Briefly, and as described before by others, the BJ:Baf60c-MYOD1-hiPSC line was generated by co-transfecting WT BJ siPS with 2.5 μg each of the ePB-Bsd-TT-BAF60c and ePB-Puro-TT-m-MyoD vectors, along with 1 μg of pRP[Exp]-mCherry-CAG&gt;hyPBase (<xref ref-type="bibr" rid="R85">Lenzi et al. 2016</xref>, <xref ref-type="bibr" rid="R151">Tiago et al. 2021</xref>). Selection was performed using 1 μg/ml puromycin and 5 μg/ml blasticidin for two weeks and gave rise to stable and doxycycline inducible cell lines. Afterwards, we performed single cell cloning as described elsewhere (<xref ref-type="bibr" rid="R56">Grass et al. 2024</xref>).</p></sec><sec id="S15"><title>hiPSC aggregate formation and SCO patterning</title><p id="P30">Once hiPSC colonies reached terminal size and plates showed about 60-80% confluency, they were processed for further experiments. For aggregate generation, hiPSC colonies were first washed with 1xDPBS and treated 1 min with ReLeSR solution at room temperature and then lifted off the plates, using Corning® Cell Lifter 3008 (Corning). Cells were immediately transferred into 5ml of mTesR (StemCell) medium and dissociated into clumps. <underline><italic>For SCO protocol screen</italic></underline>. The cells were transferred into in P10 ultra-low attachment Petri dishes (Corning), containing 10ml of mTesR medium, ROCK inhibitor Y-27632 (StemCell) and 20ng/ml recombinant FGF2 (Qkine). After 24h, half of mTesR medium was refreshed and 20ng/ml FGF2 was added. EBs were grown for another 24h. EBs were continuously shaken at 60rpm inside of an incubator (37°C, 5% CO2). After three days in culture, the EBs were transferred into mTesR containing the cocktail CEPT (<xref ref-type="bibr" rid="R25">Chen et al. 2021</xref>, <xref ref-type="bibr" rid="R128">Ryu et al. 2023</xref>), and shaken at 60 rpm for another 18h. The EBs were then transferred into NIM medium containing the WNT agonist CHIRON99021 (Tocris) at 3μM and 20ng/ml FGF2. After 48h, 25nM of RA (Sigma-Aldrich) was added for 2h. Lastly, NIM was replaced and NMP-like aggregates were cultured in NIM with 20ng/ml FGF2 for 12h. They were then transferred onto P24 ULA Ultra Low attachment plates (Corning) to start the patterning protocols (or drug treatments). <underline><italic>For CASCO formation</italic></underline>. Instead of clump formation, adherently patterned cells were treated with Accutase (Corning) for 5min at 37°C, viable cells were counted with a Neubauer Chamber and 10,000 cells of adherently patterned NSCs and NMPs were mixed together at a ratio of 1:1 in P96 ULA plates (Corning) and spun down at 120g for 3 minutes. These were left in NIM+CEPT+FGF2+SAG for one day to recover before neural induction with SB+LDN in NIM, and then successive patterning steps continued. Concentration of small molecules for SCO protocols used: 10 μM SB431542 (Stemgent), 1μM LDN193189 (Stemgent), 3μM CHIRON99021 (Tocris), 1μM RXR inhibitor UVI 3003 (Tocris), 1μM RAR inhibitor AGN 193109 (Tocris), 1μM, 50nM or 25nM RA (Sigma-Aldrich), 200ng/ml FGF8 (Peprotech), 10μM Notch-inhibitor DAPT (Tocris), 120ng/ml FGF2 (Qkine), 1μM Smoothened Agonist SAG (Merck), 50ng/ml GDF11 (Peprotech), 10ng/ml BDNF (Qkine), 10ng/ml GDNF (Qkine). Neural Induction Media (NIM) for SCO culture contained 477.5 ml Advanced DMEM and 477.5 ml Neurobasal Media (both from Life Technologies), 10 ml Penicillin-Streptamycin and 10 ml B27 supplement with Vitamin A (Thermo Scientific), 10 ml GlutaMax (Gibco), 1.82 ml ß-Mercaptoethanol (Sigma-Aldrich), 5 ml N2 supplement (Thermo Scientific), 8 ml 20% glucose in 1xDPBS (sterile filtered from Sigma Aldrich), 200 μl 5,000x Ascorbic Acid (StemCell), and 1 ml 1,000x Antioxidant Supplement (Thermo Scientific).</p></sec><sec id="S16"><title>High content live imaging</title><p id="P31">Live imaging of SCOs derived from healthy reporter line BJ-ISL1:mNeonGreen under different patterning approaches was performed with an Operetta CLS (PerkinElmer, USA). Images were taken every 6 hours for multiple days, using a 10x Air Objective. NIM with small molecules was briefly exchanged for Neurobasal Medium without Phenol Red (Thermo) and after imaging, the respective patterning medium was supplied again. SCOs were counterstained for 90min with 5μM Calcein Red dye at 37°C and re-stained at day 6 and day 12 of the differentiations. Mean fluorescence intensity of ISL1:mNeonGreen was automatically quantified with high-content imaging analysis software HARMONY (PerkinElmer), restricted to the EBs identified in Brightfield (BF) or by CellTrace™ Calcein Red-Orange (Invitrogen) dye.</p></sec><sec id="S17"><title>RNA isolation, cDNA synthesis, primer Design and qRT-PCR</title><p id="P32">After two successive washes in 1xDPBS, total RNA and protein were extracted from the RNA/Protein NucleoSpin Kit (Macherey Nagel) or TRI Reagent (Zymogen), following the manufacturer's instructions. The following adjustments for the Nucleospin extraction were meade: In the lysis buffer RP1, 1xHalt-Protease Inhibitor (ThermoScientific) and 2x ß-Mercaptoethanol (Sigma-Aldrich) were added, with subsequent RNA purification involving four instead of two washes in ice-cold RA3 wash buffer and incubation of RNA in 70% ethanol with 20μl of 3M Sodium Acetate (pH adjusted to 5.2 with Glacial Acetic Acid) for 5 minutes. Double elution with 20-30μl of Nuclease-free Water (Promega) was performed. The following adjustment for the TRI Reagent extraction were made: Glyogen (Thermo Scientific) was added to the aqueous phase after Chloroform-mediated separation of the Phenol at 1μg/μl to enhance yield. RNA concentration and quality was measured using NanoDrop TM 1000 Spectrophotometer (Thermo Scientific). For cDNA synthesis, 250-500ng of RNA was reverse transcribed using the Applied Biosystems™ High-Capacity cDNA Reverse Transcription Kit in a C1000 Touch Thermal Cycler (Biorad), following the manufacturer’s instructions. Primers for quantitative reverse transcription PCR (qRT-PCR) were designed using PrimerBLAST NCBI (<xref ref-type="bibr" rid="R170">Ye et al., 2012</xref>) and controlled for dimer formation using IDT OligoAnalyze (IDT) and validated using pooled cDNA from hiPSCs and SCOs at different developmental stages. qRT-PCR was conducted using the GoTaq qPCR Master Mix (Promega) on a 384-well QuantStudio™ 5 Real-Time PCR System (Applied Biosystems) in Comparative Cт (ΔΔCт) mode with CXR reference dye, analyzing gene expression levels relative to the housekeeping gene h18S. Data was analyzed with the ΔCq method according to <xref ref-type="bibr" rid="R119">Pfaffl (2001)</xref> and ultimately in PRISM (Graphpad) or R Studio (R). Gene expression is indicated as LOG2FC of ΔCq or FC with respect to the housekeeping gene h18S.</p></sec><sec id="S18"><title>Dissociation and scRNAseq of NSC-derived SCOs</title><p id="P33">WT BJ hiPSC aggregates were patterned as described in <xref ref-type="fig" rid="F1">Fig1A</xref> and at day 20 they were dissociated as described in <xref ref-type="bibr" rid="R56">Grass et al 2024</xref>, using a papain/DNase solution (Worthington, LK003178, LK003172). Cell viability was determined using trypan blue staining and 50K cells per sample were pooled at a final concentration of 2K cells/μL in 0.04% PBS-BSA. Droplet-based scRNA-seq was performed using the 10x Genomics Chromium Single Cell Kit v3. Raw sequencing data was processed using the count command of Cell Ranger (v7.0.0) provided by 10xGenomics. To build the reference, human genome GRch38/hg38 and gene annotation Ensembl104 were downloaded from Ensembl. The annotation file was filtered using mkgtf command of Cell Ranger (options:attribute=gene_biotype:protein_coding,attribute=gene_biotype:lincRNA,attribute=gene_biotyp e:antisense) then using the filtered annotation and genome sequence as input to the mkref. command to build the reference. FASTQ files were processed with the count command, which aligned reads to the reference, generating a gene-barcode-matrix, representing gene counts per cell. For further bioinformatical analysis, the dataset was filtered to exclude low-quality cells (criteria: nFeatures &gt; 1000 and percent of mitochondrial genes &lt; 10%). We analyzed the gene expression profiles of 12,637 cells. On average, we mapped 95.6% of all reads to the human genome and determined 586,951,087 unique reads, accounting for 5,067 median genes per cell. Next, we applied normalization, scaling, and dimensionality reduction using standard Seurat functions (<xref ref-type="bibr" rid="R133">Sajita et al 2015</xref>). For normalization, gene expression values were adjusted by total UMI counts per cell, multiplied by 10,000 (TP10K), and then log-transformed using log10(TP10K + 1). Dimensionality reduction was performed using principal component analysis (PCA) on the top 2,000 variable genes identified via the vst method. For two-dimensional data visualization, uniform manifold approximation and projection (UMAP) was computed using the first 20 principal components (PCs). Cell clustering was carried out using the Louvain algorithm, also based on the first 20 PCs, with a resolution set at 0.1, generating Dotplots to show LOG2FC of gene expression per cluster. Marker genes specific to each cluster were identified with the Wilcoxon rank sum test, utilizing the FindAllMarkers Seurat function (parameters: only.pos = TRUE, min.pct = 0.20, logFC.threshold = 0.20, min.diff.pct = 0.1). The biological identity of each cluster was inspired by previous cluster annotations from hiPSC-derived SCOs (<xref ref-type="bibr" rid="R56">Grass et al., 2024</xref>) and from published studies on spinal cord gene expression (<xref ref-type="bibr" rid="R142">Stifani et al. 2014</xref>; <xref ref-type="bibr" rid="R129">Sagner et al. 2019</xref>, <xref ref-type="bibr" rid="R6">Andersen et al 2023</xref>, <xref ref-type="bibr" rid="R23">Catela et al., 2024</xref>). The confusion matrix was calculated to represent the frequency of cells from each group within each cluster. All visualizations were created using standard Seurat functions along with custom ggplot2 (v. 3.4.0) scripts. The code utilized in this study will be made available on GitHub upon manuscript acceptance. Seurat objects and processed data files will be available upon request.</p></sec><sec id="S19"><title>Cryosectioning, immunofluorescence staining, imaging and image processing</title><p id="P34">After o.n. fixation of organoids in 4%PFA in 1xDPBS, organoids were incubated for 15 min at RT in 0.5M Glycine-PBS solution to quench aldehyde groups. Then, they were subjected to cryoprotection in 15%Saccharose/PBS for 48h and 30% Saccharose/PBS, flash-frozen on dry-ice in TissueTek OCT embedding compound (Sigma) and stored at -80°C. Cryoblocks were sectioned at 15μm thickness with the Cryostat Leica CM3050S (Leica) and sections collected onto Thermo Scientific™ SuperFrost Plus Slides (Thermo). Slides were dried at 37°C on a TFP40 Stretching Table (MEDlite) for 10min before extended storage at −80°C. For immunofluorescence staining of organoid sections, slides were thawed at RT for 5 min, rehydrated in 1xDPBS for 10min and post-fixed in 4% PFA (ChemCruz) in 1xDPBS for 10 min. Slides were washed in 1xDPBs twice and blocked for 1 h with Blocking Buffer (BB) (0.25% TritonX, 4% NGS or 3% BSA, 0.1% Tween20 in 1xDPBS) at RT in a humid chamber. Afterwards, sections were circled with an Elite Pap-Pen (Diagnostic BioSystems), slides were washed once for 10min in DPBS and Primary Antibodies in BB were added for 2h at RT. Slides were washed in 1xDPBs twice (10min each) and Hoechst33342 nuclear dye was added at 2μg/ml for 10min. Slides were washed in 1xDPBs twice, mounted with Vectashield Antifade Mounting Medium (VectorLabs) on HighPrecision (170±5μm) coverslips (Carl Roth) and sealed with clear nailpolish. All washing steps in 1xDPBS were carried out at RT on a neoLabLine Multi Shaker (neoLab) at 100rpm. Imaging was carried out with a Zeiss Confocal Spinning Disc, using automatic scan of manually selected organoids/tile regions, with a 20x Air Objective unless indicated otherwise. Z-Stack scans were recorded for each organoid section, Niquist theorem was always considered, to select optimal interval size in z-direction. For imaging of the organoids in the protocol-screen, unbiased-automated slide scanning was performed on a Zeiss Axioscan.Z1 microscope, using a 20x Zeiss Plan-Apochromat Air objective. Extended Depth of Focus option (EDF) was used for recording Z-Stack scans of at least 12 μM thickness with an interval of 1 μm. Maximum Intensity Projections were made and tiles stitched with 15% tile section overlap by Hoechst33342 as reference channel. All Images were sharpened by 20%, adjusted for contrast, brightness and gamma, using always the same LUT setting an intensity cutoffs for background determination for each group. Automatic quantification of SCO sections was carried out in Arivis Vision4D 3.3.0 (Zeiss) after batch-transcribing the files with ArivisSIS converter (Zeiss). Briefly, CZI.files were converted into arivisSIS format with no compression. The quantification pipelines in Arivis Vision4D 3.3.0 usually included: 1) A percentage-based Threshold for the channel of interest, restricting histogram values. 2) Global Enhancement “Simple Sharpening Filter" or Richardsson-Lucy-Deconvolution. 3) Usage of BlobFinder- Nuclear Segmentation Tool for identifying Nuclear Shapes with Diameter &gt;12μM, Probability threshold=4%, Split sensitivity=80%, slightly adjusted dependent on the marker of interest 4) Pixel-based Compartment Analysis with “Fill-Holes”-option, segmentation in x,y,z-direction to identify cells that are double positive for certain HOX markers and ISL1(2). 5) Segment operation “Feature-Filter" on Surface-Area (μm<sup>2</sup>) &gt; 60 μm<sup>2</sup>, VOXEL &gt; 150 μm3, Sphericity &gt; 0.6. HOXC10 protein can be present both in nucleus and cytoplasm (Pathiraja et al 2014). In our analysis HOXC10 signal was assessed in volumetric overlap with nucleus staining (Hoechst). We proceeded similarly regarding other HOXs, always setting at least 70-80% nuclear volumetric overlap as an analysis parameter. For analyzing MAP2 staining and Nestin staining, we used Frangi’s vesselness measure (<xref ref-type="bibr" rid="R46">Frangi et al. 1998</xref>). For PSD95/MAGUK, BDNF and CHAT we trained a machine-learning model based on Illastik for minimum 150 features and hosted the model in Arivis (<xref ref-type="bibr" rid="R16">Berg et al. 2019</xref>). Quantification was carried out in an unbiased way, always using “Batch Analysis" option for all organoids. Dispersion around the mean or median is shown always either as SEM or interquartile range, respectively. Analysis outputs were exported as CSV files, and then compiled using a custom R-code, available on request. Final analysis values were sorted using Microsoft Excel 2016, normalizing the Hoechst33342 cell count number for each organoid, performing one-point normalization to the average relative value for the control group, and plotted using Graphpad PRISM. The distance map was created in Zen by drawing a peripheral line, using the “Profile” option, showing separation of post and presynaptic marker staining. All Images were assembled in Affinity Designer 2.</p></sec><sec id="S20"><title>CellTiter Glo Assay for ATP measurement in SCOs</title><p id="P35">The ATP assay was conducted following the manufacturer’s instructions using white opaque walled microwell assay plates containing 1-3 SCOs per condition. CellTiter-Glo® Reagent was added in an equal volume to all wells, followed by mixing the contents for 2 minutes on an orbital shaker to induce cell lysis. Finally, luminescence was recorded using an Infinite 200 Pro Reader. Signal in RLU was normalized against an ATP-Standard curve (1μM to 10nM), with freshly prepared dilutions every time.</p></sec><sec id="S21"><title>Statistical analysis of measurements</title><p id="P36">We routinely carried out Shapiro-Wilk test for normality assessment of data points. Only if all experimental groups were Gaussian distributed, we proceed with parametric tests (<xref ref-type="bibr" rid="R143">Starbuck et al 2023</xref>). Outlier detection was set with the lower limit at 2 standard deviations below the mean (μ - 2σ) and the upper limit at 2 standard deviations above the mean (μ + 2σ). To analyse median changes of LOG2FC of gene expression, we regularly used a one-tailed Mann-Whitney U test (<xref ref-type="bibr" rid="R106">Nachar 2008</xref>, <xref ref-type="bibr" rid="R93">Mann et Whitney 1947</xref>) due to the non-normal distribution in some qPCR experiments. For experiments with higher number of data points and Gaussian distribution of the data, we conducted a one-way ANOVA followed by Fisher's LSD post hoc tests for pairwise comparisons (<xref ref-type="bibr" rid="R145">Stuhle et Wold 1989</xref>, <xref ref-type="bibr" rid="R100">Meier 2006</xref>). If needed, data were analyzed using a two-way Mixed Model (<xref ref-type="bibr" rid="R9">Ato García et al 2013</xref>) or two-way ANOVA with Fisher's LSD Test, respectively. For the analysis of related cell counts during assessment of the organoid protocol screen, we used the non-parametric Kruskal-Wallis test (<xref ref-type="bibr" rid="R80">Kruskal et Wallis 1952</xref>) and uncorrected Dunn's test (<xref ref-type="bibr" rid="R40">Dunn 1961</xref>). Regarding the analysis of cell numbers in mixed organoids in <xref ref-type="fig" rid="F4">Fig. 4</xref>-<xref ref-type="fig" rid="F5">5</xref>, given the complexity involving multiple experimental conditions and various cell lines, we opted for a two-way ANOVA with Tukey-Kramer post hoc test (<xref ref-type="bibr" rid="R169">Yates 1934</xref>, <xref ref-type="bibr" rid="R49">Fujikoshi 1993</xref>) to facilitate reliable pairwise comparisons between experimental conditions with unequal sample sizes and variant numbers of samples (<xref ref-type="bibr" rid="R38">Driscoll 1996</xref>). To assess the difference in synaptic puncta (Synaptophysin, Pan-MAGUK) and ChAT/BDNF signal, we conducted Unadjusted, one-sided and pairwise t-Test with Welch correction for multiple comparisons due to unequal variances between conditions (<xref ref-type="bibr" rid="R162">Welch 1951</xref>). Exact information about biological and technical replicate number is indicated in each figure legend.</p></sec></sec><sec id="S22"><label>4.14</label><title>Methods - Reagents and Tools Table</title><table-wrap id="T1" position="anchor" orientation="portrait"><table frame="box" rules="all"><thead><tr style="background-color:#E6E6E6"><th valign="top" align="left">Reagent/Resource</th><th valign="top" align="left">Reference or Source</th><th valign="top" align="left">Identifier or Catalog Number</th></tr></thead><tbody><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Experimental Models</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">One-Shot TOP10 Bacteria (<italic>E.coli</italic>)</td><td valign="top" align="left">Thermo Scientific</td><td valign="top" align="left">C404010</td></tr><tr><td valign="top" align="left">VB Ultra Stable Bacteria (<italic>E.coli</italic>)</td><td valign="top" align="left">VectorBuilder</td><td valign="top" align="left">UC001-010</td></tr><tr><td valign="top" align="left">BJ-siPS hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">Harvard University</td><td valign="top" align="left">HVRDi005-A</td></tr><tr><td valign="top" align="left">1016A hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">Harvard University</td><td valign="top" align="left">HVRDi007-A</td></tr><tr><td valign="top" align="left">KOLFC1 hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">Wellcome Trust Sanger Institute</td><td valign="top" align="left">WTSIi018-B-1</td></tr><tr><td valign="top" align="left">CRTD1 hiPSCs (<italic>H.sapiens</italic>)</td><td valign="top" align="left">Center for Regenerative Therapies TU Dresden</td><td valign="top" align="left">CRTDi004-A</td></tr><tr><td valign="top" align="left">18A hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">Harvard University</td><td valign="top" align="left">CVCL_8993</td></tr><tr><td valign="top" align="left">BJ:ISL1:P2A:mNeonGreen hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">This paper</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">BJ:ETV2i hiPSC (<italic>H. sapiens</italic>)</td><td valign="top" align="left">This paper</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">BJ:Baf60c-MYOD1 hiPSCs (<italic>H. sapiens</italic>)</td><td valign="top" align="left">This paper</td><td valign="top" align="left">This paper</td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Recombinant DNA</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">pCAG-Cre:GFP</td><td valign="top" align="left">heraBioLabs</td><td valign="top" align="left"><xref ref-type="bibr" rid="R97">Matsuda et al 2007</xref></td></tr><tr><td valign="top" align="left">pRP[Exp]-mCherry-CAG&gt;hyPBase</td><td valign="top" align="left">VectorBuilder</td><td valign="top" align="left">VB010000-9365tax</td></tr><tr><td valign="top" align="left">pBAN-Puro-TT-hETV2-isoform2</td><td valign="top" align="left">Harvard University</td><td valign="top" align="left"><xref ref-type="bibr" rid="R112">Ng et al 2021</xref></td></tr><tr><td valign="top" align="left">epB-Bsd-TT-mBAF60c</td><td valign="top" align="left">University of Rome</td><td valign="top" align="left"><xref ref-type="bibr" rid="R85">Lenzi et al 2016</xref></td></tr><tr><td valign="top" align="left">epB-Puro-TT-mMyoD</td><td valign="top" align="left">University of Rome</td><td valign="top" align="left"><xref ref-type="bibr" rid="R85">Lenzi et al 2016</xref></td></tr><tr><td valign="top" align="left">pSpCas9(BB)-2A-GFP (PX458)</td><td valign="top" align="left">Addgene Plasmid #48138</td><td valign="top" align="left">Feng Zhang Laboratory</td></tr><tr><td valign="top" align="left">pTG-HR-Islet1-P2A-mNeonGreen</td><td valign="top" align="left">This paper</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">PrecisionX™ GFP-pA-LoxP-EF1-alpha-RFP- T2A- Puro- pA- LoxP-MCS</td><td valign="top" align="left">System Biosciences</td><td valign="top" align="left">HR120PA-1</td></tr><tr><td valign="top" align="left">Crispr gRNA FOR 5’ GCCAGTCCTATTGAGGCATG 3’</td><td valign="top" align="left">This paper</td><td valign="top" align="left">IDT</td></tr><tr><td valign="top" align="left">Crispr gRNA REV 5’ CATGCCTCAATAGGACTGGC 3’</td><td valign="top" align="left">This paper</td><td valign="top" align="left">IDT</td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Antibodies</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">anti-Bra/TBXT, monoclonal, rb IgG, 1:200</td><td valign="top" align="left">Cell Signaling</td><td valign="top" align="left">81694</td></tr><tr><td valign="top" align="left">anti-CDX2, monoclonal, ms IgG1, 1:200</td><td valign="top" align="left">Proteintech</td><td valign="top" align="left">60243-1-Ig</td></tr><tr><td valign="top" align="left">anti-CD31, monoclonal, ms IgG1, 1:200</td><td valign="top" align="left">BD Pharmingen</td><td valign="top" align="left">555444</td></tr><tr><td valign="top" align="left">anti-ChAT, polyclonal, rb IgG, 1:200</td><td valign="top" align="left">Proteintech</td><td valign="top" align="left">20747-1-AP</td></tr><tr><td valign="top" align="left">anti-DESMIN, monoclonal, rb IgG 1:500</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab15200</td></tr><tr><td valign="top" align="left">anti-FLK1, monoclonal, rt IgG2a, 1:200</td><td valign="top" align="left">BD Pharmingen</td><td valign="top" align="left">550549</td></tr><tr><td valign="top" align="left">anti-HB9-c, monoclonal, ms IgG1, 1:25</td><td valign="top" align="left">DSHB</td><td valign="top" align="left">81.5C10</td></tr><tr><td valign="top" align="left">anti-HOXA5, monoclonal, ms IgG1, 1:25</td><td valign="top" align="left">SantaCruz</td><td valign="top" align="left">sc365784</td></tr><tr><td valign="top" align="left">anti-HOXA10, monoclonal, rb IgG 1:200</td><td valign="top" align="left">AtlasAntibodies</td><td valign="top" align="left">HPA071918</td></tr><tr><td valign="top" align="left">anti-HOXB4, monoclonal, ms IgG1, 1:25</td><td valign="top" align="left">SantaCruz</td><td valign="top" align="left">sc365927</td></tr><tr><td valign="top" align="left">anti-HOXC6, monoclonal, ms IgG2a, 1:50</td><td valign="top" align="left">SantaCruz</td><td valign="top" align="left">sc376330</td></tr><tr><td valign="top" align="left">anti-HOXC9, monoclonal, ms IgG2b, 1:15</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab50839</td></tr><tr><td valign="top" align="left">anti-HOXC10, monoclonal, rb IgG, 1:150</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab153904</td></tr><tr><td valign="top" align="left">anti-ISL1, monoclonal, rb IgG; 1:1000</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab109517</td></tr><tr><td valign="top" align="left">anti-ISL1/2-c, monoclonal, ms IgG2b, 1:50</td><td valign="top" align="left">DSHB</td><td valign="top" align="left">39.4D5</td></tr><tr><td valign="top" align="left">anti-LHX3/LIM, polyclonal, rb IgG, 1:100</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab14555</td></tr><tr><td valign="top" align="left">anti-MAP2, polyclonal, ck IgY, 1:200</td><td valign="top" align="left">NovusBio</td><td valign="top" align="left">NB300-213</td></tr><tr><td valign="top" align="left">anti-MYOD1, monoclonal, ms IgG1, 1:150</td><td valign="top" align="left">BD Pharmingen</td><td valign="top" align="left">554130</td></tr><tr><td valign="top" align="left">anti-NESTIN, monoclonal, ms IgG1, 1:200</td><td valign="top" align="left">BD Pharmingen</td><td valign="top" align="left">611658</td></tr><tr><td valign="top" align="left">anti-NEUN, monoclonal, rb IgG, 1:500</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab177487</td></tr><tr><td valign="top" align="left">anti-NEUN, polyclonal, ck IgY, 1:200</td><td valign="top" align="left">Merck</td><td valign="top" align="left">ABN91</td></tr><tr><td valign="top" align="left">anti-NeuroD1, monoclonal, rb IgG, 1:1000</td><td valign="top" align="left">abcam</td><td valign="top" align="left">ab213725</td></tr><tr><td valign="top" align="left">anti-NGN2, monoclonal, ms IgG2a, 1:100</td><td valign="top" align="left">R&amp;D Systems</td><td valign="top" align="left">MAB3314</td></tr><tr><td valign="top" align="left">anti-NKX2.2-c, monoclonal, ms IgG2b, 1:20</td><td valign="top" align="left">DSHB</td><td valign="top" align="left">74.5A5</td></tr><tr><td valign="top" align="left">anti-NKX6.1-c, monoclonal, ms IgG1, 1:50</td><td valign="top" align="left">DSHB</td><td valign="top" align="left">F55A10</td></tr><tr><td valign="top" align="left">anti-OLIG2, polyclonal, rb IgG, 1:200</td><td valign="top" align="left">Proteintech</td><td valign="top" align="left">13999-1-AP</td></tr><tr><td valign="top" align="left">anti-PAN-MAGUK/PSD-95, monoclonal, ms IgG1, 1:500</td><td valign="top" align="left">Merck</td><td valign="top" align="left">MABN72</td></tr><tr><td valign="top" align="left">anti-PAX6-c, monoclonal, ms IgG1, 1:25</td><td valign="top" align="left">DSHB</td><td valign="top" align="left">PAX6_P3U1</td></tr><tr><td valign="top" align="left">anti-proBDNF, monoclonal, ms IgG1, 1:50</td><td valign="top" align="left">SantaCruz</td><td valign="top" align="left">sc65514</td></tr><tr><td valign="top" align="left">anti-REST, polyclonal, rb IgG, 1:200</td><td valign="top" align="left">Proteintech</td><td valign="top" align="left">22242-1-AP</td></tr><tr><td valign="top" align="left">anti-SOX1, polyclonal, gt IgG, 1:100</td><td valign="top" align="left">NovusBio</td><td valign="top" align="left">AF3369</td></tr><tr><td valign="top" align="left">anti-SOX2, monoclonal, rt IgG, 1:200</td><td valign="top" align="left">Invitrogen</td><td valign="top" align="left">14-9811-82</td></tr><tr><td valign="top" align="left">anti-SYNAPTOPHYSIN, monoclonal, rb IgG, 1:500</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab32127</td></tr><tr><td valign="top" align="left">anti-Chicken IgY (H+L) Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A11039</td></tr><tr><td valign="top" align="left">anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21121</td></tr><tr><td valign="top" align="left">anti-Mouse IgG2a Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21131</td></tr><tr><td valign="top" align="left">anti-Mouse IgG2b Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21141</td></tr><tr><td valign="top" align="left">anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A32731</td></tr><tr><td valign="top" align="left">anti-Rat IgG (H+L) Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A11006</td></tr><tr><td valign="top" align="left">anti-Goat IgG (H+L) Secondary Antibody, Alexa Fluor 488</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A11055</td></tr><tr><td valign="top" align="left">anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 546</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21123</td></tr><tr><td valign="top" align="left">anti-Mouse IgG2a Secondary Antibody, Alexa Fluor 555</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21137</td></tr><tr><td valign="top" align="left">anti-Mouse IgG2b Secondary Antibody, Alexa Fluor 546</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21143</td></tr><tr><td valign="top" align="left">anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 546</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A11035</td></tr><tr><td valign="top" align="left">anti-Chicken IgY (H+L) Secondary Antibody, Alexa Fluor 647</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A78952</td></tr><tr><td valign="top" align="left">anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 647</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21240</td></tr><tr><td valign="top" align="left">anti-Mouse IgG2b Secondary Antibody, Alexa Fluor 647</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21242</td></tr><tr><td valign="top" align="left">anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 647</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A21245</td></tr><tr><td valign="top" align="left">anti-Chicken IgY (H+L) Secondary Antibody, Alexa Fluor 647</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">A32933</td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Oligonucleotides and other sequence- based reagents</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">18s fw: AAACGGCTACCACATCCAAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">18s rev: CCTCCAATGGATCCTCGTTA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">BDNF fw: TAACGGCGGCAGACAAAAAGA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">BDNF rev: TGCACTTGGTCTCGTAGAAGTAT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">CDX2 fw: TGCGAGTGGATGCGGAAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">CDX2 rev: TTTCCTCCGGATGGTGATGTAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">CHAT fw: CGACAAGTCCCTGCAGTTTG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">CHAT rev: ACGGAGTCTGCTCGGATCA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">CXCR4 fw: AAATCTTCCTGCCCACCATC</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">CXCR4 rev: GTACTTGTCCGTCATGCTTCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">DCX fw: GTGTTTATTGCCTGTGGTCCTG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">DCX rev: GGAGGTTCCGTTTGCTGAGT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">DLG4 fw: GCCCCAGGATATGTGAACGG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">DLG4 rev: ATGTGTGGGTTGTCAGTGCC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">FGF8 fw: CCTACCAACTCTACAGCCGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">FGF8 rev: CTTTGCCGTTGCTCTTGGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">FLK1 fw: TGGTTGTGTATGTCCCACCC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">FLK1 rev: GGAGGAATGGCATAGACCGT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">GBX2 fw: GACGAGTCAAAGGTGGAAGAC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">GBX2 rev: GATTGTCATCCGAGCTGTAGTC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">GDF11 fw: TACACGACTTCCAGGGCGA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">GDF11 rev: CTGTACTGCTGGGTCCGTCTC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOM1 fw: AGTACACCTT CACAG GAATCCGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOM1 rev: TTGAGGGTAGCCAGTTCAGCC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA10 fw: AAGGATTCCCTGGGCAATTC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA10 rev: CCAGATTTTCACTTGTCTGTCC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA5 fw: GCTGCACATAAGTCATGACAACA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA5 rev: CCTTCTGCGGGTCAGGTAAC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA7 fw: ATGCGGTCTTCAGGACCTG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXA7 rev: GTGGGCGATTTCAATGCGG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC10 fw: CACCTCGGATAACGAAGCGA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC10 rev: TCCAATTCCAGCGTCTGGTG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC4 fw: AAATTCACGTTAGCACGGTGAAC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC4 rev: AGTGGGCGATCTCGATCCTTCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC6 fw: ATGAATTCGCACAGTGGGGT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC6 rev: CCGCGTTAGGTAGCGATTGA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC8 fw: CCTCCGCCAACACTAACAGTA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC8 rev: CTGTAAGTTTGCCGTCCACT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC9 rev GGGCGTGAATCCAGTTGGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">HOXC9 rev: GGGCGTGAATCCAGTTGGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">ISL1 fw: TGCTTTTCAGCAACTGGTCAAT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">ISL1 rev: AGGACTGGCTACCATGCTGT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">MAP2 fw: GTCACAGTGGAGGAAGCAGC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">MAP2 rev: CTGGGCTCTTGGTTACTCCG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">MNX1/HB9 fw: CTGGAGCACCAGTTCAAGCTCA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">MNX1/HB9 rev: TGGAACCAAATCTTCACCTGGGT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">NES fw: CTCAGCTTTCAGGACCCCAAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">NES rev: TCTCAAGGGTAGCAGGCAAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">NKX6.1 fw: CCTGTACCCCTCATCAAGGA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">NKX6.1 rev: GAATAGGCCAAACGAGCCCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">NT5E fw: CCTCTCAATCATGCCGCTTT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">NT5E rev: CCAGGTAATTGTGCCATTGTTG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">OLIG2 fw: TCAAATCGCATCCAGATTTTCGG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">OLIG2 rev: CAGAAAAAGGTCATCGGGCTCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">PAX6 fw: TTGCCCGAGAAAGACTAGCA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">PAX6 rev: TGGAGCCAGATGTGAAGGAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">SOX1 fw: CTGACGTCCACTCTCAGTCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">SOX1 rev: CCACATCCTAATCTTGAGCCA</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">SOX2 fw: GTACAACTCCATGACCAGCTC</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">SOX2 rev: CTTCAGCACCGAACCCAT</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><xref ref-type="bibr" rid="R56">Grass et al 2024</xref></td></tr><tr><td valign="top" align="left">SYN1 fw: GCACCCCCAGCTCAACAAAT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">SYN1 rev: GCGGATGGTCTCAGCTTTCA</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">TBX6 fw: GTCAGAAGCTGTCGGACTCAC</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">TBX6 rev: GGTGTCCAGTTCGGGGTAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">TUBB3 fw: GGCCTTTGGACATCTCTTCAG</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">TUBB3 rev: CCTCCGTGTAGTGACCCTT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">WNT3A fw: GGCCCCACTCGGATACTTCT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr><td valign="top" align="left">WNT3A rev: CAGCCAGCGACCACCAGAT</td><td valign="top" align="left">IDT</td><td valign="top" align="left">This paper</td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Chemicals, Enzymes and other reagents</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">10% SDS solution</td><td valign="top" align="left">Fisher BioReagents</td><td valign="top" align="left">10265153</td></tr><tr><td valign="top" align="left">1000x Antioxidant Supplement</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">A1345</td></tr><tr><td valign="top" align="left">1000x Polyamine Supplement</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">P8483</td></tr><tr><td valign="top" align="left">10x Genomics Chromium Single Cell Kit v3</td><td valign="top" align="left">10xGenomics</td><td valign="top" align="left">PN-1000268</td></tr><tr><td valign="top" align="left">2-Mercaptoethanol</td><td valign="top" align="left">Life Technologies</td><td valign="top" align="left">21985023</td></tr><tr><td valign="top" align="left">4% Paraformaldehyde solution in 1xPBS</td><td valign="top" align="left">SantaCruz</td><td valign="top" align="left">sc-281692</td></tr><tr><td valign="top" align="left">Absolute Ethanol Analar NP</td><td valign="top" align="left">VWR International</td><td valign="top" align="left">20821.33</td></tr><tr><td valign="top" align="left">Accutase</td><td valign="top" align="left">Corning</td><td valign="top" align="left">25-058-Cl</td></tr><tr><td valign="top" align="left">Advanced DMEM/F12</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">12634028</td></tr><tr><td valign="top" align="left">AGN193109</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">5758</td></tr><tr><td valign="top" align="left">Antipyrine</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">A5882-100G</td></tr><tr><td valign="top" align="left">Ascorbic Acid</td><td valign="top" align="left">SigmaAldrich</td><td valign="top" align="left">A4403</td></tr><tr><td valign="top" align="left">B27 with Vit.A</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">17504044</td></tr><tr><td valign="top" align="left">Blasticidin S Hydrochlorid</td><td valign="top" align="left">Carl Roth</td><td valign="top" align="left">Cp14.2</td></tr><tr><td valign="top" align="left">BSA</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">A9418</td></tr><tr><td valign="top" align="left">BbsI-HF</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left"/></tr><tr><td valign="top" align="left">CellTiter-Glo 3D Cell Viability Assay</td><td valign="top" align="left">Promega</td><td valign="top" align="left">G9682</td></tr><tr><td valign="top" align="left">CellTrace Calcein Red-Orange Dye</td><td valign="top" align="left">ThermoScientific</td><td valign="top" align="left">C34851</td></tr><tr><td valign="top" align="left">CHIR99021</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">4423</td></tr><tr><td valign="top" align="left">Chloroform for RNA Isolation</td><td valign="top" align="left">Serva Electrophoresis GmbH</td><td valign="top" align="left">39553.01</td></tr><tr><td valign="top" align="left">Chroman 1</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">7163</td></tr><tr><td valign="top" align="left">Cryostor CS10 Freezing Medium</td><td valign="top" align="left">STEMCELL Technologies</td><td valign="top" align="left">100-1061</td></tr><tr><td valign="top" align="left">DAPT</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">2634/10</td></tr><tr><td valign="top" align="left">DirectPCR Lysis-Reagent Cell</td><td valign="top" align="left">VWR</td><td valign="top" align="left">31-301-C</td></tr><tr><td valign="top" align="left">DNase</td><td valign="top" align="left">Worthington</td><td valign="top" align="left">LK003172</td></tr><tr><td valign="top" align="left">Doxycycline</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">D9891</td></tr><tr><td valign="top" align="left">EcoRI</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">R0101S</td></tr><tr><td valign="top" align="left">Emricasan</td><td valign="top" align="left">HyCultec</td><td valign="top" align="left">HY-10396</td></tr><tr><td valign="top" align="left">Fluoromount G</td><td valign="top" align="left">Invitrogen</td><td valign="top" align="left">00-4958-02</td></tr><tr><td valign="top" align="left">Gibson Assembly Master Mix</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">NEB #E2611</td></tr><tr><td valign="top" align="left">Gibson Assembly Cloning Kit</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">NEB #E5510S</td></tr><tr><td valign="top" align="left">Glacial Acetic Acid Solution</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">A6283</td></tr><tr><td valign="top" align="left">Glucose</td><td valign="top" align="left">Sigma Aldrich</td><td valign="top" align="left">G7021</td></tr><tr><td valign="top" align="left">GlutaMAX</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">35050087</td></tr><tr><td valign="top" align="left">Glycine</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">J16407.36</td></tr><tr><td valign="top" align="left">GoTaq qPCR Master Mix</td><td valign="top" align="left">Promega</td><td valign="top" align="left">A6002</td></tr><tr><td valign="top" align="left">Halt-Protease Inhibitor</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">78429</td></tr><tr><td valign="top" align="left">High Capacity cDNA Reverse Transcription Kit</td><td valign="top" align="left">Applied Biosystems</td><td valign="top" align="left">4374967</td></tr><tr><td valign="top" align="left">Hoechst 33342 Dye</td><td valign="top" align="left">Life Technologies</td><td valign="top" align="left">H3570</td></tr><tr><td valign="top" align="left">LDN193189</td><td valign="top" align="left">Stemgent</td><td valign="top" align="left">04-0074</td></tr><tr><td valign="top" align="left">LB-Medium (Luria/Miller)</td><td valign="top" align="left">Carl Roth</td><td valign="top" align="left">X968.1</td></tr><tr><td valign="top" align="left">Matrigel</td><td valign="top" align="left">Corning</td><td valign="top" align="left">354234</td></tr><tr><td valign="top" align="left">mTesR plus</td><td valign="top" align="left">STEMCELL Technologies</td><td valign="top" align="left">100-0276</td></tr><tr><td valign="top" align="left">N2</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">17502048</td></tr><tr><td valign="top" align="left">N-butyldiethanolamine</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">11352367</td></tr><tr><td valign="top" align="left">Neurobasal Medium</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">21103049</td></tr><tr><td valign="top" align="left">Neurobasal Medium without Phenol Red</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">12348017</td></tr><tr><td valign="top" align="left">NruI-HF</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">R3192L</td></tr><tr><td valign="top" align="left">NGS</td><td valign="top" align="left">Abcam</td><td valign="top" align="left">ab7481</td></tr><tr><td valign="top" align="left">NucleoSpin RNA/Protein Kit</td><td valign="top" align="left">Macherey Nagel</td><td valign="top" align="left">740933250</td></tr><tr><td valign="top" align="left">P3 Primary Cell 4D-Nucleofector Kit</td><td valign="top" align="left">Lonza</td><td valign="top" align="left">V4XP-3032</td></tr><tr><td valign="top" align="left">Papain</td><td valign="top" align="left">Worthington</td><td valign="top" align="left">LK003178</td></tr><tr><td valign="top" align="left">Penicillin-Streptomycin</td><td valign="top" align="left">Life Technologies</td><td valign="top" align="left">15140122</td></tr><tr><td valign="top" align="left">Puromycin dihydrochlorid</td><td valign="top" align="left">Merck</td><td valign="top" align="left">P8833</td></tr><tr><td valign="top" align="left">Proteinase K</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">EO0492</td></tr><tr><td valign="top" align="left">RA (Retinoic Acid)</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">R2625</td></tr><tr><td valign="top" align="left">Recombinant BDNF</td><td valign="top" align="left">Qkine</td><td valign="top" align="left">QK050</td></tr><tr><td valign="top" align="left">Recombinant FGF2</td><td valign="top" align="left">Qkine</td><td valign="top" align="left">Qk027</td></tr><tr><td valign="top" align="left">Recombinant FGF8b</td><td valign="top" align="left">Preprotech</td><td valign="top" align="left">100-25</td></tr><tr><td valign="top" align="left">Recombinant GDF11</td><td valign="top" align="left">Preprotech</td><td valign="top" align="left">120-11</td></tr><tr><td valign="top" align="left">Recombinant GDNF</td><td valign="top" align="left">Qkine</td><td valign="top" align="left">QK051</td></tr><tr><td valign="top" align="left">ReLeSR</td><td valign="top" align="left">STEMCELL Technologies</td><td valign="top" align="left">100-0484</td></tr><tr><td valign="top" align="left">Saccharose</td><td valign="top" align="left">Millipore</td><td valign="top" align="left">107651</td></tr><tr><td valign="top" align="left">SAG (Smoothened Agonist)</td><td valign="top" align="left">Merck</td><td valign="top" align="left">364590-63-6</td></tr><tr><td valign="top" align="left">SB431542</td><td valign="top" align="left">Stemgent</td><td valign="top" align="left">04-0010</td></tr><tr><td valign="top" align="left">Seche Vite Dry Fast Top Coat</td><td valign="top" align="left">Amazon</td><td valign="top" align="left">B0027VCNGO</td></tr><tr><td valign="top" align="left">Sodium Azide</td><td valign="top" align="left">Merck</td><td valign="top" align="left">822335</td></tr><tr><td valign="top" align="left">Sodium Acetate</td><td valign="top" align="left">Sigma-Aldrich</td><td valign="top" align="left">S8750</td></tr><tr><td valign="top" align="left">T7 DNA ligase</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">M0318S</td></tr><tr><td valign="top" align="left">TissueTek OCT</td><td valign="top" align="left">Sakura Finetek</td><td valign="top" align="left">4583</td></tr><tr><td valign="top" align="left">trans-ISRIB</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">5284</td></tr><tr><td valign="top" align="left">TRI-Reagent</td><td valign="top" align="left">ZymoResearch</td><td valign="top" align="left">R2050-1-200</td></tr><tr><td valign="top" align="left">Triton-X</td><td valign="top" align="left">Merck</td><td valign="top" align="left">108643</td></tr><tr><td valign="top" align="left">0.4% Trypan Blue Solution</td><td valign="top" align="left">Merck</td><td valign="top" align="left">T8154</td></tr><tr><td valign="top" align="left">Tween20</td><td valign="top" align="left">Carl Roth</td><td valign="top" align="left">9127.1</td></tr><tr><td valign="top" align="left">UltraPure 0.5M EDTA, pH 8.0-4</td><td valign="top" align="left">Invitrogen</td><td valign="top" align="left">11568896</td></tr><tr><td valign="top" align="left">Ultrapure Glycogen</td><td valign="top" align="left">Thermo Fisher Scientific</td><td valign="top" align="left">10814010</td></tr><tr><td valign="top" align="left">UVI3003</td><td valign="top" align="left">Tocris</td><td valign="top" align="left">3303</td></tr><tr><td valign="top" align="left">Vectashield Antifade Mounting Medium</td><td valign="top" align="left">Biozol Diagnostica</td><td valign="top" align="left">VEC-H-1000</td></tr><tr><td valign="top" align="left">XhoI</td><td valign="top" align="left">New England Biolabs</td><td valign="top" align="left">R0146S</td></tr><tr><td valign="top" align="left">Y-27632 (ROCKi)</td><td valign="top" align="left">StemCell</td><td valign="top" align="left">72308</td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Software and software packages (V= Version)</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">Affinity Designer 2</td><td valign="top" align="left">Serif Europe</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://affinity.serif.com/de/">https://affinity.serif.com/de/</ext-link></td></tr><tr><td valign="top" align="left">Arivis SIS Converter Pro V4.1</td><td valign="top" align="left">Carl Zeiss Microscopy Deutschland GmbH</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr><tr><td valign="top" align="left">Arivis Vision 4D V.4</td><td valign="top" align="left">Carl Zeiss Microscopy Deutschland GmbH</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr><tr><td valign="top" align="left">dMqPCR-Caclulations Webtool</td><td valign="top" align="left">Universite Clermont Auvergne</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://umrh-bioinfo.clermont.inrae.fr/do_my_qPCRcalc/">https://umrh-bioinfo.clermont.inrae.fr/do_my_qPCRcalc/</ext-link>, <xref ref-type="bibr" rid="R152">Tournayre et al 2019</xref></td></tr><tr><td valign="top" align="left">Cell Ranger (v7.0.0)</td><td valign="top" align="left">10xGenomics</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/support/software/cell-ranger/latest">https://www.10xgenomics.com/support/software/cell-ranger/latest</ext-link></td></tr><tr><td valign="top" align="left">Geneious Prime V.2024.0</td><td valign="top" align="left">GraphPad Software/ Dotmatics</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.geneious.com/">https://www.geneious.com/</ext-link></td></tr><tr><td valign="top" align="left">Graphpad PRISM V.10</td><td valign="top" align="left">GraphPad Software/Dotmatics</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td></tr><tr><td valign="top" align="left">Harmony V4.0</td><td valign="top" align="left">Perkin Elmer</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://content.perkinelmer.com/">https://content.perkinelmer.com/</ext-link></td></tr><tr><td valign="top" align="left">IDT Oligo Analyzer Webtool</td><td valign="top" align="left">IDT</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/pages/tools/oligoanalyzer">https://eu.idtdna.com/pages/tools/oligoanalyzer</ext-link></td></tr><tr><td valign="top" align="left">Microsoft Excel V.2013</td><td valign="top" align="left">Microsoft</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.microsoft.com/de-de/microsoft-365/previous-versions/microsoft-excel-2013">https://www.microsoft.com/de-de/microsoft-365/previous-versions/microsoft-excel-2013</ext-link></td></tr><tr><td valign="top" align="left">NCBI Primer Blast</td><td valign="top" align="left">NIH</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/">https://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link>, <xref ref-type="bibr" rid="R170">Ye et al 2012</xref></td></tr><tr><td valign="top" align="left">OpenAI ChatGPT V4.0 (08.07.24)</td><td valign="top" align="left">OpenAI</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://chatgpt.com/">https://chatgpt.com/</ext-link></td></tr><tr><td valign="top" align="left">QuantStudio V.7</td><td valign="top" align="left">Applied Biosystems</td><td valign="top" align="left">CMCB Technology Platform, Siewecke Laboratory</td></tr><tr><td valign="top" align="left">ZEN Blue V3.2</td><td valign="top" align="left">Carl Zeiss Microscopy Deutschland GmbH</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://posit.co/download/rstudio-desktop">https://posit.co/download/rstudio-desktop</ext-link></td></tr><tr><td valign="top" align="left">R Studio V3.5</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://www.microshop.zeiss.com/de/de/softwarefinder/software-categories/zen-blue">https://www.microshop.zeiss.com/de/de/softwarefinder/software-categories/zen-blue</ext-link></td></tr><tr><td valign="top" align="left">R package: agricolae_V1.3.7</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><xref ref-type="bibr" rid="R33">De Mendiburu 2009</xref></td></tr><tr><td valign="top" align="left">R package: ggplot2_V.3.5.1</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><xref ref-type="bibr" rid="R164">Wickham 2016</xref></td></tr><tr><td valign="top" align="left">R package: lme4_V.1.1-35.5</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left">Bates et al 2015</td></tr><tr><td valign="top" align="left">R package: PMCMRplus_V1.9.10</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><xref ref-type="bibr" rid="R121">Pohlert 2023</xref></td></tr><tr><td valign="top" align="left">R package: Seurat V.5</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><xref ref-type="bibr" rid="R133">Satija et al 2015</xref>, Hao et al 2023</td></tr><tr><td valign="top" align="left">R package: tidyverse_V.2.0.0</td><td valign="top" align="left"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org">https://cran.r-project.org</ext-link></td><td valign="top" align="left"><xref ref-type="bibr" rid="R165">Wickham et al 2019</xref></td></tr><tr style="background-color:#E6E6E6"><td valign="top" align="left"><bold>Other</bold></td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">4D-Nucleofector® X Unit</td><td valign="top" align="left">Lonza</td><td valign="top" align="left">AAF-1003X</td></tr><tr><td valign="top" align="left">Biorad C1000 Touch Thermal Cycler</td><td valign="top" align="left">Biorad</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">Corning 100 mm Ultra-Low Attachment Culture Dish</td><td valign="top" align="left">Corning</td><td valign="top" align="left">4615</td></tr><tr><td valign="top" align="left">Corning 96-well Spheroid Microplates</td><td valign="top" align="left">Corning</td><td valign="top" align="left">4515</td></tr><tr><td valign="top" align="left">Corning Cell Lifter</td><td valign="top" align="left">Corning</td><td valign="top" align="left">3008</td></tr><tr><td valign="top" align="left">Corning Costar 24-well Clear Flat Bottom Ultra-Low Attachment Plates</td><td valign="top" align="left">Corning</td><td valign="top" align="left">3473</td></tr><tr><td valign="top" align="left">Corning Costar 6-well Clear TC-treated Multiple Well Plates</td><td valign="top" align="left">Corning</td><td valign="top" align="left">3516</td></tr><tr><td valign="top" align="left">Cryostat Leica CM3050S</td><td valign="top" align="left">Leica</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">Infinite 200 Pro Reader</td><td valign="top" align="left">Tecan</td><td valign="top" align="left">CMCB Technology Platform</td></tr><tr><td valign="top" align="left">Merck S2GPT10RE Merck Steritop 1000ml</td><td valign="top" align="left">Merck</td><td valign="top" align="left">15939180</td></tr><tr><td valign="top" align="left">Mr. Frosty Freezing Container</td><td valign="top" align="left">Thermo Scientific</td><td valign="top" align="left">10110051</td></tr><tr><td valign="top" align="left">Microseal 'B' PCR Plate Sealing Film, adhesive, optical</td><td valign="top" align="left">Biorad</td><td valign="top" align="left">MSB1001</td></tr><tr><td valign="top" align="left">Multi Shaker</td><td valign="top" align="left">neoLabLine</td><td valign="top" align="left">7-0950</td></tr><tr><td valign="top" align="left">NanoDrop TM 1000 Spectrophotometer V3.8</td><td valign="top" align="left">Thermo Scientific</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">Nikon Eclipse Ts2 Microscope</td><td valign="top" align="left">Nikon</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">Operetta CLS High-Content Imaging System</td><td valign="top" align="left">Perkin Elmer</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">PCR Plate, 384-well, standard</td><td valign="top" align="left">Thermo Scientific</td><td valign="top" align="left">AB1384</td></tr><tr><td valign="top" align="left">QuantStudio Real-Time PCR System, 384-well</td><td valign="top" align="left">Applied Biosystems</td><td valign="top" align="left">CMCB Technology Platform</td></tr><tr><td valign="top" align="left">TFP40 OTS40 Stretching Table</td><td valign="top" align="left">MEDlite</td><td valign="top" align="left">DZNE Technology Platform</td></tr><tr><td valign="top" align="left">Zeiss Apotome.3 Microscope</td><td valign="top" align="left">Zeiss</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr><tr><td valign="top" align="left">Zeiss Axioscan Z.1</td><td valign="top" align="left">Zeiss</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr><tr><td valign="top" align="left">Zeiss Confocal Spinning Disc Microscope</td><td valign="top" align="left">Zeiss</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr><tr><td valign="top" align="left">Zeiss LSM 980 AiryScan</td><td valign="top" align="left">Zeiss</td><td valign="top" align="left">Imaging Platform of the DZNE Dresden</td></tr></tbody></table></table-wrap></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS202387-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d65aAcFbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S23"><title>Acknowledgments</title><p>We would like to thank Thomas Becker (CRTD, TU Dresden) and Ana Rita Encarnação Aires (CRTD, TU Dresden) for their insightful feedback on our manuscript. We thank Lee Rubin (Harvard University) and Katrin Neumann (CRTD Stem cell Engineering facility, TU Dresden) for providing the MTAs enabling the work with the BJ-siPS WT, 1016A WT hiPSCs, 18A WT hiPSCs and the CRTD1 line, respectively, and the Sanger Institute for providing the KOLF-C1 hiPSC line. We thank Fabian Rost and all members of the DRESDEN-concept Genome Center (DcGC) (CMCB Technology Platform, TUD) for performing the scRNAseq experiment. We thank Silke White (Imaging, DZNE) and Ellen Geibelt (DZNE Imaging Platform and Light Microscopy Facility of CMCB) for their support and training on multiple microscopes and Zeynep Tansu Atasavum for training of our team on Arivis. We thank Anna Dalinskaya and Ines Rosignol for technical assistance. We thank Mike Karl (DZNE) for access to the Leica Cryostat and Michael Siewecke (CRTD) for access to the Applied Biosystem qPCR machine. We thank Gerd Kempermann (DZNE) for anti-NeuroD1 antibody and all past and present members of the Rodriguez-Muela Laboratory for their contributions to insightful discussions.</p><sec id="S24"><title>Funding</title><p>This work was supported by the European Research Council (ERC-StG 802182), Funding Programs for DZNE-Helmholtz, TU Dresden CRTD and MPI-CBG to NRM and German Society for Muscle Diseases (DGM e.V., Bu4/1) to FB, TG and NRM.</p></sec></ack><fn-group><fn id="FN1" fn-type="con"><p id="P37"><bold>Author Contributions</bold> Felix Buchner: Conceptualization; data curation; formal analysis; visualization; methodology; writing, review and editing, funding acquisition. Zeynep Dokuzluoglu: conceptualization; data curation; formal analysis; review and editing. Joshua Thomas: data curation; formal analysis; methodology; review and editing. Antonio Caldarelli: data curation; formal analysis. Shrutika Kavali: formal analysis; methodology. Fabian Rost: data curation; formal analysis; methodology. Tobias grass: data curation; formal analysis, methodology; review and editing. Natalia Rodríguez-Muela: Conceptualization; supervision; writing, review and editing, funding acquisition; project administration.</p></fn><fn id="FN2" fn-type="conflict"><p id="P38"><bold>Declaration of interests</bold> Authors declare that they have no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>Youngwook</given-names></name><name><surname>Mullan</surname><given-names>Hillary E</given-names></name><name><surname>Krumlauf</surname><given-names>Robb</given-names></name></person-group><article-title>Long-Range Regulation by Shared Retinoic Acid Response Elements Modulates Dynamic Expression of Posterior Hoxb Genes in CNS Development</article-title><source>Developmental Biology</source><year>2014</year><month>April</month><day>1</day><volume>388</volume><issue>1</issue><fpage>134</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">24525295</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>Shilu</given-names></name><name><surname>Neijts</surname><given-names>Roel</given-names></name><name><surname>Simmini</surname><given-names>Salvatore</given-names></name><name><surname>van Rooijen</surname><given-names>Carina</given-names></name><name><surname>Tan</surname><given-names>Sander C</given-names></name><name><surname>Kester</surname><given-names>Lennart</given-names></name><name><surname>van Oudenaarden</surname><given-names>Alexander</given-names></name><name><surname>Creyghton</surname><given-names>Menno P</given-names></name><name><surname>Deschamps</surname><given-names>Jacqueline</given-names></name></person-group><article-title>Cdx and T Brachyury Co-Activate Growth Signaling in the Embryonic Axial Progenitor Niche</article-title><source>Cell Reports</source><year>2016</year><month>December</month><day>20</day><volume>17</volume><issue>12</issue><fpage>3165</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">28009287</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoroso</surname><given-names>Mackenzie W</given-names></name><name><surname>Croft</surname><given-names>Gist F</given-names></name><name><surname>Williams</surname><given-names>Damian J</given-names></name><name><surname>O’Keeffe</surname><given-names>Sean</given-names></name><name><surname>Carrasco</surname><given-names>Monica A</given-names></name><name><surname>Davis</surname><given-names>Anne R</given-names></name><name><surname>Roybon</surname><given-names>Laurent</given-names></name></person-group><article-title>Accelerated High-Yield Generation of Limb-Innervating Motor Neurons from Human Stem Cells</article-title><source>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience</source><year>2013</year><month>January</month><day>9</day><volume>33</volume><issue>2</issue><fpage>574</fpage><lpage>86</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC3711539</pub-id><pub-id pub-id-type="pmid">23303937</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0906-12.2013</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Disi</given-names></name><etal/></person-group><article-title>Stem Cell-Derived Cranial and Spinal Motor Neurons Reveal Proteostatic Differences between ALS Resistant and Sensitive Motor Neurons</article-title><source>eLife</source><year>2019</year><month>June</month><person-group person-group-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><etal/></person-group><volume>8</volume><elocation-id>e44423</elocation-id><comment>eLife</comment><pub-id pub-id-type="pmcid">PMC6594754</pub-id><pub-id pub-id-type="pmid">31157617</pub-id><pub-id pub-id-type="doi">10.7554/eLife.44423</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>Jimena</given-names></name><name><surname>Revah</surname><given-names>Omer</given-names></name><name><surname>Miura</surname><given-names>Yuki</given-names></name><name><surname>Thom</surname><given-names>Nicholas</given-names></name><name><surname>Amin</surname><given-names>Neal D</given-names></name><name><surname>Kelley</surname><given-names>Kevin W</given-names></name><name><surname>Singh</surname><given-names>Mandeep</given-names></name></person-group><article-title>Generation of Functional Human 3D Cortico-Motor Assembloids</article-title><source>Cell</source><year>2020</year><month>December</month><day>23</day><volume>183</volume><issue>7</issue><fpage>1913</fpage><lpage>1929</lpage><elocation-id>e26</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC8711252</pub-id><pub-id pub-id-type="pmid">33333020</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.017</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>Jimena</given-names></name><etal/></person-group><article-title>Single-Cell Transcriptomic Landscape of the Developing Human Spinal Cord</article-title><source>Nature Neuroscience</source><year>2023</year><month>May</month><volume>26</volume><issue>5</issue><fpage>902</fpage><lpage>14</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmid">37095394</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>Olov</given-names></name><name><surname>Reissmann</surname><given-names>Eva</given-names></name><name><surname>Ibáñez</surname><given-names>Carlos F</given-names></name></person-group><article-title>Growth differentiation factor 11 signals through the transforming growth factor-β receptor ALK5 to regionalize the anterior–posterior axis</article-title><source>EMBO Reports</source><year>2006</year><month>August</month><volume>7</volume><issue>8</issue><fpage>831</fpage><lpage>37</lpage><pub-id pub-id-type="pmcid">PMC1525155</pub-id><pub-id pub-id-type="pmid">16845371</pub-id><pub-id pub-id-type="doi">10.1038/sj.embor.7400752</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arber</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name><name><surname>Sockanathan</surname><given-names>S</given-names></name></person-group><article-title>Requirement for the Homeobox Gene Hb9 in the Consolidation of Motor Neuron Identity</article-title><source>Neuron</source><year>1999</year><month>August</month><volume>23</volume><issue>4</issue><fpage>659</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">10482234</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ato García</surname><given-names>Manuel</given-names></name><name><surname>Seco</surname><given-names>Guillermo Vallejo</given-names></name><name><surname>Pol</surname><given-names>Alfonso Palmer</given-names></name></person-group><article-title>The Two-Way Mixed Model: A Long and Winding Controversy</article-title><source>Psicothema</source><year>2013</year><month>February</month><issue>25.1</issue><fpage>130</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">23336555</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aires</surname><given-names>Rita</given-names></name><etal/></person-group><article-title>Tail Bud Progenitor Activity Relies on a Network Comprising Gdf11, Lin28, and Hox13 Genes</article-title><source>Developmental Cell</source><year>2019</year><month>Feb</month><volume>48</volume><issue>3</issue><fpage>383</fpage><lpage>395</lpage><elocation-id>e8</elocation-id><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">30661984</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>Myungin</given-names></name><etal/></person-group><article-title>Columnar-Intrinsic Cues Shape Premotor Input Specificity in Locomotor Circuits</article-title><source>Cell Reports</source><year>2017</year><month>Oct</month><volume>21</volume><issue>4</issue><fpage>867</fpage><lpage>77</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC5665584</pub-id><pub-id pub-id-type="pmid">29069594</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.004</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>Douglas</given-names></name><name><surname>Maechler</surname><given-names>Martin</given-names></name><name><surname>Bolker</surname><given-names>Ben</given-names></name><name><surname>Walker</surname><given-names>Steven</given-names></name></person-group><article-title>Lme4: Linear Mixed-Effects Models Using ‚Eigen‘ and S4</article-title><year>2003</year><month>June</month><day>25</day><pub-id pub-id-type="doi">10.32614/CRAN.package.lme4</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxi</surname><given-names>Emily G</given-names></name><name><surname>Thompson</surname><given-names>Terri</given-names></name><name><surname>Li</surname><given-names>Jonathan</given-names></name><name><surname>Kaye</surname><given-names>Julya A</given-names></name><name><surname>Lim</surname><given-names>Ryan G</given-names></name><name><surname>Wu</surname><given-names>Jie</given-names></name><name><surname>Ramamoorthy</surname><given-names>Divya</given-names></name></person-group><article-title>„Answer ALS, a Large-Scale Resource for Sporadic and Familial ALS Combining Clinical and Multi-Omics Data from Induced Pluripotent Cell Lines</article-title><source>Nature Neuroscience</source><year>2022</year><month>February</month><volume>25</volume><issue>2</issue><fpage>226</fpage><lpage>37</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC8825283</pub-id><pub-id pub-id-type="pmid">35115730</pub-id><pub-id pub-id-type="doi">10.1038/s41593-021-01006-0</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becht</surname><given-names>Etienne</given-names></name><name><surname>McInnes</surname><given-names>Leland</given-names></name><name><surname>Healy</surname><given-names>John</given-names></name><name><surname>Dutertre</surname><given-names>Charles-Antoine</given-names></name><name><surname>Kwok</surname><given-names>Immanuel WH</given-names></name><name><surname>Ng</surname><given-names>Lai Guan</given-names></name><name><surname>Ginhoux</surname><given-names>Florent</given-names></name><name><surname>Newell</surname><given-names>Evan W</given-names></name></person-group><article-title>Dimensionality Reduction for Visualizing Single-Cell Data Using UMAP</article-title><source>Nature Biotechnology</source><year>2018</year><month>December</month><comment>1</comment><pub-id pub-id-type="pmid">30531897</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shushan</surname><given-names>Etti</given-names></name><etal/></person-group><article-title>Notch Signaling Regulates Motor Neuron Differentiation of Human Embryonic Stem Cells</article-title><source>Stem Cells</source><year>2015</year><month>Feb</month><volume>33</volume><issue>2</issue><fpage>403</fpage><lpage>15</lpage><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmid">25335858</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>Stuart</given-names></name><etal/></person-group><article-title>Ilastik: Interactive Machine Learning for (Bio)Image Analysis</article-title><source>Nature Methods</source><year>2019</year><month>Dec</month><volume>16</volume><issue>12</issue><fpage>1226</fpage><lpage>32</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmid">31570887</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>B</given-names></name><etal/></person-group><article-title>An Essential Role for Retinoid Signaling in Anteroposterior Neural Patterning</article-title><source>Development (Cambridge, England)</source><year>1997</year><month>Jan</month><volume>124</volume><issue>2</issue><fpage>373</fpage><lpage>79</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">9053313</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchner</surname><given-names>Felix</given-names></name><name><surname>Dokuzluoglu</surname><given-names>Zeynep</given-names></name><name><surname>Grass</surname><given-names>Tobias</given-names></name><name><surname>Rodriguez-Muela</surname><given-names>Natalia</given-names></name></person-group><article-title>Spinal Cord Organoids to Study Motor Neuron Development and Disease</article-title><source>Life (Basel, Switzerland)</source><year>2023</year><month>Mai</month><day>25</day><volume>13</volume><issue>6</issue><fpage>1254</fpage><pub-id pub-id-type="pmcid">PMC10303776</pub-id><pub-id pub-id-type="pmid">37374039</pub-id><pub-id pub-id-type="doi">10.3390/life13061254</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolondi</surname><given-names>Adriano</given-names></name><etal/></person-group><article-title>Reconstructing Axial Progenitor Field Dynamics in Mouse Stem Cell-Derived Embryoids</article-title><source>Developmental Cell</source><year>2024</year><month>June</month><volume>59</volume><issue>12</issue><fpage>1489</fpage><lpage>1505</lpage><elocation-id>e14</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC11187653</pub-id><pub-id pub-id-type="pmid">38579718</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2024.03.024</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulting</surname><given-names>Gabriella L</given-names></name><etal/></person-group><article-title>A Functionally Characterized Test Set of Human Induced Pluripotent Stem Cells</article-title><source>Nature Biotechnology</source><year>2011</year><month>Mar</month><volume>29</volume><issue>3</issue><fpage>279</fpage><lpage>86</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC3229307</pub-id><pub-id pub-id-type="pmid">21293464</pub-id><pub-id pub-id-type="doi">10.1038/nbt.1783</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cakir</surname><given-names>Bilal</given-names></name><etal/></person-group><article-title>Engineering of Human Brain Organoids with a Functional Vascular-like System</article-title><source>Nature Methods</source><year>2019</year><month>Nov</month><volume>16</volume><issue>11</issue><fpage>1169</fpage><lpage>75</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC6918722</pub-id><pub-id pub-id-type="pmid">31591580</pub-id><pub-id pub-id-type="doi">10.1038/s41592-019-0586-5</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erica</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Fei</given-names></name><name><surname>Jiang</surname><given-names>Guanglong</given-names></name><name><surname>Tan</surname><given-names>Zhiyong</given-names></name><name><surname>Cunningham</surname><given-names>Geneva M</given-names></name><name><surname>Wu</surname><given-names>Xi</given-names></name><name><surname>Philips</surname><given-names>Santosh</given-names></name><name><surname>Schneider</surname><given-names>Bryan P</given-names></name></person-group><article-title>„Passage Number Affects Differentiation of Sensory Neurons from Human Induced Pluripotent Stem Cells</article-title><source>Scientific Reports</source><year>2022</year><month>September</month><day>23</day><volume>12</volume><issue>1</issue><elocation-id>15869</elocation-id><pub-id pub-id-type="pmcid">PMC9508090</pub-id><pub-id pub-id-type="pmid">36151116</pub-id><pub-id pub-id-type="doi">10.1038/s41598-022-19018-6</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catela</surname><given-names>Catarina</given-names></name><etal/></person-group><article-title>The Iroquois (Iro/Irx) Homeobox Genes Are Conserved Hox Targets Involved in Motor Neuron Development</article-title><source>bioRxiv: The Preprint Server for Biology</source><year>2024</year><month>May</month><elocation-id>2024.05.30.596714</elocation-id><comment>PubMed</comment><pub-id pub-id-type="doi">10.1101/2024.05.30.596714</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>Stuart M</given-names></name><name><surname>Fasano</surname><given-names>Christopher A</given-names></name><name><surname>Papapetrou</surname><given-names>Eirini P</given-names></name><name><surname>Tomishima</surname><given-names>Mark</given-names></name><name><surname>Sadelain</surname><given-names>Michel</given-names></name><name><surname>Studer</surname><given-names>Lorenz</given-names></name></person-group><article-title>„Highly Efficient Neural Conversion of Human ES and iPS Cells by Dual Inhibition of SMAD Signaling</article-title><source>Nature Biotechnology</source><year>2009</year><month>March</month><volume>27</volume><issue>3</issue><fpage>275</fpage><lpage>80</lpage><pub-id pub-id-type="pmcid">PMC2756723</pub-id><pub-id pub-id-type="pmid">19252484</pub-id><pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Yu</given-names></name><name><surname>Tristan</surname><given-names>Carlos A</given-names></name><name><surname>Chen</surname><given-names>Lu</given-names></name><name><surname>Jovanovic</surname><given-names>Vukasin M</given-names></name><name><surname>Malley</surname><given-names>Claire</given-names></name><name><surname>Chu</surname><given-names>Pei-Hsuan</given-names></name><name><surname>Ryu</surname><given-names>Seungmi</given-names></name></person-group><article-title>A Versatile Polypharmacology Platform Promotes Cytoprotection and Viability of Human Pluripotent and Differentiated Cells</article-title><source>Nature Methods</source><year>2021</year><month>Mai</month><volume>18</volume><issue>5</issue><fpage>528</fpage><lpage>41</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC8314867</pub-id><pub-id pub-id-type="pmid">33941937</pub-id><pub-id pub-id-type="doi">10.1038/s41592-021-01126-2</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciruna</surname><given-names>B</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><article-title>FGF Signaling Regulates Mesoderm Cell Fate Specification and Morphogenetic Movement at the Primitive Streak</article-title><source>Developmental Cell</source><year>2001</year><month>July</month><volume>1</volume><issue>1</issue><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">11703922</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>RA</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><article-title>„Exogenous Retinoic Acid Rapidly Induces Anterior Ectopic Expression of Murine Hox-2 Genes in Vivo</article-title><source>Development (Cambridge, England)</source><year>1992</year><month>October</month><volume>116</volume><issue>2</issue><fpage>357</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">1363087</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>Thomas J</given-names></name><name><surname>Duester</surname><given-names>Gregg</given-names></name></person-group><article-title>Mechanisms of Retinoic Acid Signalling and Its Roles in Organ and Limb Development</article-title><source>Nature Reviews. Molecular Cell Biology</source><year>2015</year><month>February</month><volume>16</volume><issue>2</issue><fpage>110</fpage><lpage>23</lpage><pub-id pub-id-type="pmcid">PMC4636111</pub-id><pub-id pub-id-type="pmid">25560970</pub-id><pub-id pub-id-type="doi">10.1038/nrm3932</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>Thomas J</given-names></name><name><surname>Zhao</surname><given-names>Xianling</given-names></name><name><surname>Duester</surname><given-names>Gregg</given-names></name></person-group><article-title>Uncoupling of Retinoic Acid Signaling from Tailbud Development before Termination of Body Axis Extension</article-title><source>Genesis</source><year>2011</year><month>October</month><volume>49</volume><issue>10</issue><fpage>776</fpage><lpage>83</lpage><pub-id pub-id-type="pmcid">PMC3216692</pub-id><pub-id pub-id-type="pmid">21538808</pub-id><pub-id pub-id-type="doi">10.1002/dvg.20763</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasen</surname><given-names>Jeremy S</given-names></name><name><surname>Liu</surname><given-names>Jeh-Ping</given-names></name><name><surname>Jessell</surname><given-names>Thomas M</given-names></name></person-group><article-title>Motor Neuron Columnar Fate Imposed by Sequential Phases of Hox-c Activity</article-title><source>Nature</source><year>2003</year><month>October</month><day>30</day><volume>425</volume><issue>6961</issue><fpage>926</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">14586461</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>Graeme W</given-names></name></person-group><article-title>Not Fade Away: Mechanisms of Neuronal ATP Homeostasis</article-title><source>Neuron</source><year>2020</year><month>Feb</month><volume>105</volume><issue>4</issue><fpage>591</fpage><lpage>93</lpage><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">32078791</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis-Dusenbery</surname><given-names>Brandi N</given-names></name><name><surname>Williams</surname><given-names>Luis A</given-names></name><name><surname>Klim</surname><given-names>Joseph R</given-names></name><name><surname>Eggan</surname><given-names>Kevin</given-names></name></person-group><article-title>How to Make Spinal Motor Neurons</article-title><source>Development (Cambridge, England)</source><year>2014</year><month>February</month><volume>141</volume><issue>3</issue><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">24449832</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>De Mandiburu</surname><given-names>Felipe</given-names></name></person-group><source>A statistical analysis tool for agricultural research</source><year>2009</year><publisher-name>National Engineering University</publisher-name><publisher-loc>Lima-Peru</publisher-loc><comment>Unpublished [package:agricolae]</comment></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demestre</surname><given-names>M</given-names></name><etal/></person-group><article-title>Formation and Characterisation of Neuromuscular Junctions between hiPSC Derived Motoneurons and Myotubes</article-title><source>Stem Cell Research</source><year>2015</year><month>Sept</month><volume>15</volume><issue>2</issue><fpage>328</fpage><lpage>36</lpage><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">26255853</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschamps</surname><given-names>Jacqueline</given-names></name><name><surname>Duboule</surname><given-names>Denis</given-names></name></person-group><article-title>Embryonic timing, axial stem cells, chromatin, dynamics and the Hox clock</article-title><source>Genes &amp; Development</source><year>2017</year><month>July</month><day>15</day><volume>31</volume><issue>14</issue><fpage>1406</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC5588924</pub-id><pub-id pub-id-type="pmid">28860158</pub-id><pub-id pub-id-type="doi">10.1101/gad.303123.117</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname><given-names>Eric</given-names></name><name><surname>Ribes</surname><given-names>Vanessa</given-names></name><name><surname>Balaskas</surname><given-names>Nikolaos</given-names></name><name><surname>Yang</surname><given-names>Lin Lin</given-names></name><name><surname>Pierani</surname><given-names>Alessandra</given-names></name><name><surname>Kicheva</surname><given-names>Anna</given-names></name><name><surname>Novitch</surname><given-names>Bennett G</given-names></name><name><surname>Briscoe</surname><given-names>James</given-names></name><name><surname>Sasai</surname><given-names>Noriaki</given-names></name></person-group><article-title>Dynamic Assignment and Maintenance of Positional Identity in the Ventral Neural Tube by the Morphogen Sonic Hedgehog</article-title><source>PLOS Biology</source><year>2010</year><month>January</month><day>6</day><volume>8</volume><issue>6</issue><elocation-id>e1000382</elocation-id><pub-id pub-id-type="pmcid">PMC2879390</pub-id><pub-id pub-id-type="pmid">20532235</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000382</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez del Corral</surname><given-names>Ruth</given-names></name><name><surname>Olivera-Martinez</surname><given-names>Isabel</given-names></name><name><surname>Goriely</surname><given-names>Anne</given-names></name><name><surname>Gale</surname><given-names>Emily</given-names></name><name><surname>Maden</surname><given-names>Malcolm</given-names></name><name><surname>Storey</surname><given-names>Kate</given-names></name></person-group><article-title>Opposing FGF and Retinoid Pathways Control Ventral Neural Pattern, Neuronal Differentiation and Segmentation during Body Axis Extension</article-title><source>Neuron</source><year>2003</year><month>September</month><day>25</day><volume>40</volume><issue>1</issue><fpage>65</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">14527434</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driscoll</surname><given-names>Wade C</given-names></name></person-group><article-title>Robustness of the ANOVA and Tukey-Kramer Statistical Tests</article-title><source>Computers &amp; Industrial Engineering</source><year>1996</year><month>October</month><volume>31</volume><issue>1–2</issue><fpage>265</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/03608352(96)00127-1</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duclot</surname><given-names>Florian</given-names></name><name><surname>Kabbaj</surname><given-names>Mohamed</given-names></name></person-group><article-title>The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders</article-title><source>Frontiers in Behavioral Neuroscience</source><year>2017</year><volume>11</volume><comment>APA PsycNet</comment><pub-id pub-id-type="pmcid">PMC5337695</pub-id><pub-id pub-id-type="pmid">28321184</pub-id><pub-id pub-id-type="doi">10.3389/fnbeh.2017.00035</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>Olive Jean</given-names></name></person-group><article-title>Multiple Comparisons among Means</article-title><source>Journal of the American Statistical Association</source><year>1961</year><month>March</month><volume>56</volume><issue>293</issue><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1080/01621459.1961.10482090</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durston</surname><given-names>AJ</given-names></name><name><surname>Timmermans</surname><given-names>JPM</given-names></name><name><surname>Hage</surname><given-names>WJ</given-names></name><name><surname>Hendriks</surname><given-names>HFJ</given-names></name><name><surname>de Vries</surname><given-names>NJ</given-names></name><name><surname>Heideveld</surname><given-names>M</given-names></name><name><surname>Nieuwkoop</surname><given-names>PD</given-names></name></person-group><article-title>Retinoic Acid Causes an Anteroposterior Transformation in the Developing Central Nervous System</article-title><source>Nature</source><year>1989</year><month>July</month><volume>340</volume><issue>6229</issue><fpage>140</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">2739735</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisinga</surname><given-names>Rob</given-names></name><name><surname>Heskes</surname><given-names>Tom</given-names></name><name><surname>Pelzer</surname><given-names>Ben</given-names></name><name><surname>Te Grotenhuis</surname><given-names>Manfred</given-names></name></person-group><article-title>Exact P-Values for Pairwise Comparison of Friedman Rank Sums, with Application to Comparing Classifiers</article-title><source>BMC Bioinformatics</source><year>2017</year><month>January</month><day>25</day><volume>18</volume><issue>1</issue><fpage>68</fpage><pub-id pub-id-type="pmcid">PMC5267387</pub-id><pub-id pub-id-type="pmid">28122501</pub-id><pub-id pub-id-type="doi">10.1186/s12859-017-1486-2</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erb</surname><given-names>Madalynn</given-names></name><name><surname>Lee</surname><given-names>Bora</given-names></name><name><surname>Seo</surname><given-names>So Yeon</given-names></name><name><surname>Lee</surname><given-names>Jae W</given-names></name><name><surname>Lee</surname><given-names>Seunghee</given-names></name><name><surname>Lee</surname><given-names>Soo-Kyung</given-names></name></person-group><article-title>The Isl1Lhx3 Complex Promotes Motor Neuron Specification by Activating Transcriptional Pathways that Enhance Its Own Expression and Formation</article-title><source>eNeuro</source><year>2017</year><month>March</month><day>30</day><volume>4</volume><issue>2</issue><elocation-id>ENEURO.034916.2017</elocation-id><pub-id pub-id-type="pmcid">PMC5394944</pub-id><pub-id pub-id-type="pmid">28451636</pub-id><pub-id pub-id-type="doi">10.1523/ENEURO.0349-16.2017</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faustino Martins</surname><given-names>Jorge-Miguel</given-names></name><name><surname>Fischer</surname><given-names>Cornelius</given-names></name><name><surname>Urzi</surname><given-names>Alessia</given-names></name><name><surname>Vidal</surname><given-names>Ramon</given-names></name><name><surname>Kunz</surname><given-names>Severine</given-names></name><name><surname>Ruffault</surname><given-names>Pierre-Louis</given-names></name><name><surname>Kabuss</surname><given-names>Loreen</given-names></name></person-group><article-title>Self-Organizing 3D Human Trunk Neuromuscular Organoids</article-title><source>Cell Stem Cell</source><year>2020</year><month>February</month><day>6</day><volume>26</volume><issue>2</issue><fpage>172</fpage><lpage>186</lpage><elocation-id>e6</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmid">31956040</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forlani</surname><given-names>Sylvie</given-names></name><name><surname>Lawson</surname><given-names>Kirstie A</given-names></name><name><surname>Deschamps</surname><given-names>Jacqueline</given-names></name></person-group><article-title>Acquisition of Hox Codes during Gastrulation and Axial Elongation in the Mouse Embryo</article-title><source>Development</source><year>2003</year><month>August</month><day>15</day><volume>130</volume><issue>16</issue><fpage>3807</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">12835396</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Frangi</surname><given-names>Alejandro F</given-names></name><etal/></person-group><source>Multiscale Vessel Enhancement Filtering</source><conf-name>Medical Image Computing and Computer-Assisted Intervention — MICCAI’98</conf-name><year>1998</year><person-group person-group-type="editor"><name><surname>Wells</surname><given-names>William M</given-names></name><etal/></person-group><publisher-name>Springer</publisher-name><fpage>130</fpage><lpage>37</lpage><comment>Springer Link</comment><pub-id pub-id-type="doi">10.1007/BFb0056195</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>Milton</given-names></name></person-group><article-title>The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance</article-title><source>Journal of the American Statistical Association</source><year>1937</year><month>December</month><volume>32</volume><issue>200</issue><fpage>675</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1080/01621459.1937.10503522</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frohlich</surname><given-names>Jan</given-names></name><name><surname>Kovacovicova</surname><given-names>Kristina</given-names></name><name><surname>Raffaele</surname><given-names>Marco</given-names></name><name><surname>Virglova</surname><given-names>Tereza</given-names></name><name><surname>Cizkova</surname><given-names>Eliska</given-names></name><name><surname>Kucera</surname><given-names>Jan</given-names></name><name><surname>Bienertova-Vasku</surname><given-names>Julye</given-names></name></person-group><article-title>GDF11 inhibits adipogenesis and improves mature adipocytes metabolic function via WNT/β-catenin and ALK5/SMAD2/3 pathways</article-title><source>Cell Proliferation</source><year>2022</year><month>August</month><day>3</day><volume>55</volume><issue>10</issue><elocation-id>e13310</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC9528760</pub-id><pub-id pub-id-type="pmid">35920128</pub-id><pub-id pub-id-type="doi">10.1111/cpr.13310</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujikoshi</surname><given-names>Yasunori</given-names></name></person-group><article-title>Two-way ANOVA models with unbalanced data</article-title><source>Discrete Mathematics</source><year>1993</year><month>June</month><day>1</day><volume>116</volume><issue>1</issue><fpage>315</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/0012-365X(93)90410-U</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Chong</given-names></name><etal/></person-group><article-title>Neuromuscular Organoids Model Spinal Neuromuscular Pathologies in C9orf72 Amyotrophic Lateral Sclerosis</article-title><source>Cell Reports</source><year>2024</year><month>Mar</month><volume>43</volume><issue>3</issue><elocation-id>113892</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmid">38431841</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaunt</surname><given-names>Stephen J</given-names></name></person-group><article-title>Gdf11/Smad Signalling and Cdx Proteins Cooperate to Activate the Hoxc8 Early Enhancer in HepG2 Cells</article-title><source>The International Journal of Developmental Biology</source><year>2017</year><volume>61</volume><issue>6–7</issue><fpage>427</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">28695962</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaunt</surname><given-names>Stephen J</given-names></name><name><surname>Cockley</surname><given-names>Adam</given-names></name><name><surname>Drage</surname><given-names>Deborah</given-names></name></person-group><article-title>Additional Enhancer Copies, with Intact Cdx Binding Sites, Anteriorize Hoxa-7/lacZ Expression in Mouse Embryos: Evidence in Keeping with an Instructional Cdx Gradient</article-title><source>The International Journal of Developmental Biology</source><year>2004</year><month>September</month><volume>48</volume><issue>7</issue><fpage>613</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15470633</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><collab>General Assembly of the World Medical Association</collab><article-title>World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects</article-title><source>The Journal of the American College of Dentists</source><year>2014</year><volume>81</volume><issue>3</issue><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">25951678</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouti</surname><given-names>Mina</given-names></name><name><surname>Delile</surname><given-names>Julyen</given-names></name><name><surname>Stamataki</surname><given-names>Despina</given-names></name><name><surname>Wymeersch</surname><given-names>Filip J</given-names></name><name><surname>Huang</surname><given-names>Yali</given-names></name><name><surname>Kleinjung</surname><given-names>Jens</given-names></name><name><surname>Wilson</surname><given-names>Valerie</given-names></name><name><surname>Briscoe</surname><given-names>James</given-names></name></person-group><article-title>A Gene Regulatory Network Balances Neural and Mesoderm Specification during Vertebrate Trunk Development</article-title><source>Developmental Cell</source><year>2017</year><month>Mai</month><day>8</day><volume>41</volume><issue>3</issue><fpage>243</fpage><lpage>261</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC5425255</pub-id><pub-id pub-id-type="pmid">28457792</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2017.04.002</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouti</surname><given-names>Mina</given-names></name><name><surname>Tsakiridis</surname><given-names>Anestis</given-names></name><name><surname>Wymeersch</surname><given-names>Filip J</given-names></name><name><surname>Huang</surname><given-names>Yali</given-names></name><name><surname>Kleinjung</surname><given-names>Jens</given-names></name><name><surname>Wilson</surname><given-names>Valerie</given-names></name><name><surname>Briscoe</surname><given-names>James</given-names></name></person-group><article-title>In Vitro Generation of Neuromesodermal Progenitors Reveals Distinct Roles for Wnt Signalling in the Specification of Spinal Cord and Paraxial Mesoderm Identity</article-title><source>PLOS Biology</source><year>2014</year><month>August</month><day>26</day><volume>12</volume><issue>8</issue><elocation-id>e1001937</elocation-id><pub-id pub-id-type="pmcid">PMC4144800</pub-id><pub-id pub-id-type="pmid">25157815</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001937</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grass</surname><given-names>Tobias</given-names></name><name><surname>Dokuzluoglu</surname><given-names>Zeynep</given-names></name><name><surname>Buchner</surname><given-names>Felix</given-names></name><name><surname>Rosignol</surname><given-names>Ines</given-names></name><name><surname>Thomas</surname><given-names>Joshua</given-names></name><name><surname>Caldarelli</surname><given-names>Antonio</given-names></name><name><surname>Dalinskaya</surname><given-names>Anna</given-names></name></person-group><article-title>Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation</article-title><source>Cell Reports Medicine</source><year>2024</year><month>July</month><volume>26</volume><elocation-id>101659</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC11384962</pub-id><pub-id pub-id-type="pmid">39067446</pub-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2024.101659</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gribaudo</surname><given-names>Simona</given-names></name><name><surname>Robert</surname><given-names>Rémi</given-names></name><name><surname>van Sambeek</surname><given-names>Björn</given-names></name><name><surname>Mirdass</surname><given-names>Camil</given-names></name><name><surname>Lyubimova</surname><given-names>Anna</given-names></name><name><surname>Bouhali</surname><given-names>Kamal</given-names></name><name><surname>Ferent</surname><given-names>Julyen</given-names></name><name><surname>Morin</surname><given-names>Xavier</given-names></name><name><surname>van Oudenaarden</surname><given-names>Alexander</given-names></name><name><surname>Nedelec</surname><given-names>Stéphane</given-names></name></person-group><article-title>Self-Organizing Models of Human Trunk Organogenesis Recapitulate Spinal Cord and Spine Co-Morphogenesis</article-title><source>Nature Biotechnology</source><year>2023</year><month>September</month><day>14</day><pub-id pub-id-type="pmid">37709912</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>Brian</given-names></name><name><surname>Zhang</surname><given-names>Jingliang Simon</given-names></name><name><surname>Duncan</surname><given-names>Leighton H</given-names></name><name><surname>Johnston</surname><given-names>Robert J</given-names></name></person-group><article-title>Human neural organoids: Models for developmental neurobiology and disease</article-title><source>Developmental biology</source><year>2021</year><month>October</month><volume>478</volume><fpage>102</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC8364509</pub-id><pub-id pub-id-type="pmid">34181916</pub-id><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.06.012</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haushalter</surname><given-names>Carole</given-names></name><name><surname>Asselin</surname><given-names>Laure</given-names></name><name><surname>Fraulob</surname><given-names>Valérie</given-names></name><name><surname>Dollé</surname><given-names>Pascal</given-names></name><name><surname>Rhinn</surname><given-names>Muriel</given-names></name></person-group><article-title>Retinoic Acid Controls Early Neurogenesis in the Developing Mouse Cerebral Cortex</article-title><source>Developmental Biology</source><year>2017</year><month>October</month><day>1</day><volume>430</volume><issue>1</issue><fpage>129</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">28790015</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Yuhan</given-names></name><name><surname>Stuart</surname><given-names>Tim</given-names></name><name><surname>Kowalski</surname><given-names>Madeline H</given-names></name><name><surname>Choudhary</surname><given-names>Saket</given-names></name><name><surname>Hoffman</surname><given-names>Paul</given-names></name><name><surname>Hartman</surname><given-names>Austin</given-names></name><name><surname>Srivastava</surname><given-names>Avi</given-names></name></person-group><article-title>Dictionary Learning for Integrative, Multimodal and Scalable Single-Cell Analysis</article-title><source>Nature Biotechnology</source><year>2024</year><month>February</month><volume>42</volume><issue>2</issue><fpage>293</fpage><lpage>304</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC10928517</pub-id><pub-id pub-id-type="pmid">37231261</pub-id><pub-id pub-id-type="doi">10.1038/s41587-023-01767-y</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hergenreder</surname><given-names>Emiliano</given-names></name><etal/></person-group><article-title>Combined Small-Molecule Treatment Accelerates Maturation of Human Pluripotent Stem Cell-Derived Neurons</article-title><source>Nature Biotechnology</source><year>2024</year><month>Oct</month><volume>42</volume><issue>10</issue><fpage>1515</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC11348887</pub-id><pub-id pub-id-type="pmid">38168993</pub-id><pub-id pub-id-type="doi">10.1038/s41587-023-02031-z</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildebrandt</surname><given-names>Matthew R</given-names></name><name><surname>Reuter</surname><given-names>Miriam S</given-names></name><name><surname>Wei</surname><given-names>Wei</given-names></name><name><surname>Tayebi</surname><given-names>Naeimeh</given-names></name><name><surname>Liu</surname><given-names>Jiajie</given-names></name><name><surname>Sharmin</surname><given-names>Sazia</given-names></name><name><surname>Mulder</surname><given-names>Jaap</given-names></name></person-group><article-title>Precision Health Resource of Control iPSC Lines for Versatile Multilineage Differentiation</article-title><source>Stem Cell Reports</source><year>2019</year><month>December</month><day>5</day><volume>13</volume><issue>6</issue><fpage>1126</fpage><lpage>41</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC6915802</pub-id><pub-id pub-id-type="pmid">31813827</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.11.003</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamazaki</surname><given-names>Nobuhiko</given-names></name><etal/></person-group><article-title>Retinoic Acid Induces Human Gastruloids with Posterior Embryo-like Structures</article-title><source>Nature Cell Biology</source><year>2024</year><month>Oct</month><volume>26</volume><issue>10</issue><fpage>1790</fpage><lpage>803</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC11469962</pub-id><pub-id pub-id-type="pmid">39164488</pub-id><pub-id pub-id-type="doi">10.1038/s41556-024-01487-8</pub-id></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hor</surname><given-names>Jin Hui</given-names></name><name><surname>Soh</surname><given-names>Eunice Shi-Yi</given-names></name><name><surname>Tan</surname><given-names>Li Yi</given-names></name><name><surname>Lim</surname><given-names>Valerie Jing Wen</given-names></name><name><surname>Santosa</surname><given-names>Munirah Mohamad</given-names></name><name><surname>Winanto</surname></name><name><surname>Ho</surname><given-names>Beatrice Xuan</given-names></name><name><surname>Fan</surname><given-names>Yong</given-names></name><name><surname>Soh</surname><given-names>Boon-Seng</given-names></name><name><surname>Ng</surname><given-names>Shi-Yan</given-names></name></person-group><article-title>Cell Cycle Inhibitors Protect Motor Neurons in an Organoid Model of Spinal Muscular Atrophy</article-title><source>Cell Death &amp; Disease</source><year>2018</year><month>October</month><day>27</day><volume>9</volume><issue>11</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC6204135</pub-id><pub-id pub-id-type="pmid">30368521</pub-id><pub-id pub-id-type="doi">10.1038/s41419-018-1081-0</pub-id></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>C</given-names></name><name><surname>Maden</surname><given-names>M</given-names></name></person-group><article-title>Endogenous Distribution of Retinoids during Normal Development and Teratogenesis in the Mouse Embryo</article-title><source>Developmental Dynamics: An Official Publication of the American Association of Anatomists</source><year>1995</year><month>March</month><volume>202</volume><issue>3</issue><fpage>312</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">7780180</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>Jee-Yeon</given-names></name><name><surname>Zukin</surname><given-names>R Suzanne</given-names></name></person-group><article-title>REST, a Master Transcriptional Regulator in Neurodegenerative Disease</article-title><source>Current Opinion in Neurobiology</source><year>2018</year><month>Feb</month><volume>48</volume><fpage>193</fpage><lpage>200</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC5892838</pub-id><pub-id pub-id-type="pmid">29351877</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2017.12.008</pub-id></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>Nisha R</given-names></name><name><surname>Ashton</surname><given-names>Randolph S</given-names></name></person-group><article-title>Bioengineering the Human Spinal Cord</article-title><source>Frontiers in Cell and Developmental Biology</source><year>2022</year><month>Aug</month><volume>10</volume><elocation-id>942742</elocation-id><comment>pmc.ncbi.nlm.nih.gov</comment><pub-id pub-id-type="pmcid">PMC9458954</pub-id><pub-id pub-id-type="pmid">36092702</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2022.942742</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>Nisha R</given-names></name><etal/></person-group><article-title>Modular Derivation of Diverse, Regionally Discrete Human Posterior CNS Neurons Enables Discovery of Transcriptomic Patterns</article-title><source>Science Advances</source><year>2022</year><month>Sept</month><volume>8</volume><issue>39</issue><elocation-id>eabn7430</elocation-id><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC9524835</pub-id><pub-id pub-id-type="pmid">36179024</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abn7430</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janesick</surname><given-names>Amanda</given-names></name><name><surname>Wu</surname><given-names>Stephanie Cherie</given-names></name><name><surname>Blumberg</surname><given-names>Bruce</given-names></name></person-group><article-title>Retinoic Acid Signaling and Neuronal Differentiation</article-title><source>Cellular and Molecular Life Sciences</source><year>2015</year><month>April</month><day>1</day><volume>72</volume><issue>8</issue><fpage>1559</fpage><lpage>76</lpage><pub-id pub-id-type="pmcid">PMC11113123</pub-id><pub-id pub-id-type="pmid">25558812</pub-id><pub-id pub-id-type="doi">10.1007/s00018-014-1815-9</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javali</surname><given-names>Alok</given-names></name><name><surname>Misra</surname><given-names>Aritra</given-names></name><name><surname>Leonavicius</surname><given-names>Karolis</given-names></name><name><surname>Acharyya</surname><given-names>Debalina</given-names></name><name><surname>Vyas</surname><given-names>Bhakti</given-names></name><name><surname>Sambasivan</surname><given-names>Ramkumar</given-names></name></person-group><article-title>Co-Expression of Tbx6 and Sox2 Identifies a Novel Transient Neuromesoderm Progenitor Cell State</article-title><source>Development (Cambridge, England)</source><year>2017</year><month>December</month><day>15</day><volume>144</volume><issue>24</issue><fpage>4522</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">29084802</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joksimovic</surname><given-names>Milan</given-names></name><name><surname>Jeannotte</surname><given-names>Lucie</given-names></name><name><surname>Tuggle</surname><given-names>Christopher K</given-names></name></person-group><article-title>Dynamic expression of murine HOXA5 protein in the central nervous system</article-title><source>Gene Expression Patterns</source><year>2005</year><month>August</month><day>1</day><volume>5</volume><issue>6</issue><fpage>792</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">15922675</pub-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurberg</surname><given-names>Arnon Dias</given-names></name><etal/></person-group><article-title>Switching Axial Progenitors from Producing Trunk to Tail Tissues in Vertebrate Embryos</article-title><source>Developmental Cell</source><year>2013</year><month>June</month><volume>25</volume><issue>5</issue><fpage>451</fpage><lpage>62</lpage><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">23763947</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kampmann</surname><given-names>Martin</given-names></name></person-group><article-title>Molecular and Cellular Mechanisms of Selective Vulnerability in Neurodegenerative Diseases</article-title><source>Nature Reviews Neuroscience</source><year>2024</year><month>May</month><volume>25</volume><issue>5</issue><fpage>351</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmid">38575768</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawanishi</surname><given-names>CY</given-names></name><name><surname>Hartig</surname><given-names>P</given-names></name><name><surname>Bobseine</surname><given-names>KL</given-names></name><name><surname>Schmid</surname><given-names>J</given-names></name><name><surname>Cardon</surname><given-names>M</given-names></name><name><surname>Massenburg</surname><given-names>G</given-names></name><name><surname>Chernoff</surname><given-names>N</given-names></name></person-group><article-title>Axial Skeletal and Hox Expression Domain Alterations Induced by Retinoic Acid Valproic, Acid and Bromoxynil during Murine Development</article-title><source>Journal of Biochemical and Molecular Toxicology</source><year>2003</year><volume>17</volume><issue>6</issue><fpage>346</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">14708090</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keenan</surname><given-names>Iain D</given-names></name><name><surname>Sharrard</surname><given-names>R Michael</given-names></name><name><surname>Isaacs</surname><given-names>Harry V</given-names></name></person-group><article-title>FGF Signal Transduction and the Regulation of Cdx Gene Expression</article-title><source>Developmental Biology</source><year>2006</year><month>November</month><day>15</day><volume>299</volume><issue>2</issue><fpage>478</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">16982047</pub-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelle</surname><given-names>Dolunay</given-names></name><etal/></person-group><article-title>Capture of Human Neuromesodermal and Posterior Neural Tube Axial Stem Cells</article-title><source>bioRxiv</source><year>2024</year><month>Mar</month><day>29</day><comment>bioRxiv</comment><pub-id pub-id-type="doi">10.1101/2024.03.26.586760</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessel</surname><given-names>M</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><article-title>Homeotic Transformations of Murine Vertebrae and Concomitant Alteration of Hox Codes Induced by Retinoic Acid</article-title><source>Cell</source><year>1991</year><month>October</month><day>4</day><volume>67</volume><issue>1</issue><fpage>89</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">1680565</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Suel-Kee</given-names></name><etal/></person-group><article-title>Individual Variation in the Emergence of Anterior-to-Posterior Neural Fates from Human Pluripotent Stem Cells</article-title><source>Stem Cell Reports</source><year>2024</year><month>Sept</month><volume>19</volume><issue>9</issue><fpage>1336</fpage><lpage>50</lpage><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC11411333</pub-id><pub-id pub-id-type="pmid">39151428</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2024.07.004</pub-id></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>Takuya</given-names></name><etal/></person-group><article-title>Cell-Type Non-Selective Transcription of Mouse and Human Genes Encoding Neural-Restrictive Silencer Factor</article-title><source>Molecular Brain Research</source><year>2001</year><month>June</month><volume>90</volume><issue>2</issue><fpage>174</fpage><lpage>86</lpage><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">11406295</pub-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruskal</surname><given-names>William H</given-names></name><name><surname>Wallis</surname><given-names>W Allen</given-names></name></person-group><article-title>Use of Ranks in One-Criterion Variance Analysis</article-title><source>Journal of the American Statistical Association</source><year>1952</year><month>December</month><volume>47</volume><issue>260</issue><fpage>583</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1080/01621459.1952.10483441</pub-id></element-citation></ref><ref id="R81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>Sandeep</given-names></name><name><surname>Duester</surname><given-names>Gregg</given-names></name></person-group><article-title>Retinoic Acid Controls Body Axis Extension by Directly Repressing Fgf8 Transcription</article-title><source>Development</source><year>2014</year><month>Aug</month><volume>141</volume><issue>15</issue><fpage>2972</fpage><lpage>77</lpage><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC4197666</pub-id><pub-id pub-id-type="pmid">25053430</pub-id><pub-id pub-id-type="doi">10.1242/dev.112367</pub-id></element-citation></ref><ref id="R82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacombe</surname><given-names>Julye</given-names></name><etal/></person-group><article-title>Genetic and Functional Modularity of Hox Activities in the Specification of Limb-Innervating Motor Neurons</article-title><source>PLOS Genetics</source><year>2013</year><month>Jan</month><volume>9</volume><issue>1</issue><elocation-id>e1003184</elocation-id><comment>PLoS Journals</comment><pub-id pub-id-type="pmcid">PMC3554521</pub-id><pub-id pub-id-type="pmid">23359544</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003184</pub-id></element-citation></ref><ref id="R83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmesser</surname><given-names>LT</given-names></name></person-group><article-title>The Acquisition of Motoneuron Subtype Identity and Motor Circuit Formation</article-title><source>International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience</source><year>2001</year><month>Apr</month><volume>19</volume><issue>2</issue><fpage>175</fpage><lpage>82</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">11255031</pub-id></element-citation></ref><ref id="R84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laussu</surname><given-names>Julyen</given-names></name><name><surname>Audouard</surname><given-names>Christophe</given-names></name><name><surname>Kischel</surname><given-names>Anthony</given-names></name><name><surname>Assis-Nascimento</surname><given-names>Poincyane</given-names></name><name><surname>Escalas</surname><given-names>Nathalie</given-names></name><name><surname>Liebl</surname><given-names>Daniel J</given-names></name><name><surname>Soula</surname><given-names>Cathy</given-names></name><name><surname>Davy</surname><given-names>Alice</given-names></name></person-group><article-title>Eph/Ephrin Signaling Controls Progenitor Identities In The Ventral Spinal Cord</article-title><source>Neural Development</source><year>2017</year><month>June</month><day>8</day><volume>12</volume><issue>1</issue><fpage>10</fpage><pub-id pub-id-type="pmcid">PMC5463316</pub-id><pub-id pub-id-type="pmid">28595615</pub-id><pub-id pub-id-type="doi">10.1186/s13064-017-0087-0</pub-id></element-citation></ref><ref id="R85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzi</surname><given-names>Jessica</given-names></name><etal/></person-group><article-title>Differentiation of Control and ALS Mutant Human iPSCs into Functional Skeletal Muscle Cells, a Tool for the Study of Neuromuscolar Diseases</article-title><source>Stem Cell Research</source><year>2016</year><month>July</month><volume>17</volume><issue>1</issue><fpage>140</fpage><lpage>47</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC5009183</pub-id><pub-id pub-id-type="pmid">27318155</pub-id><pub-id pub-id-type="doi">10.1016/j.scr.2016.06.003</pub-id></element-citation></ref><ref id="R86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letchuman</surname><given-names>Sunjay</given-names></name><name><surname>Tucker</surname><given-names>Ashley</given-names></name><name><surname>Miranda</surname><given-names>Diego</given-names></name><name><surname>Adkins</surname><given-names>Robert L</given-names></name><name><surname>Aceves</surname><given-names>Miriam</given-names></name><name><surname>Dietz</surname><given-names>Valerie</given-names></name><name><surname>Jagrit</surname><given-names>Vipin</given-names></name><name><surname>Leonards</surname><given-names>Amy</given-names></name><name><surname>Lee</surname><given-names>Young Il</given-names></name><name><surname>Dulin</surname><given-names>Jennifer N</given-names></name></person-group><article-title>Transcription Factor Hb9 Is Expressed in Glial Cell Lineages in the Developing Mouse Spinal Cord</article-title><source>eNeuro</source><year>2022</year><volume>9</volume><issue>6</issue><elocation-id>ENEURO.0214-22.2022</elocation-id><pub-id pub-id-type="pmcid">PMC9636997</pub-id><pub-id pub-id-type="pmid">36265906</pub-id><pub-id pub-id-type="doi">10.1523/ENEURO.0214-22.2022</pub-id></element-citation></ref><ref id="R87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>Ethan S</given-names></name><name><surname>Williams</surname><given-names>Clay E</given-names></name><name><surname>Ruhl</surname><given-names>David A</given-names></name><name><surname>Estevez-Silva</surname><given-names>Maria C</given-names></name><name><surname>Chapman</surname><given-names>Edwin R</given-names></name><name><surname>Coon</surname><given-names>Joshua J</given-names></name><name><surname>Ashton</surname><given-names>Randolph S</given-names></name></person-group><article-title>Deterministic HOX Patterning in Human Pluripotent Stem Cell-Derived Neuroectoderm</article-title><source>Stem Cell Reports</source><year>2015</year><month>April</month><day>14</day><volume>4</volume><issue>4</issue><fpage>632</fpage><lpage>44</lpage><pub-id pub-id-type="pmcid">PMC4400649</pub-id><pub-id pub-id-type="pmid">25843047</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.02.018</pub-id></element-citation></ref><ref id="R88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JP</given-names></name><name><surname>Laufer</surname><given-names>E</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name></person-group><article-title>Assigning the Positional Identity of Spinal Motor Neurons: Rostrocaudal Patterning of Hox-c Expression by FGFs, Gdf11, and Retinoids</article-title><source>Neuron</source><year>2001</year><month>December</month><day>20</day><volume>32</volume><issue>6</issue><fpage>997</fpage><lpage>1012</lpage><pub-id pub-id-type="pmid">11754833</pub-id></element-citation></ref><ref id="R89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Jeh-Ping</given-names></name></person-group><article-title>The Function of Growth/Differentiation Factor 11 (Gdf11) in Rostrocaudal Patterning of the Developing Spinal Cord</article-title><source>Development</source><year>2006</year><month>August</month><day>1</day><volume>133</volume><issue>15</issue><fpage>2865</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">16790475</pub-id></element-citation></ref><ref id="R90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Hongke</given-names></name><name><surname>Guo</surname><given-names>Yuchen</given-names></name><name><surname>Liu</surname><given-names>Yuting</given-names></name><name><surname>Wang</surname><given-names>Yuan</given-names></name><name><surname>Zheng</surname><given-names>Rixin</given-names></name><name><surname>Ban</surname><given-names>Yu</given-names></name><name><surname>Peng</surname><given-names>Lin</given-names></name><name><surname>Yuan</surname><given-names>Quan</given-names></name><name><surname>Liu</surname><given-names>Weiqing</given-names></name></person-group><article-title>Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta/Smad signalling pathway</article-title><source>Cell Proliferation</source><year>2019</year><month>April</month><day>30</day><volume>52</volume><issue>4</issue><elocation-id>e12631</elocation-id><pub-id pub-id-type="pmcid">PMC6668979</pub-id><pub-id pub-id-type="pmid">31038259</pub-id><pub-id pub-id-type="doi">10.1111/cpr.12631</pub-id></element-citation></ref><ref id="R91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maden</surname><given-names>M</given-names></name><name><surname>Gale</surname><given-names>E</given-names></name><name><surname>Kostetskii</surname><given-names>I</given-names></name><name><surname>Zile</surname><given-names>M</given-names></name></person-group><article-title>Vitamin A-Deficient Quail Embryos Have Half a Hindbrain and Other Neural Defects</article-title><source>Current Biology: CB</source><year>1996</year><month>April</month><day>1</day><volume>6</volume><issue>4</issue><fpage>417</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8723346</pub-id></element-citation></ref><ref id="R92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahony</surname><given-names>Shaun</given-names></name><name><surname>Mazzoni</surname><given-names>Esteban O</given-names></name><name><surname>McCuine</surname><given-names>Scott</given-names></name><name><surname>Young</surname><given-names>Richard A</given-names></name><name><surname>Wichterle</surname><given-names>Hynek</given-names></name><name><surname>Gifford</surname><given-names>David K</given-names></name></person-group><article-title>Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis</article-title><source>Genome Biology</source><year>2011</year><month>January</month><day>13</day><volume>12</volume><issue>1</issue><fpage>R2</fpage><pub-id pub-id-type="pmcid">PMC3091300</pub-id><pub-id pub-id-type="pmid">21232103</pub-id><pub-id pub-id-type="doi">10.1186/gb-2011-12-1-r2</pub-id></element-citation></ref><ref id="R93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>HB</given-names></name><name><surname>Whitney</surname><given-names>DR</given-names></name></person-group><article-title>On a Test of Whether One of Two Random Variables Is Stochastically Larger than the Other</article-title><source>The Annals of Mathematical Statistics</source><year>1947</year><month>March</month><volume>18</volume><issue>1</issue><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1214/aoms/1177730491</pub-id></element-citation></ref><ref id="R94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>Abed AlFatah</given-names></name><etal/></person-group><article-title>An in Vivo Model of Functional and Vascularized Human Brain Organoids</article-title><source>Nature Biotechnology</source><year>2018</year><month>May</month><volume>36</volume><issue>5</issue><fpage>432</fpage><lpage>41</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC6331203</pub-id><pub-id pub-id-type="pmid">29658944</pub-id><pub-id pub-id-type="doi">10.1038/nbt.4127</pub-id></element-citation></ref><ref id="R95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>Heather</given-names></name><name><surname>Nonchev</surname><given-names>Stefan</given-names></name><name><surname>Sham</surname><given-names>Mai Har</given-names></name><name><surname>Muchamore</surname><given-names>Ian</given-names></name><name><surname>Lumsden</surname><given-names>Andrew</given-names></name><name><surname>Krumlauf</surname><given-names>Robb</given-names></name></person-group><article-title>Retinoic Acid Alters Hindbrain Hox Code and Induces Transformation of Rhombomeres 2/3 into a 4/5 Identity</article-title><source>Nature</source><year>1992</year><month>December</month><volume>360</volume><issue>6406</issue><fpage>737</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">1361214</pub-id></element-citation></ref><ref id="R96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>VB</given-names></name><etal/></person-group><article-title>Brain-Derived Neurotrophic Factor Is Produced by Skeletal Muscle Cells in Response to Contraction and Enhances Fat Oxidation via Activation of AMP-Activated Protein Kinase</article-title><source>Diabetologia</source><year>2009</year><month>July</month><volume>52</volume><issue>7</issue><fpage>1409</fpage><lpage>18</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">19387610</pub-id></element-citation></ref><ref id="R97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>Takahiko</given-names></name><name><surname>Cepko</surname><given-names>Constance L</given-names></name></person-group><article-title>Controlled Expression of Transgenes Introduced by in Vivo Electroporation</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2007</year><month>Jan</month><volume>104</volume><issue>3</issue><fpage>1027</fpage><lpage>32</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC1764220</pub-id><pub-id pub-id-type="pmid">17209010</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0610155104</pub-id></element-citation></ref><ref id="R98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maury</surname><given-names>Yves</given-names></name><etal/></person-group><article-title>Combinatorial Analysis of Developmental Cues Efficiently Converts Human Pluripotent Stem Cells into Multiple Neuronal Subtypes</article-title><source>Nature Biotechnology</source><year>2015</year><month>Jan</month><volume>33</volume><issue>1</issue><fpage>89</fpage><lpage>96</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">25383599</pub-id></element-citation></ref><ref id="R99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname><given-names>Esteban O</given-names></name><name><surname>Mahony</surname><given-names>Shaun</given-names></name><name><surname>Closser</surname><given-names>Michael</given-names></name><name><surname>Morrison</surname><given-names>Carolyn A</given-names></name><name><surname>Nedelec</surname><given-names>Stephane</given-names></name><name><surname>Williams</surname><given-names>Damian J</given-names></name><name><surname>An</surname><given-names>Disi</given-names></name><name><surname>Gifford</surname><given-names>David K</given-names></name><name><surname>Wichterle</surname><given-names>Hynek</given-names></name></person-group><article-title>Synergistic Binding of Transcription Factors to Cell-Specific Enhancers Programs Motor Neuron Identity</article-title><source>Nature Neuroscience</source><year>2013</year><month>September</month><volume>16</volume><issue>9</issue><fpage>1219</fpage><lpage>27</lpage><pub-id pub-id-type="pmcid">PMC3820498</pub-id><pub-id pub-id-type="pmid">23872598</pub-id><pub-id pub-id-type="doi">10.1038/nn.3467</pub-id></element-citation></ref><ref id="R100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>Ulrich</given-names></name></person-group><article-title>A Note on the Power of Fisher’s Least Significant Difference Procedure</article-title><source>Pharmaceutical Statistics</source><year>2006</year><month>October</month><volume>5</volume><issue>4</issue><fpage>253</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">17128424</pub-id></element-citation></ref><ref id="R101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meinhardt</surname><given-names>Andrea</given-names></name><name><surname>Eberle</surname><given-names>Dominic</given-names></name><name><surname>Tazaki</surname><given-names>Akira</given-names></name><name><surname>Ranga</surname><given-names>Adrian</given-names></name><name><surname>Niesche</surname><given-names>Marco</given-names></name><name><surname>Wilsch-Bräuninger</surname><given-names>Michaela</given-names></name><name><surname>Stec</surname><given-names>Agnieszka</given-names></name><name><surname>Schackert</surname><given-names>Gabriele</given-names></name><name><surname>Lutolf</surname><given-names>Matthias</given-names></name><name><surname>Tanaka</surname><given-names>Elly M</given-names></name></person-group><article-title>3D Reconstitution of the Patterned Neural Tube from Embryonic Stem Cells</article-title><source>Stem Cell Reports</source><year>2014</year><month>December</month><day>9</day><volume>3</volume><issue>6</issue><fpage>987</fpage><lpage>99</lpage><pub-id pub-id-type="pmcid">PMC4264068</pub-id><pub-id pub-id-type="pmid">25454634</pub-id><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.09.020</pub-id></element-citation></ref><ref id="R102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzis</surname><given-names>Vicki</given-names></name><name><surname>Steinhauser</surname><given-names>Sebastian</given-names></name><name><surname>Pakanavicius</surname><given-names>Edvinas</given-names></name><name><surname>Gouti</surname><given-names>Mina</given-names></name><name><surname>Stamataki</surname><given-names>Despina</given-names></name><name><surname>Ivanovitch</surname><given-names>Kenzo</given-names></name><name><surname>Watson</surname><given-names>Thomas</given-names></name></person-group><article-title>Nervous System Regionalization Entails Axial Allocation before Neural Differentiation</article-title><source>Cell</source><year>2018</year><month>November</month><day>1</day><volume>175</volume><issue>4</issue><fpage>1105</fpage><lpage>1118</lpage><elocation-id>e17</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC6218657</pub-id><pub-id pub-id-type="pmid">30343898</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.09.040</pub-id></element-citation></ref><ref id="R103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Zhuo-Xian</given-names></name><etal/></person-group><article-title>BAF60c Drives Glycolytic Muscle Formation and Improves Glucose Homeostasis through Deptor-Mediated AKT Activation</article-title><source>Nature Medicine</source><year>2013</year><month>Apr</month><volume>19</volume><issue>5</issue><fpage>640</fpage><comment>pmc.ncbi.nlm.nih.gov</comment><pub-id pub-id-type="pmcid">PMC3650110</pub-id><pub-id pub-id-type="pmid">23563706</pub-id><pub-id pub-id-type="doi">10.1038/nm.3144</pub-id></element-citation></ref><ref id="R104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouilleau</surname><given-names>Vincent</given-names></name><name><surname>Vaslin</surname><given-names>Célia</given-names></name><name><surname>Robert</surname><given-names>Rémi</given-names></name><name><surname>Gribaudo</surname><given-names>Simona</given-names></name><name><surname>Nicolas</surname><given-names>Nour</given-names></name><name><surname>Jarrige</surname><given-names>Margot</given-names></name><name><surname>Terray</surname><given-names>Angélique</given-names></name></person-group><article-title>Dynamic Extrinsic Pacing of the HOX Clock in Human Axial Progenitors Controls Motor Neuron Subtype Specification</article-title><source>Development (Cambridge, England)</source><year>2021</year><month>March</month><day>29</day><volume>148</volume><issue>6</issue><elocation-id>dev194514</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC8034877</pub-id><pub-id pub-id-type="pmid">33782043</pub-id><pub-id pub-id-type="doi">10.1242/dev.194514</pub-id></element-citation></ref><ref id="R105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>Lance A</given-names></name><etal/></person-group><article-title>A Beginner’s Guide on the Use of Brain Organoids for Neuroscientists: A Systematic Review</article-title><source>Stem Cell Research &amp; Therapy</source><year>2023</year><month>Apr</month><volume>14</volume><issue>1</issue><fpage>87</fpage><comment>BioMed Central</comment><pub-id pub-id-type="pmcid">PMC10105545</pub-id><pub-id pub-id-type="pmid">37061699</pub-id><pub-id pub-id-type="doi">10.1186/s13287-023-03302-x</pub-id></element-citation></ref><ref id="R106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nachar</surname><given-names>Nadim</given-names></name></person-group><article-title>The Mann-Whitney U: A Test for Assessing Whether Two Independent Samples Come from the Same Distribution</article-title><source>Tutorials in Quantitative Methods for Psychology</source><year>2008</year><month>March</month><day>1</day><volume>4</volume><issue>1</issue><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.20982/tqmp.04.1.p013</pub-id></element-citation></ref><ref id="R107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Kae</given-names></name><etal/></person-group><article-title>Wnt Signal-Dependent Antero-Posterior Specification of Early-Stage CNS Primordia Modeled in EpiSC-Derived Neural Stem Cells</article-title><source>Frontiers in Cell and Developmental Biology</source><year>2024</year><month>Feb</month><volume>11</volume><elocation-id>1260528</elocation-id><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC10884098</pub-id><pub-id pub-id-type="pmid">38405136</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2023.1260528</pub-id></element-citation></ref><ref id="R108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neijts</surname><given-names>Roel</given-names></name><name><surname>Amin</surname><given-names>Shilu</given-names></name><name><surname>van Rooijen</surname><given-names>Carina</given-names></name><name><surname>Deschamps</surname><given-names>Jacqueline</given-names></name></person-group><article-title>Cdx is crucial for the timing mechanism driving colinear Hox activation and defines a trunk segment in the Hox cluster topology</article-title><source>Developmental Biology</source><year>2017</year><month>February</month><day>15</day><volume>422</volume><issue>2</issue><fpage>146</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">28041967</pub-id></element-citation></ref><ref id="R109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichterwitz</surname><given-names>Susanne</given-names></name><etal/></person-group><article-title>LCM-Seq Reveals Unique Transcriptional Adaptation Mechanisms of Resistant Neurons and Identifies Protective Pathways in Spinal Muscular Atrophy</article-title><source>Genome Research</source><year>2020</year><month>Aug</month><volume>30</volume><issue>8</issue><fpage>1083</fpage><lpage>96</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC7462070</pub-id><pub-id pub-id-type="pmid">32820007</pub-id><pub-id pub-id-type="doi">10.1101/gr.265017.120</pub-id></element-citation></ref><ref id="R110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizzardo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Synaptotagmin 13 Is Neuroprotective across Motor Neuron Diseases</article-title><source>Acta Neuropathologica</source><year>2020</year><month>May</month><volume>139</volume><issue>5</issue><fpage>837</fpage><lpage>53</lpage><comment>Springer Link</comment><pub-id pub-id-type="pmcid">PMC7181443</pub-id><pub-id pub-id-type="pmid">32065260</pub-id><pub-id pub-id-type="doi">10.1007/s00401-020-02133-x</pub-id></element-citation></ref><ref id="R111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Shi-Yan</given-names></name><name><surname>Soh</surname><given-names>Boon Seng</given-names></name><name><surname>Rodriguez-Muela</surname><given-names>Natalia</given-names></name><name><surname>Hendrickson</surname><given-names>David G</given-names></name><name><surname>Price</surname><given-names>Feodor</given-names></name><name><surname>Rinn</surname><given-names>John L</given-names></name><name><surname>Rubin</surname><given-names>Lee L</given-names></name></person-group><article-title>Genome-Wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy</article-title><source>Cell Stem Cell</source><year>2015</year><month>November</month><day>5</day><volume>17</volume><issue>5</issue><fpage>569</fpage><lpage>84</lpage><pub-id pub-id-type="pmcid">PMC4839185</pub-id><pub-id pub-id-type="pmid">26321202</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2015.08.003</pub-id></element-citation></ref><ref id="R112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Alex HM</given-names></name><etal/></person-group><article-title>A Comprehensive Library of Human Transcription Factors for Cell Fate Engineering</article-title><source>Nature Biotechnology</source><year>2021</year><month>Apr</month><volume>39</volume><issue>4</issue><fpage>510</fpage><lpage>19</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC7610615</pub-id><pub-id pub-id-type="pmid">33257861</pub-id><pub-id pub-id-type="doi">10.1038/s41587-020-0742-6</pub-id></element-citation></ref><ref id="R113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolte</surname><given-names>Christof</given-names></name><etal/></person-group><article-title>Hox Genes: Downstream ‘Effectors’ of Retinoic Acid Signaling in Vertebrate Embryogenesis</article-title><source>Genesis (New York N.Y.: 2000)</source><year>2019</year><month>July</month><volume>57</volume><issue>7–8</issue><elocation-id>e23306</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmid">31111645</pub-id></element-citation></ref><ref id="R114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordström</surname><given-names>Ulrika</given-names></name><name><surname>Maier</surname><given-names>Esther</given-names></name><name><surname>Jessell</surname><given-names>Thomas M</given-names></name><name><surname>Edlund</surname><given-names>Thomas</given-names></name></person-group><article-title>An Early Role for Wnt Signaling in Specifying Neural Patterns of Cdx and Hox Gene Expression and Motor Neuron Subtype Identity</article-title><source>PLOS Biology</source><year>2006</year><month>July</month><day>18</day><volume>4</volume><issue>8</issue><fpage>e252</fpage><pub-id pub-id-type="pmcid">PMC1502144</pub-id><pub-id pub-id-type="pmid">16895440</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0040252</pub-id></element-citation></ref><ref id="R115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novitch</surname><given-names>BG</given-names></name><etal/></person-group><article-title>Coordinate Regulation of Motor Neuron Subtype Identity and Pan-Neuronal Properties by the bHLH Repressor Olig2</article-title><source>Neuron</source><year>2001</year><month>Sept</month><volume>31</volume><issue>5</issue><fpage>773</fpage><lpage>89</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">11567616</pub-id></element-citation></ref><ref id="R116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>Takenori</given-names></name><name><surname>Sakaguchi</surname><given-names>Hideya</given-names></name><name><surname>Miyamoto</surname><given-names>Susumu</given-names></name><name><surname>Takahashi</surname><given-names>Jun</given-names></name></person-group><article-title>Three-Dimensional Induction of Dorsal, Intermediate and Ventral Spinal Cord Tissues from Human Pluripotent Stem Cells</article-title><source>Development (Cambridge, England)</source><year>2018</year><month>July</month><day>30</day><volume>145</volume><issue>16</issue><elocation-id>dev162214</elocation-id><pub-id pub-id-type="pmcid">PMC6124545</pub-id><pub-id pub-id-type="pmid">30061169</pub-id><pub-id pub-id-type="doi">10.1242/dev.162214</pub-id></element-citation></ref><ref id="R117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Hollins</surname><given-names>AJ</given-names></name><name><surname>Wishart</surname><given-names>TM</given-names></name><name><surname>Puddifoot</surname><given-names>CA</given-names></name><name><surname>Álvarez</surname><given-names>S</given-names></name><name><surname>de Lera</surname><given-names>AR</given-names></name><name><surname>Wyllie</surname><given-names>DJA</given-names></name></person-group><article-title>Retinoid-Independent Motor Neurogenesis from Human Embryonic Stem Cells Reveals a Medial Columnar Ground State</article-title><source>Nature Communications</source><year>2011</year><month>March</month><day>1</day><volume>2</volume><issue>1</issue><fpage>214</fpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC3072066</pub-id><pub-id pub-id-type="pmid">21364553</pub-id><pub-id pub-id-type="doi">10.1038/ncomms1216</pub-id></element-citation></ref><ref id="R118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>João D</given-names></name><name><surname>DuBreuil</surname><given-names>Daniel M</given-names></name><name><surname>Devlin</surname><given-names>Anna-Claire</given-names></name><name><surname>Held</surname><given-names>Aaron</given-names></name><name><surname>Sapir</surname><given-names>Yechiam</given-names></name><name><surname>Berezovski</surname><given-names>Eugene</given-names></name><name><surname>Hawrot</surname><given-names>James</given-names></name><name><surname>Dorfman</surname><given-names>Katherine</given-names></name><name><surname>Chander</surname><given-names>Vignesh</given-names></name><name><surname>Wainger</surname><given-names>Brian J</given-names></name></person-group><article-title>Human Sensorimotor Organoids Derived from Healthy and Amyotrophic Lateral Sclerosis Stem Cells Form Neuromuscular Junctions</article-title><source>Nature Communications</source><year>2021</year><month>August</month><day>6</day><volume>12</volume><issue>1</issue><fpage>4744</fpage><pub-id pub-id-type="pmcid">PMC8346474</pub-id><pub-id pub-id-type="pmid">34362895</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-24776-4</pub-id></element-citation></ref><ref id="R119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>MW</given-names></name></person-group><article-title>A New Mathematical Model for Relative Quantification in Real-Time RT-PCR</article-title><source>Nucleic Acids Research</source><year>2001</year><month>Mai</month><day>1</day><volume>29</volume><issue>9</issue><fpage>e45</fpage><pub-id pub-id-type="pmcid">PMC55695</pub-id><pub-id pub-id-type="pmid">11328886</pub-id><pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id></element-citation></ref><ref id="R120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>Missy T</given-names></name><etal/></person-group><article-title>Generation of Human Vascularized Brain Organoids</article-title><source>Neuroreport</source><year>2018</year><month>May</month><volume>29</volume><issue>7</issue><fpage>588</fpage><comment>pmc.ncbi.nlm.nih.gov</comment><pub-id pub-id-type="pmcid">PMC6476536</pub-id><pub-id pub-id-type="pmid">29570159</pub-id><pub-id pub-id-type="doi">10.1097/WNR.0000000000001014</pub-id></element-citation></ref><ref id="R121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohlert</surname><given-names>Thorsten</given-names></name></person-group><source>Calculate Pairwise Multiple Comparisons of Mean Rank Sums Extended</source><year>2023</year><comment>[package:PMCRplus]</comment></element-citation></ref><ref id="R122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname><given-names>F. Ann</given-names></name><etal/></person-group><article-title>Genome Engineering Using the CRISPR-Cas9 System</article-title><source>Nature Protocols</source><year>2013</year><month>Nov</month><volume>8</volume><issue>11</issue><fpage>2281</fpage><lpage>308</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC3969860</pub-id><pub-id pub-id-type="pmid">24157548</pub-id><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id></element-citation></ref><ref id="R123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayon</surname><given-names>Teresa</given-names></name><name><surname>Maizels</surname><given-names>Rory J</given-names></name><name><surname>Barrington</surname><given-names>Christopher</given-names></name><name><surname>Briscoe</surname><given-names>James</given-names></name></person-group><article-title>Single-Cell Transcriptome Profiling of the Human Developing Spinal Cord Reveals a Conserved Genetic Programme with Human-Specific Features</article-title><source>Development (Cambridge, England)</source><year>2021</year><month>August</month><day>1</day><volume>148</volume><issue>15</issue><elocation-id>dev199711</elocation-id><pub-id pub-id-type="pmcid">PMC8353162</pub-id><pub-id pub-id-type="pmid">34351410</pub-id><pub-id pub-id-type="doi">10.1242/dev.199711</pub-id></element-citation></ref><ref id="R124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revah</surname><given-names>Omer</given-names></name><etal/></person-group><article-title>Maturation and Circuit Integration of Transplanted Human Cortical Organoids</article-title><source>Nature</source><year>2022</year><month>Oct</month><volume>610</volume><issue>7931</issue><fpage>319</fpage><lpage>26</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC9556304</pub-id><pub-id pub-id-type="pmid">36224417</pub-id><pub-id pub-id-type="doi">10.1038/s41586-022-05277-w</pub-id></element-citation></ref><ref id="R125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Muela</surname><given-names>Natalia</given-names></name><name><surname>Litterman</surname><given-names>Nadia K</given-names></name><name><surname>Norabuena</surname><given-names>Erika M</given-names></name><name><surname>Mull</surname><given-names>Jesse L</given-names></name><name><surname>Galazo</surname><given-names>Maria José</given-names></name><name><surname>Sun</surname><given-names>Chicheng</given-names></name><name><surname>Ng</surname><given-names>Shi-Yan</given-names></name></person-group><article-title>Single-Cell Analysis of SMN Reveals Its Broader Role in Neuromuscular Disease</article-title><source>Cell Reports</source><year>2017</year><month>February</month><day>7</day><volume>18</volume><issue>6</issue><fpage>1484</fpage><lpage>98</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC5463539</pub-id><pub-id pub-id-type="pmid">28178525</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.01.035</pub-id></element-citation></ref><ref id="R126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Muela</surname><given-names>Natalia</given-names></name><name><surname>Parkhitko</surname><given-names>Andrey</given-names></name><name><surname>Grass</surname><given-names>Tobias</given-names></name><name><surname>Gibbs</surname><given-names>Rebecca M</given-names></name><name><surname>Norabuena</surname><given-names>Erika M</given-names></name><name><surname>Perrimon</surname><given-names>Norbert</given-names></name><name><surname>Singh</surname><given-names>Rajat</given-names></name><name><surname>Rubin</surname><given-names>Lee L</given-names></name></person-group><article-title>Blocking P62-Dependent SMN Degradation Ameliorates Spinal Muscular Atrophy Disease Phenotypes</article-title><source>The Journal of Clinical Investigation</source><year>2018</year><month>July</month><day>2</day><volume>128</volume><issue>7</issue><fpage>3008</fpage><lpage>23</lpage><pub-id pub-id-type="pmcid">PMC6025996</pub-id><pub-id pub-id-type="pmid">29672276</pub-id><pub-id pub-id-type="doi">10.1172/JCI95231</pub-id></element-citation></ref><ref id="R127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russ</surname><given-names>Daniel E</given-names></name><name><surname>Cross</surname><given-names>Ryan B Patterson</given-names></name><name><surname>Li</surname><given-names>Li</given-names></name><name><surname>Koch</surname><given-names>Stephanie C</given-names></name><name><surname>Matson</surname><given-names>Kaya JE</given-names></name><name><surname>Yadav</surname><given-names>Archana</given-names></name><name><surname>Alkaslasi</surname><given-names>Mor R</given-names></name></person-group><article-title>A Harmonized Atlas of Mouse Spinal Cord Cell Types and Their Spatial Organization</article-title><source>Nature Communications</source><year>2021</year><month>September</month><day>29</day><volume>12</volume><issue>1</issue><fpage>5722</fpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC8481483</pub-id><pub-id pub-id-type="pmid">34588430</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-25125-1</pub-id></element-citation></ref><ref id="R128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>Seungmi</given-names></name><name><surname>Weber</surname><given-names>Claire</given-names></name><name><surname>Chu</surname><given-names>Pei-Hsuan</given-names></name><name><surname>Ernest</surname><given-names>Ben</given-names></name><name><surname>Jovanovic</surname><given-names>Vukasin M</given-names></name><name><surname>Deng</surname><given-names>Tao</given-names></name><name><surname>Slamecka</surname><given-names>Jaroslav</given-names></name></person-group><article-title>Stress-Free Cell Aggregation by Using the CEPT Cocktail Enhances Embryoid Body and Organoid Fitness</article-title><source>Biofabrication</source><year>2023</year><month>December</month><day>11</day><volume>16</volume><issue>1</issue><comment>u. a.</comment><pub-id pub-id-type="pmid">37972398</pub-id></element-citation></ref><ref id="R129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagner</surname><given-names>Andreas</given-names></name><name><surname>Briscoe</surname><given-names>James</given-names></name></person-group><article-title>Establishing Neuronal Diversity in the Spinal Cord: A Time and a Place</article-title><source>Development (Cambridge, England)</source><year>2019</year><month>November</month><day>25</day><volume>146</volume><issue>22</issue><elocation-id>dev182154</elocation-id><pub-id pub-id-type="pmid">31767567</pub-id></element-citation></ref><ref id="R130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagner</surname><given-names>Andreas</given-names></name><name><surname>Gaber</surname><given-names>Zachary B</given-names></name><name><surname>Delile</surname><given-names>Julyen</given-names></name><name><surname>Kong</surname><given-names>Jennifer H</given-names></name><name><surname>Rousso</surname><given-names>David L</given-names></name><name><surname>Pearson</surname><given-names>Caroline A</given-names></name><name><surname>Weicksel</surname><given-names>Steven E</given-names></name></person-group><article-title>Olig2 and Hes regulatory dynamics during motor neuron differentiation revealed by single cell transcriptomics</article-title><source>PLoS Biology</source><year>2018</year><month>February</month><day>1</day><volume>16</volume><issue>2</issue><elocation-id>e2003127</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC5811045</pub-id><pub-id pub-id-type="pmid">29389974</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2003127</pub-id></element-citation></ref><ref id="R131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagner</surname><given-names>Andreas</given-names></name><etal/></person-group><article-title>A Shared Transcriptional Code Orchestrates Temporal Patterning of the Central Nervous System</article-title><source>PLOS Biology</source><year>2021</year><month>Nov</month><volume>19</volume><issue>11</issue><elocation-id>e3001450</elocation-id><comment>PLoS Journals</comment><pub-id pub-id-type="pmcid">PMC8612522</pub-id><pub-id pub-id-type="pmid">34767545</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001450</pub-id></element-citation></ref><ref id="R132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>Jasdeep</given-names></name><etal/></person-group><article-title>Cross-talk between Motor Neurons and Myotubes via Endogenously Secreted Neural and Muscular Growth Factors</article-title><source>Physiological Reports</source><year>2021</year><month>Apr</month><volume>9</volume><issue>8</issue><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC8087923</pub-id><pub-id pub-id-type="pmid">33931983</pub-id><pub-id pub-id-type="doi">10.14814/phy2.14791</pub-id></element-citation></ref><ref id="R133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satija</surname><given-names>Rahul</given-names></name><name><surname>Farrell</surname><given-names>Jeffrey A</given-names></name><name><surname>Gennert</surname><given-names>David</given-names></name><name><surname>Schier</surname><given-names>Alexander F</given-names></name><name><surname>Regev</surname><given-names>Aviv</given-names></name></person-group><article-title>Spatial Reconstruction of Single-Cell Gene Expression Data</article-title><source>Nature Biotechnology</source><year>2015</year><month>Mai</month><volume>33</volume><issue>5</issue><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmcid">PMC4430369</pub-id><pub-id pub-id-type="pmid">25867923</pub-id><pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id></element-citation></ref><ref id="R134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>Smita</given-names></name><etal/></person-group><article-title>A Role for Motoneuron Subtype-Selective ER Stress in Disease Manifestations of FALS Mice</article-title><source>Nature Neuroscience</source><year>2009</year><month>May</month><volume>12</volume><issue>5</issue><fpage>627</fpage><lpage>36</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">19330001</pub-id></element-citation></ref><ref id="R135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenwolf</surname><given-names>GC</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name></person-group><article-title>Mechanisms of Neurulation: Traditional Viewpoint and Recent Advances</article-title><source>Development (Cambridge, England)</source><year>1990</year><month>June</month><volume>109</volume><issue>2</issue><fpage>243</fpage><lpage>70</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">2205465</pub-id></element-citation></ref><ref id="R136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaker</surname><given-names>Mohammed R</given-names></name><name><surname>Lee</surname><given-names>Ju-Hyun</given-names></name><name><surname>Kim</surname><given-names>Kyung Hyun</given-names></name><name><surname>Ban</surname><given-names>Saeli</given-names></name><name><surname>Kim</surname><given-names>Veronica Jihyun</given-names></name><name><surname>Kim</surname><given-names>Joo Yeon</given-names></name><name><surname>Lee</surname><given-names>Ji Yeoun</given-names></name><name><surname>Sun</surname><given-names>Woong</given-names></name></person-group><article-title>Spatiotemporal contribution of neuromesodermal progenitor-derived neural cells in the elongation of developing mouse spinal cord</article-title><source>Life Sciences</source><year>2021</year><month>October</month><day>1</day><volume>282</volume><elocation-id>119393</elocation-id><pub-id pub-id-type="pmid">34004249</pub-id></element-citation></ref><ref id="R137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaker</surname><given-names>Mohammed R</given-names></name><name><surname>Lee</surname><given-names>Ju-Hyun</given-names></name><name><surname>Sun</surname><given-names>Woong</given-names></name></person-group><article-title>Embryonal Neuromesodermal Progenitors for Caudal Central Nervous System and Tissue Development</article-title><source>Journal of Korean Neurosurgical Society</source><year>2021</year><month>Mai</month><volume>64</volume><issue>3</issue><fpage>359</fpage><lpage>66</lpage><pub-id pub-id-type="pmcid">PMC8128519</pub-id><pub-id pub-id-type="pmid">33896149</pub-id><pub-id pub-id-type="doi">10.3340/jkns.2020.0359</pub-id></element-citation></ref><ref id="R138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>Christian M</given-names></name><etal/></person-group><article-title>Converging Mechanisms of P53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy</article-title><source>Cell Reports</source><year>2017</year><month>Dec</month><volume>21</volume><issue>13</issue><fpage>3767</fpage><lpage>80</lpage><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC5747328</pub-id><pub-id pub-id-type="pmid">29281826</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.003</pub-id></element-citation></ref><ref id="R139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>Ngaio C</given-names></name><name><surname>Wilkinson-White</surname><given-names>Lorna E</given-names></name><name><surname>Kwan</surname><given-names>Ann HY</given-names></name><name><surname>Trewhella</surname><given-names>Jill</given-names></name><name><surname>Matthews</surname><given-names>Jacqueline M</given-names></name></person-group><article-title>Contrasting DNA-binding behaviour by ISL1 and LHX3 underpins differential gene targeting in neuronal cell specification</article-title><source>Journal of Structural Biology: X 5</source><year>2020</year><month>December</month><day>15</day><elocation-id>100043</elocation-id><pub-id pub-id-type="pmcid">PMC7797366</pub-id><pub-id pub-id-type="pmid">33458649</pub-id><pub-id pub-id-type="doi">10.1016/j.yjsbx.2020.100043</pub-id></element-citation></ref><ref id="R140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sockanathan</surname><given-names>S</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name></person-group><article-title>Motor Neuron-Derived Retinoid Signaling Specifies the Subtype Identity of Spinal Motor Neurons</article-title><source>Cell</source><year>1998</year><month>Aug</month><volume>94</volume><issue>4</issue><fpage>503</fpage><lpage>14</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">9727493</pub-id></element-citation></ref><ref id="R141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soshnikova</surname><given-names>Natalia</given-names></name><name><surname>Dewaele</surname><given-names>Romain</given-names></name><name><surname>Janvier</surname><given-names>Philippe</given-names></name><name><surname>Krumlauf</surname><given-names>Robb</given-names></name><name><surname>Duboule</surname><given-names>Denis</given-names></name></person-group><article-title>Duplications of hox gene clusters and the emergence of vertebrates</article-title><source>Developmental Biology</source><year>2013</year><month>June</month><day>15</day><volume>378</volume><issue>2</issue><fpage>194</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">23501471</pub-id></element-citation></ref><ref id="R142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifani</surname><given-names>Nicolas</given-names></name></person-group><article-title>Motor Neurons and the Generation of Spinal Motor Neurons Diversity</article-title><source>Frontiers in Cellular Neuroscience</source><year>2014</year><month>Oct</month><volume>8</volume><comment>Frontiers</comment><pub-id pub-id-type="pmcid">PMC4191298</pub-id><pub-id pub-id-type="pmid">25346659</pub-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00293</pub-id></element-citation></ref><ref id="R143"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Starbuck</surname><given-names>Craig</given-names></name></person-group><chapter-title>Analysis of Differences</chapter-title><source>The Fundamentals of People Analytics: With Applications in R, herausgegeben von Craig Starbuck</source><year>2023</year><fpage>149</fpage><lpage>79</lpage><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-031-28674-2_9</pub-id></element-citation></ref><ref id="R144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>Benjamin Z</given-names></name><name><surname>Peng</surname><given-names>Lee F</given-names></name></person-group><article-title>Small-Molecule Modulators of the Sonic Hedgehog Signaling Pathway</article-title><source>Molecular bioSystems</source><year>2010</year><month>Jan</month><volume>6</volume><issue>1</issue><fpage>44</fpage><lpage>54</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">20024066</pub-id></element-citation></ref><ref id="R145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuhle</surname><given-names>Lars</given-names></name><name><surname>Wold</surname><given-names>Svante</given-names></name></person-group><article-title>Analysis of Variance (ANOVA)</article-title><source>Chemometrics and Intelligent Laboratory Systems</source><year>1989</year><month>November</month><volume>6</volume><issue>4</issue><fpage>259</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/0169-7439(89)80095-4</pub-id></element-citation></ref><ref id="R146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifani</surname><given-names>Nicolas</given-names></name></person-group><article-title>Motor Neurons and the Generation of Spinal Motor Neuron Diversity</article-title><source>Frontiers in Cellular Neuroscience</source><year>2014</year><volume>8</volume><fpage>293</fpage><comment>PubMed</comment><pub-id pub-id-type="doi">10.3389/fncel.2014.00293</pub-id></element-citation></ref><ref id="R147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Xin-Yao</given-names></name><etal/></person-group><article-title>Generation of Vascularized Brain Organoids to Study Neurovascular Interactions</article-title><source>eLife</source><year>2022</year><month>May</month><volume>11</volume><elocation-id>e76707</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC9246368</pub-id><pub-id pub-id-type="pmid">35506651</pub-id><pub-id pub-id-type="doi">10.7554/eLife.76707</pub-id></element-citation></ref><ref id="R148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmacz</surname><given-names>Beata</given-names></name><name><surname>Fox</surname><given-names>Heather</given-names></name><name><surname>Gutteridge</surname><given-names>Alex</given-names></name><name><surname>Lubitz</surname><given-names>Sandra</given-names></name><name><surname>Whiting</surname><given-names>Paul</given-names></name></person-group><article-title>Directing Differentiation of Human Embryonic Stem Cells Toward Anterior Neural Ectoderm Using Small Molecules</article-title><source>Stem Cells</source><year>2012</year><month>September</month><day>1</day><volume>30</volume><issue>9</issue><fpage>1875</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">22761025</pub-id></element-citation></ref><ref id="R149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swindell</surname><given-names>William R</given-names></name></person-group><article-title>Meta-Analysis of Differential Gene Expression in Lower Motor Neurons Isolated by Laser Capture Microdissection from Post-Mortem ALS Spinal Cords</article-title><source>Frontiers in Genetics</source><year>2024</year><month>Apr</month><volume>15</volume><comment>Frontiers</comment><pub-id pub-id-type="pmcid">PMC11059082</pub-id><pub-id pub-id-type="pmid">38689650</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2024.1385114</pub-id></element-citation></ref><ref id="R150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>G Christopher</given-names></name><etal/></person-group><article-title>Iterative Role of Notch Signaling in Spinal Motor Neuron Diversification</article-title><source>Cell Reports</source><year>2016</year><month>July</month><volume>16</volume><issue>4</issue><fpage>907</fpage><lpage>16</lpage><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="pmcid">PMC4975379</pub-id><pub-id pub-id-type="pmid">27425621</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2016.06.067</pub-id></element-citation></ref><ref id="R151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiago</surname><given-names>Tatiana</given-names></name><etal/></person-group><article-title>Small Heat-Shock Protein HSPB3 Promotes Myogenesis by Regulating the Lamin B Receptor</article-title><source>Cell Death &amp; Disease</source><year>2021</year><month>May</month><volume>12</volume><issue>5</issue><fpage>1</fpage><lpage>19</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC8102500</pub-id><pub-id pub-id-type="pmid">33958580</pub-id><pub-id pub-id-type="doi">10.1038/s41419-021-03737-1</pub-id></element-citation></ref><ref id="R152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tournayre</surname><given-names>Jeremy</given-names></name><name><surname>Reichstadt</surname><given-names>Matthieu</given-names></name><name><surname>Parry</surname><given-names>Laurent</given-names></name><name><surname>Fafournoux</surname><given-names>Pierre</given-names></name><name><surname>Jousse</surname><given-names>Celine</given-names></name></person-group><article-title>‚Do My qPCR Calculation‘, a Web Tool</article-title><source>Bioinformation</source><year>2019</year><volume>15</volume><issue>5</issue><fpage>369</fpage><lpage>72</lpage><pub-id pub-id-type="pmcid">PMC6589476</pub-id><pub-id pub-id-type="pmid">31249441</pub-id><pub-id pub-id-type="doi">10.6026/97320630015369</pub-id></element-citation></ref><ref id="R153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiridis</surname><given-names>Anestis</given-names></name><name><surname>Huang</surname><given-names>Yali</given-names></name><name><surname>Blin</surname><given-names>Guillaume</given-names></name><name><surname>Skylaki</surname><given-names>Stavroula</given-names></name><name><surname>Wymeersch</surname><given-names>Filip</given-names></name><name><surname>Osorno</surname><given-names>Rodrigo</given-names></name><name><surname>Economou</surname><given-names>Costas</given-names></name></person-group><article-title>Distinct Wnt-Driven Primitive Streak-like Populations Reflect in Vivo Lineage Precursors</article-title><source>Development (Cambridge, England)</source><year>2014</year><month>March</month><volume>141</volume><issue>6</issue><fpage>1209</fpage><lpage>21</lpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC3943179</pub-id><pub-id pub-id-type="pmid">24595287</pub-id><pub-id pub-id-type="doi">10.1242/dev.101014</pub-id></element-citation></ref><ref id="R154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzouanacou</surname><given-names>Elena</given-names></name><etal/></person-group><article-title>Redefining the Progression of Lineage Segregations during Mammalian Embryogenesis by Clonal Analysis</article-title><source>Developmental Cell</source><year>2009</year><month>Sept</month><volume>17</volume><issue>3</issue><fpage>365</fpage><lpage>76</lpage><comment>ScienceDirect</comment><pub-id pub-id-type="pmid">19758561</pub-id></element-citation></ref><ref id="R155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urzi</surname><given-names>Alessia</given-names></name><name><surname>Lahmann</surname><given-names>Ines</given-names></name><name><surname>Nguyen</surname><given-names>Lan Vi N</given-names></name><name><surname>Rost</surname><given-names>Benjamin R</given-names></name><name><surname>García-Pérez</surname><given-names>Angélica</given-names></name><name><surname>Lelievre</surname><given-names>Noemie</given-names></name><name><surname>Merritt-Garza</surname><given-names>Megan E</given-names></name></person-group><article-title>Efficient Generation of a Self-Organizing Neuromuscular Junction Model from Human Pluripotent Stem Cells</article-title><source>Nature Communications</source><year>2023</year><month>December</month><day>19</day><volume>14</volume><issue>1</issue><fpage>8043</fpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC10730704</pub-id><pub-id pub-id-type="pmid">38114482</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-43781-3</pub-id></element-citation></ref><ref id="R156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verrier</surname><given-names>Laure</given-names></name><etal/></person-group><article-title>Neural Differentiation, Selection and Transcriptomic Profiling of Human Neuromesodermal Progenitor-like Cells in Vitro</article-title><source>Development (Cambridge, England)</source><year>2018</year><month>July</month><volume>145</volume><issue>16</issue><elocation-id>dev166215</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC6124542</pub-id><pub-id pub-id-type="pmid">29899136</pub-id><pub-id pub-id-type="doi">10.1242/dev.166215</pub-id></element-citation></ref><ref id="R157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>José Ricardo</given-names></name><etal/></person-group><article-title>Endothelial PlexinD1 Signaling Instructs Spinal Cord Vascularization and Motor Neuron Development</article-title><source>Neuron</source><year>2022</year><month>Dec</month><volume>110</volume><issue>24</issue><elocation-id>4074-4089.e6</elocation-id><comment>PubMed</comment><pub-id pub-id-type="pmcid">PMC9796814</pub-id><pub-id pub-id-type="pmid">36549270</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2022.12.005</pub-id></element-citation></ref><ref id="R158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogenstahl</surname><given-names>Johanna</given-names></name><etal/></person-group><article-title>Vascular Regulation of Developmental Neurogenesis</article-title><source>Frontiers in Cell and Developmental Biology</source><year>2022</year><month>Apr</month><volume>10</volume><comment>Frontiers</comment><pub-id pub-id-type="pmcid">PMC9099230</pub-id><pub-id pub-id-type="pmid">35573692</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2022.890852</pub-id></element-citation></ref><ref id="R159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Völkner</surname><given-names>Manuela</given-names></name><etal/></person-group><article-title>HBEGF-TNF Induce a Complex Outer Retinal Pathology with Photoreceptor Cell Extrusion in Human Organoids</article-title><source>Nature Communications</source><year>2022</year><month>Oct</month><volume>13</volume><issue>1</issue><fpage>6183</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC9581928</pub-id><pub-id pub-id-type="pmid">36261438</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-33848-y</pub-id></element-citation></ref><ref id="R160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whye</surname><given-names>Dosh</given-names></name><name><surname>Wood</surname><given-names>Delaney</given-names></name><name><surname>Kim</surname><given-names>Kristina</given-names></name><name><surname>Chen</surname><given-names>Cidi</given-names></name><name><surname>Makhortova</surname><given-names>Nina</given-names></name><name><surname>Sahin</surname><given-names>Mustafa</given-names></name><name><surname>Buttermore</surname><given-names>Elizabeth D</given-names></name></person-group><article-title>Dynamic 3D combinatorial generation of hPSC-derived neuromesodermal organoids with diverse regional &amp; cellular identities</article-title><source>Current protocols</source><year>2022</year><month>October</month><volume>2</volume><issue>10</issue><fpage>e568</fpage><pub-id pub-id-type="pmcid">PMC9589923</pub-id><pub-id pub-id-type="pmid">36264199</pub-id><pub-id pub-id-type="doi">10.1002/cpz1.568</pub-id></element-citation></ref><ref id="R161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>H</given-names></name><etal/></person-group><article-title>The myoD Gene Family: Nodal Point during Specification of the Muscle Cell Lineage</article-title><source>Science (New York, N.Y.)</source><year>1991</year><month>Feb</month><volume>251</volume><issue>4995</issue><fpage>761</fpage><lpage>66</lpage><comment>PubMed</comment><pub-id pub-id-type="pmid">1846704</pub-id></element-citation></ref><ref id="R162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>BL</given-names></name></person-group><article-title>ON THE COMPARISON OF SEVERAL MEAN VALUES: AN ALTERNATIVE APPROACH</article-title><source>Biometrika</source><year>1951</year><volume>38</volume><issue>3–4</issue><fpage>330</fpage><lpage>36</lpage><comment>DOI.org (Crossref)</comment><pub-id pub-id-type="doi">10.1093/biomet/38.3-4.330</pub-id></element-citation></ref><ref id="R163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wichterle</surname><given-names>Hynek</given-names></name><name><surname>Lieberam</surname><given-names>Ivo</given-names></name><name><surname>Porter</surname><given-names>Jeffery A</given-names></name><name><surname>Jessell</surname><given-names>Thomas M</given-names></name></person-group><article-title>Directed Differentiation of Embryonic Stem Cells into Motor Neurons</article-title><source>Cell</source><year>2002</year><month>August</month><day>9</day><volume>110</volume><issue>3</issue><fpage>385</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">12176325</pub-id></element-citation></ref><ref id="R164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>Hadley</given-names></name></person-group><article-title>Tidyverse: Easily Install and Load the ‚Tidyverse</article-title><year>2016</year><month>September</month><day>9</day><pub-id pub-id-type="doi">10.32614/CRAN.package.tidyverse</pub-id></element-citation></ref><ref id="R165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>Hadley</given-names></name><name><surname>Averick</surname><given-names>Mara</given-names></name><name><surname>Bryan</surname><given-names>Jennifer</given-names></name><name><surname>Chang</surname><given-names>Winston</given-names></name><name><surname>McGowan</surname><given-names>Lucy</given-names></name><name><surname>François</surname><given-names>Romain</given-names></name><name><surname>Grolemund</surname><given-names>Garrett</given-names></name></person-group><article-title>Welcome to the Tidyverse</article-title><source>Journal of Open Source Software</source><year>2019</year><month>November</month><day>21</day><volume>4</volume><issue>43</issue><fpage>1686</fpage><comment>u. a.</comment><pub-id pub-id-type="doi">10.21105/joss.01686</pub-id></element-citation></ref><ref id="R166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wimmer</surname><given-names>Reiner A</given-names></name><etal/></person-group><article-title>Human Blood Vessel Organoids as a Model of Diabetic Vasculopathy</article-title><source>Nature</source><year>2019</year><month>Jan</month><volume>565</volume><issue>7740</issue><fpage>505</fpage><lpage>10</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.nature.com">www.nature.com</ext-link></comment><pub-id pub-id-type="pmcid">PMC7116578</pub-id><pub-id pub-id-type="pmid">30651639</pub-id><pub-id pub-id-type="doi">10.1038/s41586-018-0858-8</pub-id></element-citation></ref><ref id="R167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>He Jax</given-names></name><name><surname>Yao</surname><given-names>Yao</given-names></name><name><surname>Yao</surname><given-names>Fenyong</given-names></name><name><surname>Chen</surname><given-names>Jiehui</given-names></name><name><surname>Li</surname><given-names>Meishi</given-names></name><name><surname>Yang</surname><given-names>Xianfa</given-names></name><name><surname>Li</surname><given-names>Sheng</given-names></name></person-group><article-title>Generation of functional posterior spinal motor neurons from hPSCs-derived human spinal cord neural progenitor cells</article-title><source>Cell Regeneration</source><year>2023</year><month>March</month><day>23</day><volume>12</volume><issue>1</issue><fpage>15</fpage><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC10033800</pub-id><pub-id pub-id-type="pmid">36949352</pub-id><pub-id pub-id-type="doi">10.1186/s13619-023-00159-6</pub-id></element-citation></ref><ref id="R168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>Archana</given-names></name><name><surname>Matson</surname><given-names>Kaya JE</given-names></name><name><surname>Li</surname><given-names>Li</given-names></name><name><surname>Hua</surname><given-names>Isabelle</given-names></name><name><surname>Petrescu</surname><given-names>Joana</given-names></name><name><surname>Kang</surname><given-names>Kristy</given-names></name><name><surname>Alkaslasi</surname><given-names>Mor R</given-names></name></person-group><article-title>A cellular taxonomy of the adult human spinal cord</article-title><source>Neuron</source><year>2023</year><month>February</month><day>1</day><volume>111</volume><issue>3</issue><fpage>328</fpage><lpage>344</lpage><elocation-id>e7</elocation-id><comment>u. a.</comment><pub-id pub-id-type="pmcid">PMC10044516</pub-id><pub-id pub-id-type="pmid">36731429</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2023.01.007</pub-id></element-citation></ref><ref id="R169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>F</given-names></name></person-group><article-title>The Analysis of Multiple Classifications with Unequal Numbers in the Different Classes</article-title><source>Journal of the American Statistical Association</source><year>1934</year><month>March</month><volume>29</volume><issue>185</issue><fpage>51</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1080/01621459.1934.10502686</pub-id></element-citation></ref><ref id="R170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Jian</given-names></name><name><surname>Coulouris</surname><given-names>George</given-names></name><name><surname>Zaretskaya</surname><given-names>Irena</given-names></name><name><surname>Cutcutache</surname><given-names>Ioana</given-names></name><name><surname>Rozen</surname><given-names>Steve</given-names></name><name><surname>Madden</surname><given-names>Thomas L</given-names></name></person-group><article-title>Primer-BLAST: A Tool to Design Target-Specific Primers for Polymerase Chain Reaction</article-title><source>BMC Bioinformatics</source><year>2012</year><month>June</month><day>18</day><volume>13</volume><fpage>134</fpage><pub-id pub-id-type="pmcid">PMC3412702</pub-id><pub-id pub-id-type="pmid">22708584</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-13-134</pub-id></element-citation></ref><ref id="R171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Gang</given-names></name><etal/></person-group><article-title>Progress in the Generation of Spinal Cord Organoids over the Past Decade and Future Perspectives</article-title><source>Neural Regeneration Research</source><year>2023</year><month>Sept</month><volume>19</volume><issue>5</issue><fpage>1013</fpage><comment>pmc.ncbi.nlm.nih.gov</comment><pub-id pub-id-type="pmcid">PMC10749595</pub-id><pub-id pub-id-type="pmid">37862203</pub-id><pub-id pub-id-type="doi">10.4103/1673-5374.385280</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Commonly applied paradigms for hiPSC-derived spMN formation mostly produce spMNs with rostral identity</title><p><bold>A.</bold> Scheme showing the commonly used protocol to differentiate hiPSCs into ventral spMNs through the generation of NSCs.</p><p><bold>B.</bold> Immunostained hiPSC-NSC derived 20 day spheres showing immunoreactivity against pMN marker OLIG2 and spMN marker ISL1/2. Scale bar is 200 μM.</p><p><bold>C.</bold> UMAPs projections of 12.637 sequenced cells isolated from hiPSC-NSC derived 20 day spheres, subjected to 10xGenomics-based scRNAseq..</p><p><bold>D.</bold> Dotplot showing LOF2FC of marker gene expression for each cellular cluster that was previously identified in the scRNAseq analysis.</p><p><bold>E.</bold> Confusion matrix of all sequenced cells, showing relative percentage of each cell cluster.</p><p><bold>F.</bold> UMAPs showing early maturation stage of spMNs and neurons within the spinal spheres.</p><p><bold>G.</bold> UMAPs showing axial identity of hiPSC-NSC derived 20 day spheres</p></caption><graphic xlink:href="EMS202387-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>hiPSC-derived NMPs primed by retinoic acid efficiently generate caudal neuroectoderm</title><p><bold>A.</bold> Scheme showing the approach by which hiPSCs were pre-patterned into NMPs.</p><p><bold>B.</bold> Immunostaining of day 4 SB+LDN or CHIR+FGF-2+RA generated aggregates against the NSC marker SOX2 and caudal epiblast marker CDX2.</p><p><bold>C.</bold> Immunostaining of day 4 SB+LDN or CHIR+FGF-2+RA generated aggregates against the mesodermal TBXT and the proneural PAX6.</p><p><bold>D.</bold> qRT-PCR on day 4 spinal spheres generated according to the 4 paradigms shown in (G) showing NMP markers <italic>SOX2</italic>, <italic>TBXT</italic>, <italic>GBX2</italic>, <italic>NT5E</italic>, and <italic>WNT3A</italic> (Unparametric Mann-Whitney-U test, N=2 differentiations with n=1-3 technical replicates, each with 5-10 pooled spheres. Each dot is a technical replicate).</p><p><bold>E.</bold> Representative bright field images of NSC (SB+LDN) and axial progenitor (CHIR+FGF-2+RA) aggregates at day 4. Scale bar, 500 μM.</p><p><bold>F.</bold> Scheme showing NMPs’ bipotency to develop into either neural cells or mesodermal lineages, which is mediated through modulation of WNT and RA pathway activation.</p><p><bold>G.</bold> Scheme showing timeline of different patterning approaches followed to generate spinal spheres.</p><p><bold>H.</bold> qRT-PCR on day 9 spinal spheres generated according to the 4 paradigms shown in (G) showing expression of NSC genes (<italic>PAX6, NES, NKX6.1, SOX2</italic>). (One-way ANOVA with Fishers LSD or unparametric Mann-Whitney-U test N=4 differentiations with n=3 technical replicates, each with 5-10 pooled spheres).</p><p><bold>I.</bold> Gene expression of mesodermal markers (<italic>CXCR4, TBX6</italic>) from similar spheres as in H.</p><p><bold>J.</bold> Gene expression of caudal genes (<italic>FGF8, HOXC9, GDF11, CDX2</italic>) from similar spheres as in H.</p><p><bold>K.</bold> qRT-PCR on day 21 spinal spheres generated according to the 4 paradigms shown in (G) showing caudal HOXs (HOXC6, HOXC9), rostral HOX transcripts (<italic>HOXA5, HOXA7, HOXC4</italic>), and neuronal identity makers (<italic>DCX, MAP2, TUBB3, OLIG2, NKX6.1</italic>). (Unparametric Mann-Whitney-U test, N=2 differentiations with n=1-3 technical replicates, each with 5-10 pooled spheres). For all graphics: Mean+SEM are shown, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic xlink:href="EMS202387-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Neural induction during further caudalization of RA-primed NMPs generates lumbar spMNs</title><p><bold>A.</bold> Patterning protocol screen design for guided differentiation of healthy hiPSC-derived and primed NMPs was conducted. The screen was divided into three modules, according to the sequence of neural induction and caudalization.</p><p><bold>B.</bold> SCOrgs derived from RA-primed NMPs were collected at several time points (day 3, day 9, day 15, day 21) to approximate the neurogenic timeline stage-dependently, and to phenotype neurogenesis rate and axial identity according to the protocol.</p><p><bold>C.</bold> qRT-PCR on several time points (see B), showing <italic>ISL1</italic> transcript levels. (One-way ANOVA with Fishers LSD or unparametric Mann-Whitney-U test. N=3 differentiations with n=3 technical replicates, each with 5-10 pooled spheres. Each symbol represents one sample).</p><p><bold>D.</bold> qRT-PCR on several time points (see B), plotting <italic>CHAT</italic> transcript levels.</p><p><bold>E.</bold> qRT-PCR on day 21 SCOs showing HOX expression. (Unparametric Mann-Whitney U test was used. N=2 differentiations with n=1-3 technical replicates, each with 5-10 pooled SCOs. Each dot represents a technical replicate).</p><p><bold>F.</bold> Representative images of cryosectioned day 21 SCOs immunostained against the spMN marker ISL1 with HOX genes for cervical (HOXA5, violet; thoracic (HOXC9, blue). Scale bar, 200μM.</p><p><bold>G.</bold> Representative images of cryosectioned day 21 SCOs immunostained against the spMN marker ISL1(2) with ventral domain marker NKX6.1(violet), and lumbar HOXC10 (blue). Scale bar, 200μM.</p><p><bold>H.</bold> Quantified immunostaining against cervical <italic>HOXA5</italic>. (Unparametric Kruskal-Wallis test with Uncorrected Dunn's multiple comparison test. N=2-3 differentiations with n=1-4 SCOs per experiment. Each dot represents one organoid).</p><p><bold>I.</bold> Quantified immunostaining against thoracic HOXC9.</p><p><bold>J.</bold> Quantified immunostaining against lumbar HOXC10.</p><p><bold>K.</bold> Quantified immunostaining against ventral NKX6.1.</p><p><bold>L.</bold> Quantified immunostaining against spMN marker ISL1.</p><p><bold>M.</bold> Quantified co-immunostaining against HOXA5, HOXC9, ISL1 for cervical spMNs.</p><p><bold>N.</bold> Quantified co-immunostaining against HOXA5, HOXC9, ISL1 for thoracic spMNs.</p><p><bold>O.</bold> Quantified co-immunostaining against HOXC10, ISL1/2 for lumbar spMNs.</p><p><bold>P.</bold> Representative images from longitudinal high-content live imaging of SCOs derived from BJ-ISL1:P2A::mNG iPSC-Reporter Line at day 3 and day 21, shown for Condition#1 and #3. Cell culture was according to the novel differentiation protocols. Bright field was overlaid with Calcein AM (Orange) to allocate the Isl1-signal to individual SCOs. Scale bar, 2000μM.</p><p><bold>Q.</bold> ISL1-mNeonG fluorescence Intensity (A.U.) by area in the SCOs. (Two-way ANOVA with Fisher's LSD Exact Test. N=2 experiments with n=4 wells per Corning P24 ULA plate. Each well contained between 10-50 SCOs. Each symbol represents the average of related mean fluorescence intensity per time point and protocol across all organoids). Graphics show mean+SEM, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001. *compares #1 with #3. $ compares #1 with #7. # compared #1 with #10.</p></caption><graphic xlink:href="EMS202387-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>An even NMP/NSC mix as a starting stem cell population to generate SCOs results in a balanced specification of rostral and caudal NPCs</title><p><bold>A.</bold> Schematic representation of the experimental design followed to generate SCOs.</p><p><bold>B.</bold> Bright field image of one representative 96-well ULA plate showing spinal spheres 12h after stem cell aggregate formation.</p><p><bold>C.</bold> Immunostaining against caudal CDX2 (yellow) and neural SOX2 (blue) on 50% NSC:50% NMP aggregates at day 0, generated from the BJ-siPS hiPSC line, segregation is shown by the dotted white line. Scale bar, 200μM.</p><p><bold>D.</bold> Immunostaining against the NSC markers SOX2 (yellow) and NESTIN (violet) on day 3, 9 and 15 SCOs made from a BJ-siPS 50% NSC:50% NMP mix subjected to Protocol #3. Scale bar, 200μM.</p><p><bold>E.</bold> Immunostaining against NSC PAX6 (yellow), caudal progenitor NKX2.2 (violet) and lumbar HOXA10 (green) markers on day 3, 9 and 15 SCOs made from a BJ-siPS 50% NSC:50% NMP mix subjected to Protocol #3. Scale bar, 200μM.</p><p><bold>F.</bold> Immunostaining against neural progenitor NGN2 (yellow), pMN OLIG2 (violet) and ventral spinal cord domain NKX6.1 (blue) markers on day 3, 9 and 15 SCOs made from a BJ-siPS 50% NSC:50% NMP mix subjected to Protocol #3. Scale bar, 200μM.</p><p><bold>G.</bold> Quantification of the percentage of SOX2+ NSCs on BJ-siPS 50:50 SCOs subjected to Protocol #3 over time. (Friedman Test with Dunn’s posthoc test. Each dot represents the mean from all organoids of one differentiation batch. Time-points from a batch are connected by a line and have the same colour. N=4 differentiations with n=3-8 SCOs per experiment).</p><p><bold>H.</bold> Quantification of the percentage of PAX6+ NSCs on SCOs generated as in (G).</p><p><bold>I.</bold> Quantification of percentage of counted NGN2+ NSCs on SCOs generated as in (G).</p><p><bold>J.</bold> Quantification of percentage of NX2.2+ pMNs vental-caudal progenitors on SCOs generated as in (G).</p><p><bold>K.</bold> Quantification of percentage of counted OLIG2+ pMNs on SCOs generated as in (G).</p><p><bold>L.</bold> Quantification of percentage of PAX6+:HOXA10+ caudal progenitors on SCOs generated as in (G).</p><p><bold>M.</bold> Quantification of percentage of HOXA10+ cells on SCOs generated as in (G).</p><p><bold>N.</bold> Immunostaining against mature spMN marker ISL1/2 (yellow), immature spMN marker HB9 (violet) and LIM domain factor LHX3 (green) on day 3, 9 and 15 SCOs made from a BJ-siPS 50% NSC:50% NMP mix. Scale bar, 200μM.</p><p><bold>O.</bold> Quantification of percentage of HB9+ spMNs on SCOs generated as in as in (N).</p><p><bold>P.</bold> Quantification of percentage of LHX3+ cells on SCOs generated as in as in (N).</p><p><bold>Q.</bold> Quantification of percentage of ISL1/2+ spMNs on SCOs generated as in as in (N).</p><p><bold>R.</bold> Longitudinal qRT-PCR analysis showing mean LOG2FC expression of <italic>SOX2</italic> gene from day 0 to day 42 in BJ-siPS 50% NSC:50% NMP mix SCOs subjected to Protocol #3. (Friedman Test with Eisinga's correction. Each dot represents one sample from 3-8 pooled SCOs, N=4 experiments. Time-points from a batch are connected by a line and have the same colour).</p><p><bold>S.</bold> Longitudinal qRT-PCR showing mean LOG2FC of <italic>HB9</italic> transcript on SCOs generated as in (S).</p><p><bold>T.</bold> Longitudinal qRT-PCR showing mean LOG2FC of <italic>ISL1</italic> transcript on SCOs generated as in (S).</p><p><bold>U.</bold> Longitudinal qRT-PCR showing mean LOG2FC of <italic>ChAT</italic> transcript on SCOs generated as in (S).</p><p><bold>V.</bold> Longitudinal qRT-PCR showing mean LOG2FC of <italic>MAP2</italic> transcript.</p><p>For all graphics, mean± SEM or LOG2FC ± SEM is shown, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic xlink:href="EMS202387-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>SCOs derived from the mixed stem cell populations are composed by spMNs with high axial heterogeneity (CASCOs)</title><p><bold>A.</bold> Immunostaining against ISL1/2 (yellow), HOXB4 (violet) and HOXC10 (blue) on day 21 BJ-sPS SCOs generated according to three differentiation conditions: 100% NSCs, 100% NMPs, and 50% NSCs:50% NMPs. Scale bar, 200μM.</p><p><bold>B.</bold> Immunostaining against ISL1 (yellow), HOXA5 (violet) and HOXC9 (blue) on day 21 SCOs as in (A).</p><p><bold>C.</bold> Immunostaining against ISL1/2 (yellow), HOXC6 (violet) and HOXA10 (blue) on day 21 SCOs as in (A).</p><p><bold>D.</bold> Quantified co-immunostainings against ISL1/2+; HOXB4+; HOXC10- on day 21 SCOs generated according to three differentiation conditions from three healthy cell lines (BJ-siPS, 1016A, KOLFC1). Hereby, we show hindbrain spMNs. (Violin plots show median and interquartile range. N=4-5 differentiations, n=3-6 SCOs per experiment. Each dot represents one organoid, and is the average cell ratio from n=1-3 imaged cryosections per organoid. Two-way ANOVA with Tukey-Kramer post hoc test and heteroscedastic adjustment). Showing Zooms of CASOs with white arrows indicating two examples for the axial spMN population that was identified. Scale bar in Zooms, 50μM.</p><p><bold>E.</bold> Quantified co-immunostainings showing the percentage of cervical spMNs (ISL1+; HOXA5+; HOXC9-) as in (D).</p><p><bold>F.</bold> Quantified co-immunostainings showing the percentage of brachial spMNs (ISL1/2+ HOXC6+, HOXA10-) as in (D)</p><p><bold>G.</bold> Quantified co-immunostainings showing the percentage of thoracic spMNs (ISL1+; HOXA5+; HOXC9+) as in (D).</p><p><bold>H.</bold> Quantified co-immunostainings showing the percentage of lumbar spMNs (ISL1/2+; HOXB4+; HOXC10+) as in (D).</p><p><bold>I.</bold> Quantified co-immunostainings showing the percentage of lumbar spMNs (ISL1/2+ HOXC6+, HOXA10+) as in (D).</p><p><bold>J.</bold> qRT-PCR analysis on day 21 SCOs generated as in (A) showing <italic>HOXA5</italic> and <italic>HOXA10</italic> transcript levels. (Unparametric Mann-Whitney-U test. Each dot corresponds to one sample obtained from an independent differentiation batch (N=4, n=1) and was generated by pooling 3 SCOs).</p><p><bold>K.</bold> Average scaled percentage of spMNs with specific RC anatomical HOX identity assigned through co-immunostaining of ISL1 and HOX genes. Data from all SCOs analysed from all experiments performed as part of this figure (see L) and cell lines is compiled.</p><p><bold>L.</bold> Pie-Chart with overview of all analysed cryosections from all SCOs as part of this figure (biological replicates).</p><p><bold>M.</bold> Table showing dependence and statistical testing of the factors “spMN patterning” against “starting population of stem cells”.</p><p>For all graphics, LOG2FC, mean±SEM are shown, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic xlink:href="EMS202387-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Inducible vasculature and skeletal muscle are beneficial for neural maturation in CASCOs</title><p><bold>A.</bold> Scheme illustrating the approach followed to generate complex CASCOs from either only unedited hiPSCs (BJ-siPS line) or a mixture of unedited hiPSCs and hiPSCs expressing doxycycline-inducible ETV2 (transcription factor governing vascular endothelial cell specification) and/or hiPSCs expressing doxycycline-inducible MYOD/BAF60C (transcription factors promoting myoblast specification) (inducible tri-lineage organoids).</p><p><bold>B.</bold> Representative immunostaining and magnification (right) against the mature vascular surface marker CD31 (blue) on day 28 complex CASCOs generated from a 100%:iETV2 hiPSCs without and with doxycycline treatment. Note that the CD31+ cells are self-organized in tube–like structures. Scale bar, 200μM. Scale bar of Zoom, 50μM.</p><p><bold>C.</bold> Representative immunostaining against the synaptic markers PSD-95 (violet) and Synaptophysin (yellow) and the endothelial marker FLK1 (green) on day 42 CASCOs and CASCO+iETV2 showing synaptic punctae and endothelial cells. Scale bar, 200μM.</p><p><bold>D.</bold> Magnification of immunostained organoid cryosections using confocal AiryScan showing synaptic staining as in (D). Scale bar, 100μM</p><p><bold>E.</bold> Representative immunofluorescence staining against the neurotrophin BDNF (green) and the mature spMN marker CHAT (orange) on day 42 CASCOs and CASCO+iETV2. Scale bar, 200μM. Scale bar of Zoom, 50μM.</p><p><bold>F.</bold> Distance Map showing the physical separation of PSD-95 (violet) and Synaptophysin (yellow) staining signal, with synaptic punctae following a similar distance-peak pattern.</p><p><bold>G.</bold> Quantification of organoid cryosection area occupied by PSD95 puncta on day 42 BJ-siPS CASCOs and CASCO+iETV2. (One-sided, unpaired t-test with Welch's correction. N=4 independent CASCO-differentiation batches, n=1-3 organoids/experiment. Each dot corresponds to one organoid). See D.</p><p><bold>H.</bold> Quantification of organoid cryosection area occupied by SYP puncta as in (D).</p><p><bold>I.</bold> Quantification of organoid cryosection area occupied by BDNF puncta as in (E).</p><p><bold>J.</bold> Quantification of organoid cryosection area occupied CHAT-staining as in (E).</p><p><bold>K.</bold> Representative immunostaining and magnification (right) against the muscle markers MYOD (yellow) and DESMIN (green) and the pan-neural MAP2 (violet) on day 21 CASCOs generated from a 100% iMYOD/BAF60C hiPSCs in the absence or presence of doxycycline. Scale bar, 200μM.</p><p><bold>L.</bold> qRT-PCR analysis showing endothelial <italic>FLK1</italic> mRNA expression as in (L). from day 42 CASCOs or complex CASCOs+iETV2, CASCOs+iMYOD/BAF60C or CASCOs+iETV2+ iMYOD/BAF60C organoids (Friedman Test with Eisinga's correction. Each dot corresponds to one sample obtained from an independent differentiation batch (N=3, n=1) and was generated by pooling 3 day 42 SCOs).</p><p><bold>M.</bold> qRT-PCR analysis showing muscle marker <italic>DES</italic> mRNA as in (L).</p><p><bold>N.</bold> qRT-PCR analysis showing spMN marker <italic>ISL1</italic> mRNA expression as in (L).</p><p><bold>O.</bold> qRT-PCR analysis showing neurotrophin <italic>BDNF</italic> mRNA expression as in (L).</p><p><bold>P.</bold> qRT-PCR analysis showing pan-neural marker <italic>MAP2</italic> mRNA expression as in (L).</p><p><bold>Q.</bold> qRT-PCR analysis showing <italic>DlG4</italic> mRNA expression (coding for PSD95) as in (L).</p><p><bold>R.</bold> qRT-PCR analysis showing synaptic marker <italic>SYN1</italic> mRNA expression as in (L).</p><p><bold>S.</bold> qRT-PCR analysis showing synaptic marker <italic>HOMER1</italic> mRNA expression as in (L).</p><p><bold>T.</bold> qRT-PCR analysis showing immediate early gene <italic>EGR1</italic> mRNA expression as in (L).</p><p><bold>U.</bold> Renilla luminescence quantification (CellTiter-Glo Luminescent assay) on day 21 CASCOs or complex CASCOs+iETV2, CASCOs+iMYOD/BAF60C or CASCOs+iETV2+ iMYOD/BAF60C organoids (Non-parametric Kruskal-Wallis and uncorrected Dunn's test. N=4 independent differentiations, n=1-2 SCOs per experiment. Each symbol represents one technical.</p><p>For all graphics, mean±SEM is shown, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic xlink:href="EMS202387-f006"/></fig></floats-group></article>